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INTRODUCTION
The interplay between science and the law finds its reflection in
many aspects of legal practice.1  Testing the limits of our scientific
understanding is not an effort unique to patent law.2  Yet, perhaps no
other area besides patent law involves the consideration of the legal
rights to which science itself may be entitled.  In this sense, patent law
stands alone in governing science.  This result, however, is neither
the intended focus of patent law, nor the mission of the United States
Court of Appeals for the Federal Circuit (“Federal Circuit”).3
The goal of the U.S. patent system is to promote innovation to
foster the continued global competitiveness of domestic industries.4
                                                 
1. See Bert Black et al., Science and the Law in the Wake of Daubert:  A New Search for Scientific
Knowledge, 72 TEX. L. REV. 715, 716-53 (1994) (parsing certain ideological underpinnings of
scientific evidence and commenting on the difficulties in bringing scientific knowledge in
accordance with the law).
2. See, e.g., Jessie J. Barr, The Use of DNA Typing in Criminal Prosecutions:  A Flawless
Partnership of Law and Science?, 34 N.Y.L. SCH. L. REV. 485, 491-92 (1989) (commenting on the
difficulty courts face in relying upon illegal evidentiary admissibility standards to incorporate
scientific information in a principled manner); Michael D. Green, Expert Witnesses and Sufficiency
of Evidence in Toxic Substances Litigation:  The Legacy of Agent Orange and Bendectin Litigation, 86
NW. U. L. REV. 643, 645 (1992) (describing scientific methodology and its use in tort litigation);
William J. Madia, A Call for More Science in EPA Regulations, 282 SCI. 45, 45 (Oct. 2, 1998)
(expressing the concern over the perceived lack of credible scientific basis for environmental
regulations).
3. See Steven R. Trybus, Note, Federal Circuit Jurisdiction:  This Court, That Law, 61 CHI.-
KENT L. REV. 731, 737-39 (1985) (reviewing the legislative mandates for the creation of the
Federal Circuit and exploring efforts to ensure that the Federal Circuit did not become an
overly specialized court focusing solely on scientific patent issues); see also Paulik v. Rizkalla, 760
F.2d 1270, 1276, 226 U.S.P.Q. 226, 230 (Fed. Cir. 1985) (observing that the purpose of the
patent system was to advance technological innovation and its economic fruits).
4. See Jens H. Hillen, Note, The Court of Appeals for the Federal Circuit:  Independent Review of
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That science may be called into question during the application of
the patent laws is a natural by-product of the determination whether
a technology event rises to the level of innovation that merits
government protection.  Innocent victim or not, science often
captures the spotlight in such patent considerations.
Reasonable minds may differ as to the best method to ensure that
the patent system remains focused on encouraging innovation, rather
than merely protecting science.  Few, however, would argue against
the proposition that clarity and consistency in patent law
jurisprudence are necessary steps along this path.5  The Federal
Circuit has been an instrumental force in bringing patent law
practice closer to this ideal.6
Since its inception in 1982, the Federal Circuit has sought to
operate in a manner mindful of its legislative purpose, to establish
nationwide uniformity and to improve the administration of the
patent laws.7  Of course, sufficient support exists in the decisions of
the Federal Circuit to allow advocates and critics alike to debate the
court’s success with these goals.8  Nevertheless, most likely would
                                                 
Patent Decisions and the Constitutional Facts Doctrine, 67 S. CAL. L. REV. 187, 189 (1993) (“The
importance of serving the goal of technical innovation is especially important in a time of
disappearing borders and increasing global competition.”).
5. See Howard T. Markey, The Federal Circuit and Congressional Intent, 41 AM. U. L. REV. 577,
579 (1992).  The author writes:
To best serve its critical role in a free society, the law must be understandable,
uniform, reliable, and consistent with the intent of the people’s representatives who
enacted it.  To the maximum extent achievable by human beings, it can fairly be said
that the law entrusted to the Court of Appeals for the Federal Circuit fully meets those
criteria.
Id.
6. See id. at 577 (discussing the Federal Circuit’s success in fulfilling Congress’s desire to
create uniformity in patent law).  Perhaps one of the most misunderstood aspects of Federal
Circuit practice by the patent bar is the frequency of dissenting opinions among the judges.
Such division likely reflects more deliberation than divisiveness on the court.  See Helen Wilson
Nies, Dissents at the Federal Circuit and Supreme Court Review, 45 AM. U. L. REV. 1519, 1527 (1996)
(“[E]specially here at the Federal Circuit . . . dissents are virtually the sole means by which
contradicting positions on the law are presented fully and without personal bias to the Supreme
Court.”).
7. See S. REP. NO. 275, at 2 (1981), reprinted in 1982 U.S.C.C.A.N. 11, 12 (describing
legislative rationale behind the establishment of the Federal Circuit with enactment of Federal
Courts Improvement Act of 1982, Pub. L. No. 97-164, 96 Stat. 25, 37 (codified as amended at 28
U.S.C. § 1295)); Daniel J. Meador, The Origin of the Federal Circuit:  A Personal Account, 41 AM. U.
L. REV. 581, 581 (1992) (discussing national scope of the Federal Circuit in relation to its
establishment); Trybus, supra note 3, at 737-39 (reviewing the legislative mandates for the
creation of the Federal Circuit and exploring the court’s jurisdictional interface with non-
patent matters); see also Howard T. Markey, The State of the Court, 38 AM. U. L. REV. 1093, 1094
(1989) (describing the mission of the Federal Circuit as “[t]he Best Possible Decisions in the
Shortest Possible Time at the Least Possible Cost”).
8. See Victoria Slind-Flor, Federal Circuit Judged Flawed, NAT’L L.J., Aug. 3, 1998, at A1
(discussing criticisms that the courts’ decisions are too ambiguous); see also Robert P. Merges,
Commercial Success and Patent Standards:  Economic Perspectives on Innovation, 76 CAL. L. REV. 805,
806-11 (1988) (evaluating the economic effects on actual technological innovation attributable
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agree with the appraisal that the renewed, if not unprecedented,
prominence of patent rights in the United States owes much to the
Federal Circuit’s intensive efforts during the past seventeen years.9
The ability of commercial enterprise to embrace U.S. patents as
important assets in worldwide market competition depends greatly
upon the value of these legal instruments, which, in turn, depends
upon the court’s reliable patent enforcement.10  If judicial decisions
in patent cases fail to comport with either public appreciation of
technology or established legal paradigms, confidence in the patent
system can erode.11  The duality of these concerns creates a tension
that the legal framework charged with the predictable enforcement
of patents may find itself incapable of resolving with satisfaction.12
In an attempt to enhance clarity and consistency in patent law
jurisprudence, the Federal Circuit adheres to specific standards of
review over the decisions of its lower tribunals.13  In so doing, the
Federal Circuit establishes an internal control mechanism in its
operation.14  Moreover, the Federal Circuit provides a set of guiding
principles to encourage more effective advocacy of patent-related
cases well in advance of appeal.15
                                                 
to the rewards for invention disclosures offered by the U.S. patent system).
9. See Markey, supra note 7, at 1094 (discussing the internal measures employed by the
Federal Circuit to achieve uniformity in patent law).
10. See Pauline Newman, The Federal Circuit - A Reminiscence, 14 GEO. MASON L. REV. 513,
519 (1992) (“The predictability that patents improvidently granted will be held invalid is of no
less interest to us as manufacturers and purveyors of goods than the predictability that patents
will be held valid if they represent proper protection of a valuable investment in innovative
technology.”).
11. See Paul R. Michel, The Challenge Ahead:  Increasing Predictability in Federal Circuit
Jurisprudence for the New Century, 43 AM. U. L. REV. 1231, 1245 (1994) (“Greater dissonance,
however, may occur between some of our decisions and technological, economic, or industrial
reality.  That reality, which is a means for measuring the practical effects of a given ruling, is
usually missing from our records and, therefore, from our minds.”); Pauline Newman, On
Global Patent Cooperation, Address Before the Fifth Annual Conference on Intellectual
Property Law and Policy (Apr. 3, 1997), in 8 FORDHAM INTELL. PROP. MEDIA & ENT. L.J. 3, 9
(1997).  In her address, Pauline Newman notes that:
As more and more industry of all nations moves into the international marketplace,
the economic consequences of international patent disputes will become more
pervasive. . . .  Ideally a commercial law would be sufficiently comprehensive that its
application raises no uncertainty. . . .  However, the areas in which these uncertainties
arise are—it seems to me—matters not of national policy, but of technologic
understanding.
Id.
12. See Michel, supra note 11, at 1243 (discussing how shifting paradigms in patent law may
paralyze the business community and impede progress).
13. See infra Part II.B (discussing the standards of review followed by the Federal Circuit).
14. See Glenn L. Archer, Jr., Conflicts and the Federal Circuit, 29 J. MARSHALL L. REV. 835, 836-
37 (1996) (reviewing procedural mechanisms employed by the Federal Circuit to ensure
consistency and clarity in the law).
15. See Paul R. Michel & Dr. Michelle Rhyu, Improving Patent Jury Trials, 6 FED. CIR. B.J. 89,
93-102 (1996) (proposing improvements to the administration of patent jury trials, including
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On the other hand, the standards of review followed by the Federal
Circuit appear to have vested the court with increasing authority to
conduct plenary reviews of lower tribunal decisions.16  Some of these
new standards arose in the context of determining the proper roles
of the judge and jury at trial.17  Of course, in considering certain
inquiries as pure questions of law, the Federal Circuit gained greater
latitude to step back from rulings made by the U.S. district courts and
the U.S. Patent and Trademark Office (“USPTO”).
In addition, the Federal Circuit recently upheld its historical
standard of review of USPTO factual findings.18  Setting aside other
concerns about judicial activism by the appellate court, such an
expanding scope of review arguably creates a greater opportunity for
the Federal Circuit to engage in substantive analysis of the science
underlying patent-related cases.19  The potential consequences of
these forays into science by the federal judiciary, and specifically by
the Federal Circuit, is the crux of recent controversies involving the
interface between science and patent law.20
This Article addresses the difficulty at times in finding justice in the
patent law decisions of the Federal Circuit in the face of apparent
misapplications, or seemingly intentional ignorance, of otherwise
accepted scientific or engineering principles.  Part I discusses the
confusion the casual observer might encounter when studying such
decisions without an appreciation of the standards of review that
dictate the Federal Circuit’s resolution of an appeal.21  In Part II, the
                                                 
comprehensible jury instructions, special verdicts, and interrogatories).
16. See Markman v. Westview Instruments, Inc., 52 F.3d 967, 979, 34 U.S.P.Q.2d (BNA)
1321, 1329 (Fed. Cir. 1995) (en banc), aff’d, 517 U.S. 370 (1996) (holding that interpretation of
the meaning and scope of a patent claim is a legal question which the Federal Circuit reviews
without deference to the determination of the district court); infra notes 149-83 and
accompanying text (discussing Markman in greater detail).
17. See Markman, 52 F.3d at 979, 34 U.S.P.Q.2d (BNA) at 1329 (discussing the relative
duties of jury and judge in patent cases).
18. See In re Zurko, 142 F.3d 1447, 46 U.S.P.Q.2d (BNA) 1691 (Fed. Cir. 1997) (en banc),
rev’d, 119 S. Ct. 1816 (1999) (finding clearly erroneous a decision of the Board of Patent
Appeals and Interferences, which held that the claims in the patent application were obvious);
see also infra Part II.B.
19. Whether one perceives an individual or collective effort by the Federal Circuit to
engage in technological adjudication, the fact remains that panels are assigned randomly,
irrespective of the technical subject matter of the appeal.  See Helen W. Nies, Celebrating the
Tenth Anniversary of the United States Court of Appeals for the Federal Circuit, 14 GEO. MASON L. REV.
505, 505-06 (1992) (embracing the practice of assignment of cases at the Federal Circuit blindly
rather than on the basis of individual judge’s prior professional and judicial experience).
20. See Pauline Newman, The Sixth Abraham L. Pomerantz Lecture:  Commentary on the Paper by
Professor Dreyfuss, 61 BROOK. L. REV. 53, 62 (1995) (indicating that the Federal Circuit rarely has
reviewed the technologic substance of patent cases, and stating that “[a] concerned public is
the best guardian of not only the accuracy of the law, but of whether the court adequately
understands and implements the social policy underlying the law”).
21. See infra Part I (discussing the sources of conflict between scientific and legal
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Article considers several significant cases, including Dickinson v. Zurko,
in which the Federal Circuit struggles with questions about the
appropriate standard of review.22  The Article concludes in Part III
with a survey of the applicable standards of review by the Federal
Circuit on various specific patent law issues.  Through this review, the
Article seeks to facilitate a more balanced consideration of the patent
law decisions of the Federal Circuit in hopes of reaching a better
understanding of otherwise suspect holdings from a scientific validity
perspective.
I. THE PATENT (TECHNOLOGY) COURT MISNOMER
The historical relationship between science and the law generally
has been less than cooperative at times.23  In the patent law arena, the
perceived dissociation of scientific truth and physical laws from
justice in the courts can leave the parties to the litigation, and
interested spectators alike, with an incredulity usually reserved for
seemingly ill-founded criminal acquittals.
Indeed, the significance of the doctrinal rift between science and
the law has not been lost on the jurists charged with the efficient
administration of the patent laws.24  For example, Judge Newman of
the Federal Circuit commented:
The shaping of the patent law is to an exceptional degree in the
hands of the judiciary, for in patent cases a relatively simple
statutory law is applied to an extraordinary complexity of factual
circumstances.  These encompass the entire range of mechanical,
electronic, biological, and chemical subject matter.  The
entrepreneurial and creative vigor of the nation’s technology is
metered by the system of laws governing patents.  Review of the
history of patent law over the economic cycles of the nation, indeed
over the nation’s evolution from an agricultural to an industrial
economy, shows the judiciary reflecting in its patent decisions a
variety of perceptions of the place of patents in the nation’s
                                                 
principles).
22. See infra Part II (reviewing relevant case law and recent decisions of the Federal
Circuit).
23. See Black, supra note 1, at 716 (stating that “[j]udges and lawyers usually react to
science with all the enthusiasm of a child about to get a tetanus shot”).  Indeed, the issues of
legal proof and accepted scientific tenets have whipped up dramatic tempests in criminal
courtrooms.  See generally PETER W. HUBER, GALILEO’S REVENGE:  JUNK SCIENCE IN THE
COURTROOM (1991).
24. See Howard T. Markey, Jurisprudence or “Juriscience”?, 25 WM. & MARY L. REV. 525, 526
(1984) (opining that “[s]cience and the law are inherently and irreconcilably different”);
Pauline Newman, The Federal Circuit:  Judicial Stability or Judicial Activism?, 42 AM. U. L. REV. 683,
688 (1993) (recommending a simplified approach to science and the law and asserting that
undue complexity is often reflective of insufficient understanding).
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economy.  Although there was often manifest prescience and great
wisdom, increasingly, mirroring society, there appears to have been
a failure of the “two cultures” of law and science to understand
each other.  Today we cannot afford this gap, for scientific
knowledge and technologic issues underlie large segments of
modern jurisprudence, as well as of our economy.25
Where the Federal Circuit is concerned, the potential outcry in this
respect may be heightened for reasons beyond its control.  Even
before its creation, the Federal Circuit seemed burdened with the
label of specialization as either the Patent Court or the Technology
Court, a notion the court has taken great efforts to dispel.26
To be certain, public perception easily could find support in the
apparent operation of the Federal Circuit.  With exclusive jurisdiction
of patent appeals from federal courts nationwide and a judicial staff
heavily loaded with individuals trained in various technical
disciplines, the Federal Circuit seems outfitted for such a role,
whether or not formally tasked with this responsibility.  Despite the
handling of cases of arguably equivalent legal and technical
complexity, the regional circuit courts of appeals typically cannot lay
claim to such workload or staff compositions.27
In any event, a public perception of the mission of the Federal
Circuit with respect to patent-related cases apparently includes the
advancement of social policy involving the encouragement of
continued private investment in research and development to ensure
global competitiveness of U.S. companies.28  In an era of relative
economic prosperity, the patent system risks increased public scrutiny
over the ease of patent procurement in conjunction with overly broad
patent enforcement.29  Simply stated, in good times, doubts usually
                                                 
25. Newman, supra note 24, at 685-86.
26. See Randall R. Rader, Specialized Courts:  The Legislative Response, 40 AM. U. L. REV. 1003,
1004-06 (1991) (reviewing the concerns voiced by legislators during the development of the
Federal Circuit against the creation of a specialized court).
27. See Hillen, supra note 4, at 215-18 (noting the fundamental legal goals of consistency
and coherence in implementing social policy and the difficulties faced by an arguably
specialized court in achieving these goals).
28. See Lawrence G. Kastriner, The Revival of Confidence in the Patent System, 73 J. PAT &
TRADEMARK OFF. SOC’Y 5, 5 (1991) (commenting that the patent system “has always been an
integral part of the social and economic fabric of this nation”); Gerald Sobel, The Court of
Appeals for the Federal Circuit:  A Fifth Anniversary Look at Its Impact on Patent Law and Litigation, 37
AM. U. L. REV. 1087, 1092 (1988) (noting that heightened patent protection by the Federal
Circuit reflects a broad judicial movement toward greater protection of technological
development and innovation).
29. See Teresa Riordan, A Growing Fear That Internet Patents Threaten to Undermine the Very
Nature of the On-Line World, N.Y. TIMES, Feb. 22, 1999, at C11 (“The United States Patent and
Trademark Office has begun to issue a spate of patents that were applied for several years ago
when the Internet was just becoming commercially viable.  Some fear that these patents
threaten the very architecture underlying the on-line world.”).
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recur over the conventional wisdom that aggressive patent protection
is a necessary incentive to continue the strive for innovation.30
Moreover, such concerns typically arise in connection with assertions
that a strong patent system may actually inhibit innovation.31
When popular sentiment begins to sway against patent protection,
one target of criticism is often an alleged disconnect between
government action and the needs of commercial enterprise.32  With
the USPTO arguably issuing patents with seemingly overbroad
generic claims and the federal courts enforcing such claims, public
dissatisfaction can arise over their respective failures to appreciate
whether the particular technology events qualify as true innovation.33
Furthermore, such charges may be based solely upon an asserted lack
of ability of the legal arbiter to determine scientific truth or merit.
In the context of patent validity, enforceability, and infringement
determinations, the purely technical aspects of an invention often
come into play.  In particular, comparative evidence regarding the
technology typically drives the ultimate resolution of patent issues
such as novelty, inventorship (including priority), and infringement.
                                                 
30. Cf. Thomas H. Case & Scott R. Miller, An Appraisal of the Court of Appeals for the Federal
Circuit, 57 S. CAL. L. REV. 301, 325 (1984) (assessing the specialization of the Federal Circuit
and discounting the court’s impact on increasing American industrial innovation in light of its
ability to stabilize patent law).
31. Indeed, such a sentiment has been a longstanding criticism of the patent system and
the Federal Circuit’s role in its administration, an image the court has consistently rebuffed.
Compare Thomas G. Field, Jr., ‘Zurko’ Raises Issue of Patentability Standards, NAT’L L.J., Feb. 8,
1999, at C2 (“Because the invalidity rate is now lower than it was between the 1930s and the
1960s, some suspect federal circuit judges, even those not formerly on the CCPA, of being
unduly ‘pro-patent.’  Former corporate patent counsel seem to be particularly suspect.”), with
Markey, supra note 5, at 579 (“[T]he uninformed, unsupported, and unsupportable assertion
that the Federal Circuit might somehow become biased in favor of patents has apparently by
now foundered on the facts.”).  See also John Greenwood, Fields of Broken Dreams:  Agricultural
Biotechnology Holds the Promise of Modern Miracles in Food Production or Pharmaceuticals, NAT’L POST,
Oct. 29, 1998, at C12 (“In the wild-west world of agricultural biotech, it’s called patent chill—
the fear that the product you are developing infringes on someone else’s patent. . . .  Over the
past few years, virtually every company in the sector, large and small, has had a brush with it. . . .
And, observers say, because of patent chill, many [small, development companies] are in
danger of losing momentum.”).
32. See Joan E. Schaffner, Patent Preemption Unlocked, 1995 WIS. L. REV. 1081, 1089-91, 1127
(analyzing Lockean property principles as theoretical underpinnings of the United States
patent system and considering the potential impairment to innovative progress posed by an
improper balance of the property domain and the common).
33. See Allan N. Littman, Federal Circuit Rulings Damage Patent Law, NAT’L L.J., Jan. 18, 1999,
at A26.  The author states that:
The U.S. Court of Appeals for the Federal Circuit has drastically weakened judicial
safeguards against invalid patents.  A significant number of the more than 100,000
U.S. patents issued every year are invalid.  They have not met the statutory standards
for patents.  They deter true invention, and, unless invalidated by judicial decisions,
they subvert the patent system.
Id.; see also Newman, supra note 10, at 519 (“Industry is concerned not only with patent rights on
its own products, but also with the opportunity to ‘invent around,’ to improve upon, and
compete with, the patented products of others.”).
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In contrast, other inquiries like nonobviousness34 and patent damages
usually involve marketplace considerations beyond the true scientific
merit of the subject matter.35  As such, the first set of issues arguably
speaks only to the invention, whereas the second set actually
addresses the innovation attributable to that invention.  In this sense,
patent law treats science apart from innovation, but embraces both as
important concerns to implement the social policy of fostering
technological progress.
Despite the Federal Circuit’s view that it should not adjudicate
scientific principles, the public may have a different perception.36  In
more established technical fields, such as the engineering arts, the
underlying physical precepts often have not demanded rigorous
explanation by the Federal Circuit.  In newer or rapidly developing
technologies, such as biotechnology and computer software, the
Federal Circuit has taken great pains to provide detailed primers on
the relevant technical matters.37  Such descriptions in precedential
opinions, however, may give rise to controversies where the state of
the art is unsettled or quickly rendered obsolete.38
A. Schendel v. Curtis
The Federal Circuit itself is not immune to internal conflict about
the degree to which its decisions may be driven improperly by the
                                                 
34. See infra notes 393-402 and accompanying text (stating that patent protection is
afforded to nonobvious inventions only).
35. One commentator has noted that:
[T]he increasing importance given to these nontechnical indicia of nonobviousness
can be interpreted as an effort by the CAFC to move the trial courts away from a
consideration of the technical merits of an invention, which they may be unqualified
or underqualified to consider, toward an analog of specialized jury interrogatories,
which the CAFC may more easily review and reinterpret.  The secondary
characteristics are meant to provide a trial court with nontechnical means by which to
assess nonobviousness.
Hillen, supra note 4, at 199-200.
36. See Markey, supra note 24, at 540 (proposing rules for technological adjudication,
which include “Rule IV:  The Parties Shall Not Present Unanswerable Scientific Questions for
Decisions” and “Rule V:  The Court Shall Not Attempt to Decide ‘Scientific Truth’”).
37. See Amgen, Inc. v. Chugai Pharm. Co., 927 F.2d 1200, 1203, 18 U.S.P.Q.2d (BNA) 1016,
1017 (Fed. Cir.) (providing detailed technical background on a method for producing
erythropoietin, the subject of the patent litigation), cert. denied, 502 U.S. 856 (1991); see also In re
O’Farrell, 853 F.2d 894, 895-99, 7 U.S.P.Q.2d (BNA) 1673, 1674-79 (Fed. Cir. 1988) (providing
technical explanation of a genetic engineering invention).
38. See Philippe Ducor, Recombinant Products and Nonobviousness:  A Typology, 12 COMP. &
HIGH TECH. L.J. 1, 67 (1997) (indicating that the patent law rationales underlying established
technologies, such as traditional chemistry, may not extend validly to more recent
developments, like recombinant DNA inventions); see also Dow Chem. Co. v. American
Cyanamid Co., 816 F.2d 617, 623, 2 U.S.P.Q.2d (BNA) 1350, 1355-56 (Fed. Cir. 1987) (Davis, J.,
dissenting) (disagreeing with the conclusion reached by the majority because the chemical
process at issue was substantially the same as that in a previous unrelated case on a different
patent).
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court’s own view of the scientific merit of the subject matter.  Perhaps
one of the more revealing examples is the Schendel v. Curtis decision,39
where a Federal Circuit panel disagreed on the impact that certain
scientific tests should have had on the outcome of the case.40
The Schendel case involved an appeal from the decision of the
USPTO Board of Patent Appeals and Interferences, which granted
summary judgment in favor of Curtis in a patent interference
proceeding.41  The subject matter of the interference count related to
a fusion protein of interleukin-3 (IL-3) and a hematopoietin, which
could be granulocyte colony stimulating factor (G-CSF) or
granulocyte-macrophage colony stimulating factor (GM-CSF).42
Schendel alleged priority of invention based on his alleged actual
reduction to practice of an IL-3/G-CSF fusion protein before Curtis’
effective patent application filing date.43
The Federal Circuit, in a split decision, upheld the Board’s ruling
that Schendel’s evidence failed to show that he had obtained an IL-
3/G-CSF fusion protein.44  Although the scientific evidence and
declarations apparently indicated that Schendel had isolated material
having the respective biological activities of IL-3 and G-CSF, there was
no showing that this material constituted an actual fusion protein.45
In particular, the absence of any chemical composition or structural
data, such as a relatively simple molecular weight determination,
appeared significant to the ultimate resolution of the case.46
                                                 
39. 83 F.3d 1399, 38 U.S.P.Q.2d (BNA) 1743 (Fed. Cir. 1996).
40. See id. at 1406, 38 U.S.P.Q.2d (BNA) at 1750 (Newman, J., dissenting) (contending that
the majority acted improperly in deciding that the scientific record was insufficient, especially
when the scientists themselves deemed the evidence sufficient).  The judges of the Federal
Circuit have often embraced panel conflicts as a vital component of effective decision making.
See, e.g., Newman, supra note 24, at 683 (“In meeting the court’s responsibilities in each area of
the law assigned to it, the occasional ‘percolation’ of divergent views illustrates the vigor of the
judicial search for truth, the sometimes indirect progress toward the justice and fairness that
animate the law.”); Nies, supra note 6, at 1527 (noting the importance of dissenting opinions by
the Federal Circuit to the development of the law).
41. See Schendel, 83 F.3d at 1400-01, 38 U.S.P.Q.2d (BNA) at 1744 (discussing the Board’s
decision to grant summary judgment in favor of Curtis because Schendel did not adequately
establish that he had been able to reduce his claimed fusion protein to practice before Curtis
filed its patent application).
42. See id. at 1400 & n.3, 38 U.S.P.Q.2d (BNA) at 1744 & n.3 (explaining the creation of
fusion protein as part of recombinant DNA technology).
43. See id. at 1401, 38 U.S.P.Q.2d (BNA) at 1744 (outlining Schendel’s claims before the
Board of Patent Appeals and Interferences).
44. See id. at 1404, 38 U.S.P.Q.2d (BNA) at 1747.
45. See id., 38 U.S.P.Q.2d (BNA) at 1747.
46. See id., 38 U.S.P.Q.2d (BNA) at 1747 (“[W]ithout any molecular weight or other
probative data relevant to the composition or structure of the molecule he allegedly prepared,
there is insufficient evidentiary support for Schendel’s conclusory assertion that he made a . . .
fusion protein.”) (citations omitted).
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Judge Newman disagreed with the majority decision.47  In her
dissent, she stated:
Determination of whether the evidence is sufficient to make a
prima facie showing that Schendel produced what he said he
produced must be based on objective scientific standards, from the
viewpoint of the scientists in the field of the invention.  It is thus
relevant whether the fusion reaction was scientifically routine and
reliable, or exotic and unreliable; whether the bioassays were
scientifically routine and professionally performed, or whether they
were unusual or performed by amateurs.  All of the procedures and
data together present a prima facie case that Dr. Schendel had
produced the molecule of the count.  There was no contrary
evidence.  Although our standard of review of the Board’s grant of
summary judgment is plenary, at this stage of the proceedings
neither the Board nor we can weigh evidence; to the contrary,
reasonable factual inferences must be drawn in favor of the party
Schendel.  It is not our appellate role to devise experiments that
the inventor did not deem it necessary to conduct, and then to
hold that the judges’ choice of experiments is dispositive of the
issue.48
The panel majority, however, noted that the decision turned not
on the merits of the scientific evidence, but on the rulings of the
lower tribunal as upheld by the Federal Circuit under the proper
standard of review.49  In particular, the majority indicated:
The dissent runs through all the data presented by Schendel and
ends up concluding that “the analytical data confirmed that the
expected linked product was obtained.”  That there were no
analytical data is the nub of this case.  The import of the dissent’s
extensive analysis of the facts is that the identity of the claimed
product was proved and that the court has improperly assumed an
“appellate role to devise experiments that the inventor did not
deem it necessary to conduct.”
As an appellate court, we are affirming the judgment of the
expert agency because the agency did not apply an incorrect
standard and did not make clear error in its evaluation of facts.
Rather than weighing evidence and devising further experiments,
we are affirming the board’s determination that Schendel did not
establish the structure or identity of the product of the count.
                                                 
47. See id. at 1406, 38 U.S.P.Q.2d (BNA) at 1749 (Newman, J., dissenting) (concluding that
the evidence was “prima facie probative of conception and reduction to practice of the subject
matter of the count”).
48. Id., 38 U.S.P.Q.2d (BNA) at 1751-52.
49. See id. at 1404 n.8, 38 U.S.P.Q.2d (BNA) at 1749 n.8 (affirming that the expert agency
applied the correct standard of review).
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Whether we might agree, as nonexperts, that Schendel may have
obtained the product is not the point.  Even a prima facie case
requires some real proof, not just vague inference, based on
surrounding circumstances that tangentially support the inventor’s
goal.  The question here is whether Schendel proved, irrespective
of whether that proof was corroborated, that use of his starting
gene fragments resulted in the synthesis of the fusion protein.  We
conclude that the PTO did not err in holding that he did not.50
B. In re Soni
In In re Soni,51 the Federal Circuit reversed the decision of the
USPTO Board of Patent Appeals and Interferences, which upheld the
patent examiner’s final rejection of the claims as obvious.52  The
subject matter of the application involved conductive polymer
compositions.53  In rebuttal to the patent examiner’s rejection of the
claims as prima facie obvious, Soni argued that the claimed
compositions exhibited unexpectedly improved physical and
electrical properties compared to lower-weight prior art
compositions.54  Soni’s contention failed to persuade the patent
examiner or the Board.55
The Board specifically noted that Soni’s position was unsupported
by any data.56  The Federal Circuit disagreed, relying on specific data
in Soni’s specification showing improved properties.57  The Federal
Circuit held that absent evidence to the contrary, an applicant’s
assertion of surprise supported with a showing of substantially
improved results suffices to establish unexpected results.58  Given
Soni’s duty of candor, and the absence of a sound basis to question
Soni’s assertion, the Federal Circuit held that the Board clearly erred
in finding that Soni did not establish unexpected results.59
                                                 
50. Id., 38 U.S.P.Q.2d (BNA) at 1748 n.8.
51. 54 F.3d 746, 34 U.S.P.Q.2d (BNA) 1684 (Fed. Cir. 1995).
52. See id. at 748-49, 34 U.S.P.Q.2d (BNA) at 1685-86.
53. See id. at 747-48, 34 U.S.P.Q.2d (BNA) at 1685.  The application at issue was U.S. Patent
Application Serial No. 07/462,893.  See id., 34 U.S.P.Q.2d (BNA) at 1685.
54. See id. at 748, 34 U.S.P.Q.2d (BNA) at 1685 (noting distinctions between appellant’s
patent claims and other polymer compositions).
55. See id. at 748, 34 U.S.P.Q.2d (BNA) at 1685 (reviewing examiner’s rejection of claims 1-
6, 8-12, and 21 under 35 U.S.C. §§ 102-103).
56. See id. at 749, 34 U.S.P.Q.2d (BNA) at 1686 (“That which appellants characterize as
‘evidence’ consists of conclusory statements . . . which . . . are unsupported by any factual data.”)
(citations omitted).
57. See id. at 750, 34 U.S.P.Q.2d (BNA) at 1687 (concluding that the Board erred in
deciding that appellant’s evidence were merely conclusory statements).
58. See id. at 749-51, 34 U.S.P.Q.2d (BNA) at 1687-88 (noting that a showing of
“unexpected results” allows a patent applicant to rebut a presumption of obviousness that exists
between similar compositions).
59. See id. at 751, 34 U.S.P.Q.2d (BNA) at 1688 (concluding that the USPTO established a
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One member of the Soni panel expressed concern that the failure
of the court to articulate patentability standards with specificity might
result in the otherwise unnecessary adjudication of the scientific
merits.60  In his dissent, Judge Michel stated:
[P]erhaps the majority means to say, more generally, that
examiners, Board members, and Federal Circuit judges will know
“substantial” improvements when they see them.  Disagreements
among these evaluators are, of course, inevitable, and will likely be
frequent.  This reading, though less perplexing, would have far
broader implications:  unhindered by any objectively established
baseline of expected improvement in the relevant art, the
assessment of an applicant’s unsupported assertion that the
observed degree of improvement was unexpected can flex to suit
the taste of the assessor, thus destabilizing the obviousness inquiry
and virtually ensuring litigation through final appeal to us in most
every case of allegedly unexpected improvement.  The resulting
loss of objectivity and predictability bodes ill for patentability
determinations.61
The Schendel and Soni cases illustrate the problematic nature of
deciding patent-related issues where the ultimate conclusion rests on
a critique of the underlying science.62  On the other hand, these cases
also show the arguable amelioration of any disjuncture facilitated by
the faithful application by the Federal Circuit of the appropriate
standard of review.63
Recent changes in the patent law paradigm would appear to
represent the initial evolution toward minimizing the frequency that
the federal courts would need to engage in debates about the
underlying scientific principles.64  In this regard, the Federal Circuit
has increasingly admonished the patent bar regarding its duty to
notify the public about patent claims.65  Echoing this sentiment, the
                                                 
prima facie case, the applicant responded, and the USPTO failed to adequately challenge the
applicant’s response).
60. See id. at 755, 34 U.S.P.Q.2d (BNA) at 1692 (Michel, J., dissenting) (“[T]he majority’s
new rule may be inherently unworkable.  For example, one may well ask how large
improvements in results must be before the Board must consider them to be ‘substantially
improved results’ such that they amount to an effective rebuttal of a prima facie case of
obviousness.  The majority provides no guidance on the question . . . .”) (citations omitted).
61. Id. at 755, 34 U.S.P.Q.2d (BNA) at 1692 (Michel, J., dissenting).
62. See supra note 60 and accompanying text (discussing the difficulty judges will have in
adjudicating patent disputes without clear standards).
63. See Schendel v. Curtis, 83 F.3d 1399, 1406 n. 8, 38 U.S.P.Q.2d 1734, 1748 n.8 (Fed. Cir.
1996) (noting that the appellate court’s responsibility is to determine whether the agency
applied the correct standard of review, not to evaluate the scientific evidence itself).
64. See infra note 65 and accompanying text (discussing the policy trend to inform the
public about recently filed technology patents).
65. See Litton Sys., Inc. v. Honeywell, Inc., 145 F.3d 1472, 1474, 47 U.S.P.Q.2d (BNA) 1106,
1108 (Fed. Cir. 1998).  In Litton, the Federal Circuit set forth the social policy rationale for the
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Supreme Court has set out new law in two substantive patent law
issues, which essentially place a greater burden on those seeking
patent protection to explain the technology and its potential
significance to patentability.66
C. Vitronics Corp. v. Conceptronic Inc.
In Vitronics Corp. v. Conceptronic Inc.,67 the Federal Circuit provided
specific guidance concerning the practical application of claim
construction principles set forth by the Federal Circuit en banc, in
Markman v. Westview Instruments, Inc.,68 and affirmed by the Supreme
Court.69  The patented technology related to methods for the reflow
soldering of surface mounted devices to a printed circuit board in
which a conveyer moves the circuit board through a multizone oven.70
                                                 
patent system and the underlying public notice requirements:
Patents provide inventors with a legal right, for a limited time, to exclude others from
using, selling, offering to sell, or manufacturing the invention.  In essence, patents
give their owners significant power over the development of technology and markets
by giving patentees the right to exclude others from using their inventions.  For this
privilege, the government extracts a public disclosure of the invention in the hope
that, among other things, the disclosure of all inventions will add to the sum total of
knowledge available to the general public.  Competitors and the markets, as well as the
courts, must be able to ascertain what subject matter is covered by this right to
exclude.  Public notice of the scope of the right to exclude, as provided by the patent
claims, specification and prosecution history, is a critical function of the entire scheme
of patent law. The notice function is critical because it provides competitors with the
necessary information upon which they can rely to shape their behavior in the
marketplace.
Id., 47 U.S.P.Q.2d (BNA) at 1108; see also Sage Prods., Inc. v. Devon Indus., Inc., 126 F.3d 1420,
1424, 44 U.S.P.Q.2d (BNA) 1103, 1107 (Fed. Cir. 1997) (discussing the public notice function
of claims in the context of a doctrine of equivalents analysis) (citing Warner-Jenkinson Co. v.
Hilton Davis Chem. Co., 520 U.S. 17, 28 (1997)); In re Clement, 131 F.3d 1464, 1468, 45
U.S.P.Q.2d (BNA) 1161, 1164 (Fed. Cir. 1997) (holding that the “recapture  rule . . . prevents a
patentee from regaining through reissue subject matter . . . surrendered” during prosecution,
thus ensuring the ability of the public to rely on a patent’s public record) (citations omitted);
Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1583, 39 U.S.P.Q.2d (BNA) 1573, 1577
(Fed. Cir. 1996) (holding that the public is entitled to rely upon the public record of a patent
in determining the scope of the patent’s claims).
66. See Pfaff v. Wells Elecs., Inc., 525 U.S. 55,  (1998) (recognizing that the patent laws seek
to protect the public’s right to keep certain information in the public domain and the
inventor’s right to control whether and when to patent his invention), aff’g, 124 F.3d 1429, 43
U.S.P.Q.2d (BNA) 1928 (Fed. Cir. 1997); Warner-Jenkinson Co. v. Hilton Davis Chem. Co., 520
U.S. 17, 29-30 (1997), rev’g on other grounds, 62 F.3d 1512, 1516, 35 U.S.P.Q.2d (BNA) 1641,
1644 (Fed. Cir. 1995) (reconciling conflict between the notice requirement of patent claims
and the doctrine of equivalents).
67. 90 F.3d 1576, 39 U.S.P.Q.2d (BNA) 1573 (Fed. Cir. 1996).
68. 52 F.3d 967, 979, 34 U.S.P.Q.2d (BNA) 1321, 1329 (Fed. Cir. 1995) (en banc), aff’d,
517 U.S. 370 (1996) (establishing that the claims, specification, and prosecution history, but not
expert testimony, may be used to determine the meaning of claims).
69. See Vitronics, 517 U.S. at 370.
70. See Vitronics, 90 F.3d at 1578-79, 39 U.S.P.Q.2d (BNA) at 1573-74 (describing the
patented invention assigned to Vitronics as directed to soldering applications).  The patent-in-
suit was U.S. Patent No. 4,654,502.  See id. at 1578, 39 U.S.P.Q.2d (BNA) at 1573.  To attach
certain devices to a printed circuit board, solder paste between the device connectors and
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The crux of the infringement controversy was the meaning of the
claim terms “solder reflow temperature.”71  Vitronics contended that
solder reflow temperature meant a temperature of approximately
20°C above the temperature at which the solder is completely melted
and moves freely.72  In contrast, Conceptronic asserted that solder
reflow temperature meant 183°C, the temperature at which a
particular type of solder known as 63/37 (Sn/Pb) solder is
completely melted and moves freely.73  In support of its position,
Conceptronic relied heavily on expert testimony.74
At the outset, the Federal Circuit referred to the intrinsic evidence
of the record, including the patent claims themselves and the
patent’s specification and prosecution history, as the most significant
source of the legally operative meaning of the disputed language.75
On the other hand, the court held that extrinsic evidence external to
the patent and file history, including expert testimony, inventor
testimony, dictionaries, and technical treatises and articles, may be
used only to the extent it facilitates a proper understanding of the
state of the art.76  Extrinsic evidence may not be used to vary or
contradict the claim language or other parts of the specification and
should not be afforded any weight where the patent documents are
unambiguous.77
Accordingly, the Federal Circuit held that the district court
committed reversible error when it relied on expert testimony and
other extrinsic evidence in the face of a clear and unambiguous
definition in the specification of the disputed claim term.78  In
reaching this conclusion, the Federal Circuit commented on the
                                                 
board is heated to melting as the board passes on a conveyer belt through an oven with
different heating zones.  See id. at 1579, 39 U.S.P.Q.2d (BNA) at 1574.  This temperature
differential allows the solder paste to melt and reflow while the circuit board stays below the
solder reflow temperature.  See id., 39 U.S.P.Q.2d (BNA) at 1574.  The solder reflow forms a
solid connection between the device and the circuit board.  See id., 39 U.S.P.Q.2d (BNA) at
1574.
71. See id. at 1579-80, 39 U.S.P.Q.2d (BNA) at 1574.
72. See id. at 1580, 39 U.S.P.Q.2d (BNA) at 1574 (describing Vitronic’s proposed jury
instruction defining the claim term, solder reflow temperature).
73. See id., 39 U.S.P.Q.2d (BNA) at 1574.
74. See id. at 1581, 39 U.S.P.Q.2d (BNA) at 1575-76 (reporting Conceptronic’s reliance on
testimony and documentary evidence from those skilled in the art that peak reflow temperature
relates to the liquidus temperature at which the solder completely melts and moves freely).
75. See id. at 1582-83, 39 U.S.P.Q.2d (BNA) at 1573, 1576-77 (discussing the three proper
sources for determining the meaning of disputed terms).
76. See id. at 1583, 39 U.S.P.Q.2d (BNA) at 1577 (noting that in most situations analysis of
intrinsic evidence alone will resolve any ambiguity in a disputed claim term, thus prohibiting
the use of extrinsic evidence).
77. See id., 39 U.S.P.Q.2d (BNA) at 1577 (stating that use of extrinsic evidence is improper
where the public record is clear).
78. See id. at 1585, 39 U.S.P.Q.2d (BNA) at 1579.
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public notice rationale underlying its ruling.79
In most situations, an analysis of the intrinsic evidence alone will
resolve any ambiguity in a disputed claim term.  In such
circumstances, it is improper to rely on extrinsic evidence.  In those
cases where the public record unambiguously describes the scope
of the patented invention, reliance on any extrinsic evidence is
improper.  The claims, specification, and file history, rather than
extrinsic evidence, constitute the public record of the patentee’s
claim, a record on which the public is entitled to rely.  In other
words, competitors are entitled to review the public record, apply
the established rules of claim construction, ascertain the scope of
the patentee’s claimed invention and, thus, design around the
claimed invention.  Allowing the public record to be altered or
changed by extrinsic evidence introduced at trial, such as expert
testimony, would make this right meaningless.  The same holds
true whether it is the patentee or the alleged infringer who seeks to
alter the scope of the claims.80
The public notice responsibility sanctioned by the Federal Circuit
heightens the demand on those seeking government protection of
their inventions to set forth in their applications sufficient
explanations of the technology to facilitate public (including judicial)
understanding.81  From a social policy perspective, such burden
shifting is beneficial because those persons best equipped to explain
the patent’s underlying science are required to do so.82
D. Hilton Davis Chemical Co. v. Warner-Jenkinson Co.
In Hilton Davis Chemical Co. v. Warner-Jenkinson Co.,83 the Federal
Circuit clarified the law regarding infringement under the doctrine
of equivalents.84  This case presented the Federal Circuit with another
opportunity to consider the respective roles of the judge and jury in
                                                 
79. See id. at 1583, 39 U.S.P.Q.2d (BNA) at 1577 (discussing the importance of public
reliance on the claims and other information disclosed in the patent).
80. Id., 39 U.S.P.Q.2d (BNA) at 1577.
81. See id., 39 U.S.P.Q.2d (BNA) at 1577 (“The specification contains a written description
of the invention which must be clear and complete enough to enable those of ordinary skill in
the art to make and use it.”).
82. See id. at 1584, 39 U.S.P.Q.2d (BNA) at 1578 (explaining that an inventor’s intent, as it
relates to the scope of a claim, can be stated clearly in patent documents that constitute
intrinsic evidence used to resolve ambiguous claim terms).
83. 62 F.3d 1512, 35 U.S.P.Q.2d (BNA) 1641 (Fed. Cir. 1995), rev’d on other grounds, 520
U.S. 17 (1997).
84. See id. at 1516, 35 U.S.P.Q.2d (BNA) at 1644 (“Courts have applied the doctrine of
equivalents to protect the substance of the patentee’s right to exclude since the first few
decades after the enactment of the Patent Act of 1790, ch. 7, 1 stat. 109.”).  The Supreme Court
has consistently recognized the doctrine of equivalents as a protection for patent owners.  See id.
at 1516-17, 35 U.S.P.Q.2d (BNA) at 1644-45.
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patent cases.85  The Federal Circuit en banc held unequivocally that
infringement under the doctrine of equivalents is a factual issue for
the jury to resolve after the court’s instructions on the proper claim
interpretation.86  The Federal Circuit stated that a district court judge
in a patent infringement jury trial may not withhold from the jury
consideration of infringement under the doctrine of equivalents.87  In
so ruling, the appellate court rejected the argument that
infringement under the doctrine of equivalents is a matter of equity
to be applied at the discretion of the judge.88  The Federal Circuit
affirmed the district court’s entry of judgment on the jury verdict of
infringement.89
Hilton Davis had sued Warner-Jenkinson alleging infringement of
its patent to the ultrafiltration-mediated purification of commercial
dyes for food and drug use.90  The claims of the patent recited, inter
alia, parameters for ultrafiltration through a membrane at “a
hydrostatic pressure of approximately 200 to 400 p.s.i.g., at a pH from
approximately 6.0 to 9.0, . . . .”91  At trial, Hilton Davis presented
evidence that the accused Warner-Jenkinson ultrafiltration process
operated at a pressure between 200 to nearly 500 p.s.i.g., and
sometimes at a pH of 5.0.92  The jury found that Warner-Jenkinson
had infringed Hilton Davis’ patent under the doctrine of
equivalents.93
On appeal to the Federal Circuit, Warner-Jenkinson argued that
the doctrine of equivalents is an equitable remedy available only
upon a suitable threshold showing of the equities by the patent
holder, such as copying or piracy by the accused infringer.94
                                                 
85. See infra note 243 and accompanying text (discussing Federal Circuit’s holdings
regarding roles of judge and jury in patent cases).
86. See Hilton Davis, 62 F.3d at 1520-21, 35 U.S.P.Q.2d (BNA) at 1647 (citing Graver Tank
& Mfg. v. Linde Air Prods. Co., 339 U.S. 605, 609-10 (1949)).
87. See id. at 1522, 35 U.S.P.Q.2d (BNA) at 1648 (“The trial judge does not have discretion
to choose whether to apply the doctrine of equivalents when the record shows no literal
infringement.”).
88. See id. at 1521, 35 U.S.P.Q.2d (BNA) at 1648 (“[T]he Supreme Court’s cases on the
doctrine of equivalents foreclose a holding that the doctrine is a matter of equity to be applied
at the court’s discretion.”).
89. See id. at 1528-29, 35 U.S.P.Q.2d (BNA) at 1654 (concluding that the evidence supports
the jury’s verdict of infringement according to the doctrine of equivalents).
90. See id. at 1515-16, 35 U.S.P.Q.2d (BNA) at 1643.  The patent-in-suit was U.S. Patent No.
4,560,746.  See id. at 1515, 35 U.S.P.Q.2d (BNA) at 1642.
91. Id., 35 U.S.P.Q.2d (BNA) at 1643.
92. See id. at 1524, 35 U.S.P.Q.2d (BNA) at 1650 (providing evidence to establish a finding
of infringement).
93. See id. at 1516, 35 U.S.P.Q.2d (BNA) at 1643.
94. See id. at 1522-23, 35 U.S.P.Q.2d (BNA) at 1649 (indicating that Warner-Jenkinson’s
independent development of the process, without the knowledge of the plaintiff’s patent,
suggests the absence of conduct justifying application of the doctrine of equivalents).
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Furthermore, Warner-Jenkinson asserted that, as a matter of equity,
infringement under the doctrine of equivalents was a question for the
court and not the jury to decide.95  The Federal Circuit en banc,
however, rejected Warner-Jenkinson’s contentions.96  The court held
that a showing of culpable conduct is not necessary for, much less a
prerequisite to, a finding of infringement under the doctrine of
equivalents.97  The Federal Circuit thus affirmed the jury verdict of
infringement, despite the literal pressure and pH differences from
the claimed invention.98  The court relied on substantial evidence
demonstrating that the Warner-Jenkinson ultrafiltration process
performed the same function, in an equivalent way, to achieve the
same result as the patented invention.99
The Federal Circuit clearly set forth that infringement under the
doctrine of equivalents exists where the differences between the
claimed invention and the accused product or process are objectively
insubstantial.100  The court noted that often it may be adequate to rely
solely on the function-way-result test101 to establish insubstantiality,
and thus equivalency.102  In newer technologies, however, the court
recognized the possibility that the function-way-result test would not
suffice to illuminate the substantiality of the differences.103  The
Federal Circuit noted that important factors not considered in the
function-way-result test included:  evidence of known
interchangeability of the accused and claimed elements; copying;
designing around; and independent development.104  Furthermore,
                                                 
95. See id. at 1523, 35 U.S.P.Q.2d (BNA) at 1649 (stating that as a question of law, an
equitable remedy must be considered by the court).
96. See id., 35 U.S.P.Q.2d (BNA) at 1649 (upholding the trial court’s instructions to the
jury and rejecting Warner-Jenkinson’s objection to sending the doctrine of equivalents question
to the jury).
97. See id. at 1519, 35 U.S.P.Q.2d (BNA) at 1646 (asserting that the doctrine of equivalents
does not rely on subjective awareness or intent of the accused infringer).
98. See id. at 1528-29, 35 U.S.P.Q.2d (BNA) at 1654 (noting that although the plaintiff’s
claim “recited ‘a pH from approximately 6.0 to 9.0’” and defendant’s process sometimes was
below 6.0, this difference did not bar plaintiff’s cause of action).
99. See id. at 1524-25, 35 U.S.P.Q.2d (BNA) at 1650-51 (reviewing the jury’s substantial
evidence finding on the pH variation and membrane pressure measurement).
100. See id. at 1517-18, 35 U.S.P.Q.2d (BNA) at 1644-45 (noting that insubstantial
differences exist when the claimed and accused products perform the same function in the
same manner, and produce the same result).
101. See infra note 301 (reviewing the tripartite test set forth in Graver Tank).
102. See Hilton Davis, 62 F.3d at 1518, 35 U.S.P.Q.2d (BNA) at 1645 (stating that a showing
of a substantial sameness in function, way, and result between the claimed and accused process
is sufficient for the doctrine of equivalency).
103. See id., 35 U.S.P.Q.2d (BNA) at 1645 (noting that new technologies are more
sophisticated than those in existence when the function-way-result test arose).
104. See id. at 1519-20, 35 U.S.P.Q.2d (BNA) at 1646-47.  The Federal Circuit left open the
question whether evidence of interchangeability, copying, or designing around would be
sufficient, in the absence of a function-way-result analysis, to support a finding of equivalency.
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the court stated that the proper objective standard for assessing the
substantiality of differences is the perspective of a person of ordinary
skill in the relevant art.105
The Supreme Court reversed the Federal Circuit and remanded
the case.106  The Court stated:
Today we adhere to the doctrine of equivalents.  The
determination of equivalence should be applied as an objective
inquiry on an element-by-element basis.  Prosecution history
estoppel continues to be available as a defense to infringement, but
if the patent holder demonstrates that an amendment required
during prosecution had a purpose unrelated to patentability, a
court must consider that purpose in order to decide whether an
estoppel is precluded.  Where the patent-holder is unable to
establish such a purpose, a court should presume that the purpose
behind the required amendment is such that prosecution history
estoppel would apply.107
In creating new law essentially amounting to prosecution history
estoppel by silence, the Court ostensibly set out a legal framework
whereby the patent applicant bears the burden of explaining the
scientific principles underlying the invention and their relationship
to patentability.108
Mindful that claims do indeed serve both a definitional and a
notice function, we think the better rule is to place the burden on
the patent holder to establish the reason for an amendment
required during patent prosecution.  The court then would decide
whether that reason is sufficient to overcome prosecution history
estoppel as a bar to application of the doctrine of equivalents to the
element added by that amendment.  Where no explanation is
established, however, the court should presume that the patent
application had a substantial reason related to patentability for
including the limiting element added by amendment.  In those
circumstances, prosecution history estoppel would bar the
application of the doctrine equivalents as to that element.  The
presumption we have described, one subject to rebuttal if an
appropriate reason for a required amendment is established, gives
                                                 
See id. at 1518, 35 U.S.P.Q.2d (BNA) at 1645 (noting that analysis of function-way-result alone
would suffice in many cases but acknowledging that test does not necessarily end the inquiry in
certain instances).
105. See id. at 1519, 35 U.S.P.Q.2d (BNA) at 1646 (asserting that the objective test relies on
objective evidence, not subjective conclusions offered by a person such as an expert witness).
106. See Warner-Jenkinson Co. v. Hilton Davis Chem. Co., 520 U.S. 17, 24 (1997) (rejecting
the Federal Circuit’s interpretation of the doctrine of equivalents).
107. Id. at 40-41.
108. See id. at 33-34 (discussing the Court’s approach to the doctrine of equivalents and its
requirement that patent holders explain any amendments).
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proper deference to the role of claims in defining an invention and
providing public notice, and to the primacy of the PTO in ensuring
that the claims allowed cover only subject matter that is properly
patentable in a proffered patent application.109
Accordingly, with respect to infringement under the doctrine of
equivalents, the federal courts need to engage less frequently in the
evaluation of the science.110
E. Pfaff v. Wells Electronics Inc.
In Pfaff v. Wells Electronics Inc.,111 the Supreme Court established
new law with respect to the on-sale bar to patentability under 35
U.S.C. § 102(b).112  In so doing, the Supreme Court overturned
established Federal Circuit authority that stated the on-sale inquiry
must take into account all of the circumstances surrounding the sale
or offer to sell, including the stage of development and nature of the
invention.113
On April 19, 1982, Pfaff filed a patent application relating to
semiconductor sockets for testing leadless chip carriers that
eventually issued on January 1, 1985, as U.S. Patent No. 4,491,377.114
Pfaff sued Wells for infringement of this patent, and Wells filed a
counterclaim of patent invalidity.115  Wells alleged that Pfaff
commercialized his invention before April 19, 1981, the critical date
prior to which any legally sufficient sale of the invention would result
in a bar to obtaining the patent.116
The evidence revealed that Texas Instruments (“TI”) had
                                                 
109. Id..
110. See id. (stating that the rebuttable presumption of prosecution history estoppel places
the burden on the patent applicant to explain the reasons for the amendment).
111. 525 U.S. 55 (1998), aff’g 124 F.3d 1429, 43 U.S.P.Q.2d (BNA) 1928 (Fed. Cir. 1997).
112. See id. at 67 (articulating the two conditions required in order for the on-sale bar to
apply).  The Court stated:  “First, the product must be the subject of a commercial offer for
sale,” and “[s]econd, the invention must be ready for patenting.”  Id.
113. See Envirotech Corp. v. Westech Eng’g, Inc., 904 F.2d 1571, 1574, 15 U.S.P.Q.2d (BNA)
1230, 1232 (Fed. Cir. 1990) (stating that the court must consider the “totality of the
circumstances” when determining whether a new invention was on sale); UMC Elecs. Co. v.
United States, 816 F.2d 647, 656, 2 U.S.P.Q.2d (BNA) 1465, 1471-72 (Fed. Cir. 1987) (holding
that the on-sale bar does not turn on a single factor regarding the reduction to practice but all
circumstances relating to the sale of the invention); King Instrument Corp. v. Otari Corp., 767
F.2d 853, 860, 226 U.S.P.Q. (BNA) 402, 406 (Fed. Cir. 1985) (identifying the two factors which
courts may use as evidence of being “on sale”).  The first factor was “a sale or offer of sale of the
invention,” and the second factor was “an existing reduction to practice of the invention by the
time of the offer.”  Id., 226 U.S.P.Q. (BNA) at 406.
114. See Pfaff v. Wells Elecs. Inc., 9 U.S.P.Q.2d (BNA) 1366, 1368-69 (N.D. Ind. 1988)
(describing the development, in response to the need for high-density packaging for integrated
circuit devices, of leadless chip carriers).
115. See id. at 1366.
116. See id. at 1375 (arguing that plaintiff’s claim was invalid because the invention was on-
sale beyond the statutorily permitted time period).
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contacted Pfaff in November 1980 to develop a semiconductor chip
socket for its carriers.117  Pfaff made detailed engineering drawings of
the socket and sent them to a custom tooling and production
subcontractor.118  These detailed drawings showed both precise
dimensions and material requirements corresponding to the claimed
invention.119
In a handwritten note on a February 25, 1981, engineering
diagram, Pfaff indicated that the first order would be for 25,000
sockets.120  On April 8, 1981, a company acting on behalf of TI issued
a purchase order to Pfaff for 30,100 sockets for $91,155.121  This
purchase order confirmed an earlier, verbal order on March 17,
1981, and specified the materials to be used and the delivery date.122
The sockets were shipped to and accepted by TI after they were
manufactured by the subcontractor in July 1981 and performance
tested by Pfaff.123
The district court found that more than a mere concept was on sale
given the completion of engineering drawings, the ordering of
production tooling, and the commencement of fabrication of the
tooling necessary to manufacture the invention for a specific
customer.124  Even though a prototype of the invention had not been
built prior to the TI sale, the district court found that, based on his
drawings, Pfaff was confident this invention would work.125  Indeed,
Pfaff testified that “it was his practice to produce his inventions
without building any prototypes and that he had almost always been
successful with this approach.”126
Pfaff argued, on appeal to the Federal Circuit, that the on-sale bar
should not apply because no sockets were tested before the critical
date to ensure that the device would work.127  In particular, Pfaff
asserted that he could not have known that the invention would work
in advance of the results of the performance testing, months after the
critical date.128  The Federal Circuit rejected these contentions,
                                                 
117. See Pfaff v. Wells Elecs., Inc., 124 F.3d 1429, 1432, 43 U.S.P.Q.2d (BNA) 1928, 1930
(Fed. Cir. 1997).
118. See id., 43 U.S.P.Q.2d (BNA) at 1930.
119. See id., 43 U.S.P.Q.2d (BNA) at 1930.
120. See id. at 1433, 43 U.S.P.Q.2d (BNA) at 1931.
121. See id., 43 U.S.P.Q.2d (BNA) at 1931.
122. See id. at 1432-33, 43 U.S.P.Q.2d (BNA) at 1930-31.
123. See id. at 1432, 43 U.S.P.Q.2d (BNA) at 1930.
124. See id. at 1434, 43 U.S.P.Q.2d (BNA) at 1932.
125. See id., 43 U.S.P.Q.2d (BNA) at 1932.
126. Id., 43 U.S.P.Q.2d (BNA) at 1932.
127. See id. at 1435, 43 U.S.P.Q.2d (BNA) at 1932.
128. See id., 43 U.S.P.Q.2d (BNA) at 1932 (discussing plaintiff’s fears of invention
malfunction prior to performance testing).
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reasoning that the claimed invention was on-sale under 35 U.S.C.
§ 102(b) because Pfaff’s invention was substantially complete at least
by the time of the pre-critical date offer to sell and receipt of the
purchase order.129
The Supreme Court affirmed the Federal Circuit’s decision.130  The
Court held that an invention should refer to a concept that is
complete, rather than merely one that is substantially complete.131
The Court acknowledged that reduction to practice ordinarily
provides the best evidence that an invention is complete, but that
proof of reduction to practice is not necessary in every case.132
The Supreme Court concluded “that the on-sale bar applies when
two conditions are satisfied before the critical date.”133  First, a
commercial offer for sale of the product must have occurred.134
Second, “the invention must be ready for patenting.”135  This second
condition may be satisfied by proof that before the critical date the
inventor had reduced to practice, or prepared drawings or other
descriptions of the invention sufficiently specific to enable a person
skilled in the art to practice the invention.136
This change in the law allows a court to step back from a focus on
the technical aspects of the invention and to look, instead, to relevant
non-technical evidence.137  In particular, the Supreme Court has
changed the focus of the inquiry to more objective criteria, which
would belie any technically based assertion that the invention was not
ready for patenting.138  For example, the patent applicant’s own
expression in business records or activities might well establish the
                                                 
129. See id., 43 U.S.P.Q.2d (BNA) at 1933 (distinguishing plaintiff’s case from standing
precedent and pointing to the lack of authority supporting plaintiff’s position that courts
should give greater latitude to an innovative patent).
130. See Pfaff v. Wells Elecs., Inc., 525 U.S. 50, 68 (1998) (finding support for the Federal
Circuit’s decision on both textual and policy grounds).
131. See id. at 66 (holding that the requirement of having an invention be complete
provides a definite standard which Congress intended).
132. See id. (stating that an invention can be complete and ready for patenting before
reduction to practice).
133. Id. at 67.
134. See id.
135. Id.
136. See id. at 68 (ascertaining that the second condition was met in the case at bar as Pfaff
sent drawings “to the manufacturer before the critical date fully disclosed the invention”).
137. See id. (focusing on non-technical aspects of the invention, specifically the date at
which the invention was ready for patenting and when the invention went on sale).
138. See id. at 65-66 (advancing that the relevant inquiry should be based upon more
objective criteria, such as whether the inventor’s concept has been described with sufficient
clarity and precision to enable those skilled in the art to practice the invention, rather than
technically based assertions that the invention was not ready for patenting because it had not
been “reduced to practice”).
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basis for the application of a statutory bar to patentability.139
Perhaps the most recent significant controversy regarding a
standard of review by the Federal Circuit in patent-related cases deals
primarily with the question of who will have an advantage in the
determination of patentable subject matter.140  Although this dispute
does not directly confront the boundaries of scientific adjudication,
its collateral implications include a possible shift away from the
recent Federal Circuit and Supreme Court trend to resolve patent
cases without parsing the intricacies of the technology.141  In this
regard, the adoption by the Federal Circuit of more searching
standards of review represents the unfortunate creation of additional
procedural mechanisms by which the court inadvertently could open
a Pandora’s Box of technical controversy.
II. DETERMINING THE APPROPRIATE STANDARD OF REVIEW
In the early days of the Federal Circuit, the attempt to reconcile
inconsistent applications of the patent laws appeared to be the
paramount concern of the court.142  Indeed, the early precedential
opinions of the Federal Circuit devoted considerable effort to
providing guidance on substantive legal issues and an initial
jurisdictional delineation.143  Gradually, the attention of the court
shifted to more procedural questions, including those regarding trial
and appellate conduct.144  Soon enough, the Federal Circuit began to
consider the importance of clarity and consistency in its own
operation by setting forth and adhering to specific standards of
review.145
This section of the Article considers several relatively recent cases
                                                 
139. See id. at 62-64 (providing that plaintiff’s own business records proved that the plaintiff
had engaged in activities over a year before filing the patent application thereby invoking the
statutory bar to patentability).
140. See Markman v. Westview Instruments, Inc., 52 F.3d 967, 979, 34 U.S.P.Q.2d (BNA)
1321, 1329 (Fed. Cir. 1995) (en banc) (holding that construction of patent claims is a matter of
law exclusively for the court), aff’d, 517 U.S. 370 (1996); In re Zurko, 111 F.3d 887, 889, 42
U.S.P.Q.2d (BNA) 1476, 1478 (Fed. Cir. 1997) (determining that obviousness is a legal question
based on underlying factual determinations and therefore, subject to de novo review).
141. See infra Parts II.A -B (discussing Markman and Zurko in detail).
142. See Archer, supra note 14, at 835-37 (stating that the disparity in the application of
patent law in the regional circuits was a major purpose of the establishment of the Federal
Circuit and describing the early attempts of the Federal Circuit to reconcile the inconsistencies
in the regional circuits).
143. See generally Newman, supra note 10, at 523-27 (discussing the first ten years of the
Federal Circuit and its attempts to introduce “patent law into the legal mainstream”).
144. See Archer, supra note 14, at 836-39 (discussing the inconsistency that existed within the
Federal Circuit and the standards of review that recent decisions have promulgated to address
those inconsistencies).
145. See id.
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in which the Federal Circuit addressed the appropriate standards of
review on various issues.146  In particular, these standards of review
have appeared to vest the Federal Circuit with increasing authority to
conduct plenary reviews of its lower tribunal decisions.147  In addition,
the Federal Circuit reaffirmed the propriety of its historical standard
of review of USPTO factual findings.148  By creating more
opportunities for substantive analyses of the science underlying
patent-related cases, these standards of review open the Federal
Circuit to heightened challenges to the propriety of its adjudication
from a scientific perspective.  With less deferential standards of
review, the public might perceive that the Federal Circuit is
attempting to introduce its own notions regarding the technical
merits of the case, which can foster criticism inappropriately focused
on an alleged misunderstanding of the underlying science, rather
than on the sound application of the patent laws.
A. Markman v. Westview Instruments, Inc.
In Markman v. Westview Instruments, Inc.,149 the Federal Circuit
resolved an apparent inconsistency in its precedent regarding the
respective roles of judge and jury in proper claim construction.150
The appellate court faced a jury’s claim interpretation that seemingly
diverged from the trial judge’s claim construction on post-trial
motions.151  The Federal Circuit held unequivocally that claim
construction is a purely legal conclusion, which falls exclusively
within the district court’s province.152  The Federal Circuit thus
affirmed the district court’s judgment of noninfringement as a matter
of law, notwithstanding the jury verdict of infringement.153
Markman sued Westview alleging infringement of its patent to an
                                                 
146. See supra Parts II.A-B (extrapolating the relevant information regarding Markman and
Zurko).
147. See Markman v. Westview Instruments, Inc., 52 F.3d 967, 979, 34 U.S.P.Q.2d (BNA)
1321, 1329 (Fed. Cir. 1995) (holding that patent claims are “reviewed de novo on appeal”).
148. See In re Zurko, 111 F.3d 887, 890, 42 U.S.P.Q.2d (BNA) 1476, 1479 (Fed. Cir. 1997)
(reviewing the USPTO’s findings and deciding that “on the record, the obviousness of the
claimed invention has not been established”).
149. 52 F.3d 967, 34 U.S.P.Q.2d (BNA) 1321 (Fed. Cir. 1995) (en banc), aff’d, 517 U.S. 370
(1996).
150. See id. at 979, 34 U.S.P.Q.2d (BNA) at 1329 (finding that it was not an error for the
district court judge to remove the issue of claim construction from consideration by the jury).
151. See id., 34 U.S.P.Q.2d (BNA) at 1329 (commenting that Markman felt that the jury’s
implied construction of the claim was the correct interpretation while the district court’s
interpretation was incorrect).
152. See id., 34 U.S.P.Q.2d (BNA) at 1329 (stating that the interpretation of the meaning
and scope of patent claims is matter of law reviewed de novo on appeal).
153. See id. at 988-89, 34 U.S.P.Q.2d (BNA) at 1337 (finding noninfringement because the
term “inventory” does include articles of clothing within its meaning).
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automated inventory system for monitoring articles of clothing
throughout the steps of commercial laundry and dry cleaning.154  The
claims of the patent recited an “inventory control and reporting
system” that could “localize spurious additions to inventory” and that
included, inter alia, a “means to maintain an inventory total.”155  The
meaning of “inventory” was the crux of the case.156  To inform the
meaning of “inventory,” Markman introduced at trial the testimonies
of the inventor, a technical expert, and a patent law expert.157  These
individuals stated that one of ordinary skill in the art would not
necessarily have construed “inventory” to include articles of
clothing.158
The trial judge instructed the jury to construe the claims in view of
the patent documents from the perspective of those of ordinary skill
in the art.159  The jury found Westview liable for infringement on two
of Markman’s claims.160  Notwithstanding the jury verdict, the district
court granted Westview’s deferred motion for judgment as a matter
of law.161  The district court relied upon its own claim construction
and held that “inventory” included articles of clothing.162  The parties
did not dispute that even though Westview’s system could register
transactions and cash totals, it could not maintain information
regarding particular articles of clothing.163  The district court thus
entered judgment for Westview as a matter of law, based on the
absence of this claim limitation in the accused system.164
                                                 
154. See id. at 971-72, 34 U.S.P.Q.2d (BNA) at 1322-24 (noting that the patent claimed to be
infringed upon was U.S. Reissue Patent No. 33,054, reissued from U.S. Patent No. 4,550,246).
155. See id. at 972, 34 U.S.P.Q.2d (BNA) at 1323.
156. See id. at 974-75, 34 U.S.P.Q.2d (BNA) at 1325-26 (discussing whether “inventory”
requires as part of its meaning “articles of clothing”).
157. See id. at 973, 34 U.S.P.Q.2d (BNA) at 1324.
158. See id. at 983, 34 U.S.P.Q.2d (BNA) at 1332-33 (finding that the testimony of
Markman’s experts amounted to no more than legal opinion and therefore, entitled to no
deference).
159. See id. at 973, 34 U.S.P.Q.2d (BNA) at 1324 (instructing the jury that to determine the
meaning of the claims, “considerations that show how the terms of a claim would normally be
understood by those of ordinary skill in the art” are relevant).
160. See id., 34 U.S.P.Q.2d (BNA) at 1324.
161. See id., 34 U.S.P.Q.2d (BNA) at 1324 (stating that notwithstanding the jury verdict that
Westview infringed claims 1 and 10, the district court granted Westview’s deferred motion for
judgment as matter of law because Westview’s device could not function the way claims
required).
162. See id., 34 U.S.P.Q.2d (BNA) at 1324 (holding that “‘inventory’ as used in the claims
meant ‘articles of clothing’ and not simply transaction totals of dollars”).
163. See id., 34 U.S.P.Q.2d (BNA) at 1324 (noting that Westview’s system could not track
articles of clothing through the dry-cleaning process and could only produce a list of invoices
and cost total of the inventory).
164. See id., 34 U.S.P.Q.2d (BNA) at 1324 (stating that Westview’s device did not have the
“means to maintain an inventory total” and could not “detect and localize spurious additions to
inventory” and therefore, directed a verdict of non-infringement as a matter of law).
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On appeal, Markman relied upon Federal Circuit precedent
holding that a district court should submit to the jury any underlying
factual disputes about meanings of claim terms.165  The Federal
Circuit, en banc, rejected Markman’s contention, however, and
affirmed the district court’s entry of judgment as a matter of law.166  In
so ruling, the court implicitly overruled precedent contrary to its
present holding that the district court alone must construe patent
claims as a matter of law.167  The appellate court reasoned that its
holding was entirely consistent with the fundamental legal principle
that “the construction of a written evidence is exclusively with the
court.”168
The Federal Circuit emphasized that placing sole responsibility for
claim construction with the trial judge did not deprive parties to a
patent infringement case of their Seventh Amendment right to trial
by jury.169  In addition, although the dissent, one of the concurring
opinions, and certain of the amici agreed with Markman’s contention,
the majority opinion specifically discounted the argument that the
assignment of claim construction to the court’s exclusive province
                                                 
165. See id. at 973-74, 34 U.S.P.Q.2d (BNA) at 1324-25 (holding that when the meaning of a
claim term is disputed, a factual question arises that should be resolved by the trier of fact)
(citing Palumbo v. Don-Joy Co., 762 F.2d 969, 974, 226 U.S.P.Q. (BNA) 5, 8 (Fed. Cir. 1985)).
166. See id. at 979, 34 U.S.P.Q.2d (BNA) at 1329 (finding that “Markman’s principal
argument that the district court erred in taking the issue of claim construction away from the
jury is itself legally erroneous”).
167. See id. at 976-77, 34 U.S.P.Q.2d (BNA) at 1327-28 (finding that “if . . . the meaning of a
term of art in the claim is disputed and extrinsic evidence is needed to explain the meaning,
construction of the claim could be left to the jury”) (citing as inconsistent precedent McGill
Inc. v. John Zink Co., 736 F.2d 666, 672, 221 U.S.P.Q. (BNA) 944, 948 (Fed. Cir. 1984)); see, e.g.,
Tol-O-Matic, Inc. v. Proma Produkt-Und Mktg. Gesellschaft m.b.H., 945 F.2d 1546, 1550, 20
U.S.P.Q.2d (BNA) 1332, 1336 (Fed. Cir. 1991) (concluding that “[i]nterpretation of the claim
words required the jury give consideration and weight to several underlying factual questions”);
Perini Am., Inc. v. Paper Converting Mach. Co., 832 F.2d 581, 584, 4 U.S.P.Q.2d (BNA) 1621,
1624 (Fed. Cir. 1987) (stating that any disputes over the meaning of terms in a claim must be
resolved before the claim can be interpreted as matter of law); H.H. Robertson Co. v. United
Steel Deck, Inc., 820 F.2d 384, 389, 2 U.S.P.Q.2d (BNA) 1926, 1929 (Fed. Cir. 1987) (stating
that although claim construction is reviewed as a matter of law, evidentiary material may be
necessary to interpret a claim and this would be an issue of fact); Moeller v. Ionetics, Inc., 794
F.2d 653, 657, 229 U.S.P.Q. (BNA) 992, 995 (Fed. Cir. 1986) (stating that extrinsic evidence
may produce factual disputes precluding summary judgment on claim construction); Palumbo
v. Don-Joy Co., 762 F.2d 969, 974, 226 U.S.P.Q. (BNA) 5, 8 (Fed. Cir. 1985) (stating that a
factual issue results when extrinsic evidence is required to explain the meaning of a disputed
term and the trier of fact or jury should determine the construction of the claim); Bio-Rad
Labs., Inc. v. Nicolet Instrument Corp., 739 F.2d 604, 614, 222 U.S.P.Q. (BNA) 654, 661 (Fed.
Cir. 1984) (reasoning that in claim construction cases there may be factual issues triable by
jury);.
168. See Markman, 52 F.3d at 978, 34 U.S.P.Q.2d (BNA) at 1328 (quoting Levy v. Gadsby, 7
U.S. (3 Cranch) 180, 186 (1805)).
169. See id. at 983-84, 34 U.S.P.Q.2d (BNA) at 1333 (holding that the right to a jury trial in
patent infringement cases has not been deprived by holding “that part of the infringement
inquiry, constructing and determining the scope of the claims in a patent, is strictly a legal
question for the court”).
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conflicted with Supreme Court precedent.170  The majority
distinguished the cases cited by Markman as anachronistic or
inapposite.171  Responding further to the dissenting and concurring
opinions, the majority used, as an analytical framework, the analogy
of a patent to a statute to support the judge’s interpretation of patent
claims, rather than the analogy of a patent to a contract.172  Although
the majority recognized the inherent limitations of such analogies, it
nevertheless noted that general principles of statutory interpretation
were germane to patent claim construction cases.173
In Markman, the Federal Circuit provided clear guidance to the
district courts about the relative significance of certain evidence
regarding the meaning of claim terms.174  The court embraced
precedent stating that proper claim interpretation derives from
consideration of the relevant patent-related documents.175  This
“intrinsic” evidence includes:  (1) the patent itself, i.e., the
specification and the claims; and (2) the prosecution history, i.e., the
record of proceedings before the USPTO.176  The court also approved
the examination of “extrinsic” evidence, such as expert and inventor
testimony, dictionaries, and learned treatises, to inform the state of
the technology, or “prior art,” at the time of the invention.177  The
Federal Circuit emphasized, however, that extrinsic evidence is only
to be used to assist in the court’s understanding of the patent, not to
clarify ambiguity in claim language, much less to vary or contradict
the meaning of claim terms.178  Specifically, the court noted that
                                                 
170. See id. at 987, 34 U.S.P.Q.2d (BNA) at 1336-37 (stating that the majority is not
persuaded by the cited case law that assigning claim construction to judges conflicts with
Supreme Court precedent).
171. See id. at 987-88, 34 U.S.P.Q.2d (BNA) at 1336-37 (distinguishing Silsby v. Foote, 55
U.S. (14 How.) 218 (1852) and Bischoff v. Wethered, 76 U.S. (9 Wall.) 812 (1869), upon which
dissenting and concurring opinions along with Markman relied).
172. See id. at 987, 34 U.S.P.Q.2d (BNA) at 1336 (finding that the statutory interpretation,
which as a matter of law is for a court to decide, is the more appropriate analogy for
interpreting patent claims than a contractual interpretation analogy).
173. See id., 34 U.S.P.Q.2d (BNA) at 1336 (noting the differences between a patent and a
statute, but finding that as they are both public instruments the statutory interpretation model
is a more accurate model than the contractual one).
174. See id. at 979-83, 34 U.S.P.Q.2d (BNA) at 1329-33 (describing evaluation of evidence of
record to interpret meaning of claims).
175. See id. at 979-80, 34 U.S.P.Q.2d (BNA) at 1329-30 (citing Graham v. John Deere Co.,
383 U.S. 1, 33 (1966)); Autogiro Co. of Am. v. United States, 384 F.2d 391, 396-98, 155 U.S.P.Q.
(BNA) 697, 701-03 (Ct. Cl. 1967) (relying on specification and included claims).
176. See Markman, 52 F.3d at 979-80, 34 U.S.P.Q.2d (BNA) at 1329-30 (stating that the
claims, specification, and prosecution history must be examined to interpret the meaning of the
claims).
177. See id. at 980, 34 U.S.P.Q.2d (BNA) at 1330 (defining extrinsic evidence as “all evidence
external to the patent and prosecution history” in addition to listing examples of and the
correct uses of extrinsic evidence).
178. See id. at 981, 34 U.S.P.Q.2d (BNA) at 1331 (“Extrinsic evidence is to be used for the
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evidence of the subjective intent of the inventor during claim
drafting deserves little or no probative weight in claim interpretation
unless otherwise documented in the prosecution history.179
The Supreme Court affirmed the Federal Circuit decision in
Markman.180  Although the Court found no guidance in its own
decisions on the issue, it concluded that claim construction,
notwithstanding its evidentiary underpinnings, was analogous to
many other responsibilities assigned to the judge.181  Accordingly, the
Court held that “construction of a patent, including terms of art
within its claims, is exclusively within the province of the court.”182
The Supreme Court further articulated a social policy rationale for
the assignment of claim construction to judges.  The Court stated:
Finally, we see the importance of uniformity in the treatment of a
given patent as an independent reason to allocate all issues of
construction to the court. . . .  “The limits of a patent must be
known for the protection of the patentee, the encouragement of
the inventive genius of others and the assurance that the subject of
the patent will be dedicated ultimately to the public.”  Otherwise, a
“zone of uncertainty which enterprise and experimentation may
enter only at the risk of infringement claims would discourage
invention only a little less than unequivocal foreclosure of the
field, . . .” and “[t]he public [would] be deprived of rights
supposed to belong to it, without being clearly told what it is that
limits these rights.”  It was just for the sake of such desirable
uniformity that Congress created the Court of Appeals for the
Federal Circuit as an exclusive appellate court for patent cases,
observing that increased uniformity would “strengthen the United
States patent system in such a way as to foster technological growth
and industrial innovation.”  Uniformity would, however, be ill
served by submitting issues of document construction to juries.
Making them jury issues would not, to be sure, necessarily leave
evidentiary questions of meaning wide open in every new court in
which a patent might be litigated, for principles of issue preclusion
would ordinarily foster uniformity.  But whereas issue preclusion
                                                 
court’s understanding of the patent, not for the purpose of varying or contracting the terms of
the claims.”).
179. See id. at 983, 34 U.S.P.Q.2d (BNA) at 1332-33 (stating that testimony of the inventor of
patent-in-suit and of someone of ordinary skill in art pertaining to proper claim construction
amounted only to legal opinion, which the court was not required to follow).  “[T]he court has
complete discretion to adopt the expert legal opinion as its own, to find guidance from it, or to
ignore it entirely, or even to exclude it.”  Id., 34 U.S.P.Q.2d (BNA) at 1332.
180. Markman v. Westview Instruments, Inc., 517 U.S. 370, 391 (1996).
181. See id. at 390 (concluding that a judge in the normal course of trial should decide
construction of terms).  The Court further noted that by virtue of their “training in exegesis,”
judges are more likely to conduct a proper claim construction than juries.  See id. at 388-89.
182. See id. at 372.
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could not be asserted against new and independent infringement
defendants even within a given jurisdiction, treating interpretive
issues as purely legal will promote (though it will not guarantee)
intrajurisdictional certainty through the application of stare decisis
on those questions not yet subject to interjurisdictional uniformity
under the authority of the single appeals court.183
The Court thus appears to embrace the notion that the attendant
plenary, or de novo, standard of review by the Federal Circuit on claim
construction issues accomplishes the objective of promoting
uniformity in the administration of the patent law.  Although such
centralization may facilitate clarity and consistency, the shift in
authority may bring an increased likelihood of technology
adjudication, a move which would undermine the recent trend of the
Federal Circuit.
B. Dickinson v. Zurko
The Supreme Court faced a similar challenge to its recent implicit
caution against technology adjudication in considering the appeal in
Dickinson v. Zurko.184  In this case, the USPTO asked the Court to
require the Federal Circuit to exercise greater deference to the
factual findings of the USPTO Board of Patent Appeals and
Interferences.185
The Administrative Procedure Act (“APA”) sets forth a standard for
judicial review of federal agency determinations.186  The Federal
Circuit presently applies the same standard of review in appeals from
both the U.S. district courts and the USPTO.187  The court reviews
                                                 
183. Id. at 390-91 (internal citations omitted).
184. 142 F.3d 1447, 46 U.S.P.Q.2d (BNA) 1691 (Fed. Cir. 1997), rev’d, Dickinson v. Zurko,
119 S.Ct. 1816 (1999).
185. See id. at 1450, 46 U.S.P.Q.2d (BNA) at 1693-94 (discussing how the various standards
differ in the amount of deference they contemplate).
186. Administrative Procedure Act § 10(e), 5 U.S.C. § 706 (1994).  The statute provides that
the reviewing court shall:
(2)  hold unlawful and set aside agency action, findings, and conclusions found to
be—
(A) arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with
law;
(E) unsupported by substantial evidence in a case subject to sections 556 and 557 of
this title or otherwise reviewed on the record of an agency hearing provided by statute.
5 U.S.C. § 706(2)(A), (E).
187. Compare Heisig v. United States, 719 F.2d 1153, 1158 (Fed. Cir. 1983) (explaining that
the Federal Circuit applies a clearly erroneous standard to a district court’s findings of fact and
upholds its legal conclusions unless they are incorrect), with In re Kulling, 897 F.2d 1147, 1149,
14 U.S.P.Q.2d (BNA) 1056, 1057 (Fed. Cir. 1990) (noting that the Federal Circuit is bound by
USPTO’s findings of fact unless clearly erroneous), and In re Caveney, 761 F.2d 671, 674, 226
U.S.P.Q. (BNA) 1, 3 (Fed. Cir. 1985) (observing that the standard for reviewing legal
conclusions of the USPTO “is correctness or error as a matter of law”).
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questions of law de novo188 and questions of fact under a clearly
erroneous standard.189  With regard to the Federal Circuit’s review of
the USPTO’s factual findings, the clearly erroneous standard is more
stringent than the APA’s arbitrary and capricious or substantial
evidence standard.190
Since the Supreme Court’s holding in Chevron, U.S.A., Inc. v.
Natural Resources Defense Council,191 the USPTO has asserted
entitlement to the judicial deference afforded other federal
agencies.192  The presumed agency expertise rationale, which typically
militates judicial deference to agency actions, however, may be less
significant with the USPTO.193  The specialized subject matter
jurisdiction of the Federal Circuit and the exclusivity of its appellate
relationship with the USPTO undercut the basis for judicial
deference under the APA.194
The USPTO adopted the practice of raising the standard of review
issue in its briefs to the Federal Circuit.195  The Federal Circuit, in
                                                 
188. See, e.g., In re Donaldson Co., 16 F.3d 1189, 1192, 29 U.S.P.Q.2d (BNA) 1845, 1848
(Fed. Cir. 1994) (en banc) (noting that questions of law receive de novo review); In re Kathawala,
9 F.3d 942, 945, 28 U.S.P.Q.2d (BNA) 1785, 1786 (Fed. Cir. 1993) (same).
189. See, e.g., In re Baxter Travenol Labs., 952 F.2d 388, 390, 21 U.S.P.Q.2d (BNA) 1281,
1283 (Fed. Cir. 1991) (noting that questions of fact are not reversed unless clearly erroneous);
In re Woodruff, 919 F.2d 1575, 1577, 16 U.S.P.Q.2d (BNA) 1934, 1935 (Fed. Cir. 1990) (same).
190. See, e.g., In re Napier, 55 F.3d 610, 614, 34 U.S.P.Q.2d (BNA) 1782, 1785 (Fed. Cir.
1995) (acknowledging that the current standard of review of a USPTO finding is “more
stringent than” the APA’s standard); In re Brana, 51 F.3d 1560, 1569, 34 U.S.P.Q.2d (BNA)
1436, 1444 (Fed. Cir. 1995) (finding the Board’s error reversible under both clear error and
arbitrary and capricious standards, but declining to address change from clearly erroneous
standard).
191. 467 U.S. 837 (1984).  In Chevron, the Court applied a deferential standard of review to
an Environmental Protection Agency order.  See id. at 862; see also R. Carl Moy, Judicial Deference
to the PTO’s Interpretations of the Patent Law, 74 J. PAT. [& TRADEMARK] OFF. SOC’Y 406, 426-39
(1992) (discussing the applicability of Chevron deference to the USPTO).
192. See Napier, 55 F.3d at 614, 34 U.S.P.Q.2d (BNA) at 1785 (rejecting the Commissioner’s
plea to apply APA standard of review to USPTO decisions); see also Brana, 51 F.3d at 1568-69, 34
U.S.P.Q.2d (BNA) at 1443 (noting Commissioner’s contention that USPTO decisions should be
afforded deferential standard of review); Jeffrey W. Rennecker, Ex Parte Appellate Procedure in the
Patent Office and the Federal Circuit’s Respective Standards of Review, 4 TEX. INTELL. PROP. L.J. 335,
368-69 (1996) (suggesting that the Federal Circuit’s failure to address the controversy regarding
its standard of review of the USPTO decisions might reflect an internal split among the court’s
judges).
193. See Moy, supra note 191, at 434-35 (“Congress took the unusual step of consolidating all
patent appeals into the Federal Circuit for the purpose of providing that court with overall
doctrinal responsibility for the law of patents.”) (emphasis added).
194. See id. at 435 (noting that the Federal Circuit was given doctrinal responsibility for
patent law in order to increase expertise of court).
195. For example, in In re Wodkiewicz, No. 95-1280, 1995 WL 550401,  (Fed. Cir. Sept. 14,
1995) (unpublished disposition), the principal brief of the USPTO Solicitor contained the
following footnote:
The Commissioner believes that the standard of review for factual determinations
made by the agency should be the arbitrary and capricious standard set forth in the
Administrative Procedure Act, 5 U.S.C. § 706.  However, in this case the findings are
not clearly erroneous and thus should survive review under either standard.
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several precedential opinions, recognized the USPTO’s position on
this matter but declined to decide the issue.196  For example, in In re
Brana,197 the Federal Circuit held that the disposition of the case did
not turn on the standard of review.198  Similarly, in In re Napier,199 the
Federal Circuit held it unnecessary to decide the question as to which
standard of review is appropriate.200
The respective opinions of the court in Brana and Napier clarified
that the Federal Circuit would not consider the appropriate standard
of review of USPTO determinations until squarely faced with an
appeal in which the standard of review was dispositive.201  Finally, in
1997, the Federal Circuit faced such a case.202
In In re Zurko,203 the Federal Circuit reversed the USPTO Board of
Patent Appeals and Interferences, which upheld the patent
examiner’s rejection of the applicants’ claims as obvious under 35
U.S.C. § 103.204  In 1990, applicant Mary E. Zurko applied for a patent
on improved ways of maintaining a secure environment in computer
systems.205  Specifically, the claimed methods involved processing a
trusted command with untrusted code, sending that command to the
trusted computing environment, and then seeking user verification
via a trusted pathway before executing the command.206
The prior art to the claimed invention included the UNIX
operating system and a software program known as the FILER2.207
Zurko acknowledged that the UNIX operating system described the
                                                 
Brief for Appellee at 12 n.1, Wodkiewicz, 1995 WL 550401.
196. See, e.g., In re Lueders, 111 F.3d 1569, 1574-78, 42 U.S.P.Q.2d (BNA) 1481, 1484-87
(Fed. Cir. 1997) (declining to apply heightened deference to the Board); In re Mac Dermid,
Inc., 111 F.3d 890, 890-91, 42 U.S.P.Q.2d (BNA) 1479, 1480 (Fed. Cir. 1997) (deciding not to
address the issue because precondition for an en banc hearing was not satisfied); In re Kemps, 97
F.3d 1427, 1430-31 & nn.4-6, 40 U.S.P.Q.2d (BNA) 1309, 1312-13 & nn.4-6 (Fed. Cir. 1996)
(concluding that the issue was not ripe at the time).
197. 51 F.3d 1560, 34 U.S.P.Q.2d (BNA) 1436 (Fed. Cir. 1995).
198. See id. at 1569, 34 U.S.P.Q.2d (BNA) at 1444 (commenting that in order to address the
issue meaningfully it must arise in a case where the final decision turns on a resolution of the
issue).
199. 55 F.3d 610, 34 U.S.P.Q.2d (BNA) 1782 (Fed. Cir. 1995).
200. See id. at 614, 34 U.S.P.Q.2d (BNA) at 1785 (deciding that because both standards were
met it was not necessary to decide which one to use).
201. See supra notes 197-200 and accompanying text (outlining the Court’s opinions
regarding when it would address standard of review).
202. See infra notes 203-25 and accompanying text (discussing In re Zurko and its legal status
regarding the correct standard of review to apply).
203. 111 F.3d 887, 42 U.S.P.Q.2d (BNA) 1476 (Fed. Cir. 1997).
204. See id. at 890, 42 U.S.P.Q.2d (BNA) at 1479; see also 35 U.S.C. § 103 (1994) (holding
that the Board had failed to show that this problem had been previously identified anywhere in
the prior art).
205. See Zurko, 111 F.3d at 887-88, 42 U.S.P.Q.2d (BNA) at 1477-78.  The application at issue
was U.S. Patent Application Serial No. 07/479,666.  See id., 42 U.S.P.Q.2d (BNA) at 1477-78.
206. See id. at 888 & n.1, 42 U.S.P.Q.2d (BNA) at 1477-78 & n.1.
207. See id. at 888, 42 U.S.P.Q.2d (BNA) at 1478.
1999] ECHOES OF SCIENTIFIC TRUTH 1265
feasibility of having an untrusted program recognize a trusted
command, such as a user keyboard entry, and then execute the
command in a trusted computing environment.208  The applicants
also acknowledged that the FILER2 program disclosed a mechanism
for repeating potentially dangerous user commands and requesting
confirmation from the user before command execution.209
The patent examiner rejected Zurko’s claims, inter alia, as obvious
in light of the UNIX and FILER2 prior art references.210  The patent
examiner determined that one of ordinary skill in the art having the
benefit of the cited prior art would have been led from these
teachings to take the trusted command parsed in the untrusted
environment and submit it to the trusted computing environment, as
taught by UNIX, and then display the parsed command to the user
for confirmation prior to execution, as suggested by FILER2.211
On appeal from the patent examiner’s rejection, the Board
agreed.212  In particular, the Board determined that communication
in a trusted environment normally would be assumed by artisans to
be over trusted paths, so that the use of such a path for verification,
in a system designed to ensure security, was explicit, or alternatively
inherent or implicit, in the prior art.213  In so finding, the Board
rejected Zurko’s argument that the use of a trusted (as opposed to
untrusted) path to seek and receive verification from the user before
command execution constituted a non-obvious advance over the
prior art.214
Zurko appealed the Board’s decision to the Federal Circuit, which
ultimately concluded that the decision should be reversed.215  The
Federal Circuit noted at the outset that obviousness is a legal question
based on underlying factual determinations.216  Furthermore, the
court indicated that what a prior art reference teaches and “whether
                                                 
208. See id., 42 U.S.P.Q.2d (BNA) at 1478 (reciting the admission in the applicants’
information disclosure statement that “the prior art includes an untrusted program parsing a
command and then executing the command by calling a trusted service that executes in a
trusted computing environment”).
209. See id., 42 U.S.P.Q.2d (BNA) at 1478 (noting the applicants’ description in their
information disclosure statement of the FILER2 as a program that “repeats back potentially
dangerous user commands and requests confirmation from the user prior to execution”).
210. See id., 42 U.S.P.Q.2d (BNA) at 1478.
211. See id., 42 U.S.P.Q.2d (BNA) at 1478 (suggesting that a trusted path is inherent in the
prior art).
212. See id., 42 U.S.P.Q.2d (BNA) at 1478.
213. See id., 42 U.S.P.Q.2d (BNA) at 1478.
214. See id., 42 U.S.P.Q.2d (BNA) at 1478.
215. See id. at 890, 42 U.S.P.Q.2d (BNA) at 1479 (holding that the Board clearly erred in its
finding of inherency from a prior art and concluding that the obviousness of the claimed
invention had not been established).
216. See id. at 888-89, 42 U.S.P.Q.2d (BNA) at 1478.
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it teaches toward or away from the claimed invention are questions of
fact.”217  Reviewing the references cited by the Board, the Federal
Circuit held that neither UNIX nor FILER2 teaches communication
with the user over a trusted pathway.218  The Federal Circuit ruled that
the Board impermissibly used hindsight in evaluating the claimed
invention.219  The court thus held that the Board clearly erred in
finding that the prior art teaches, either explicitly or inherently, the
step of obtaining confirmation over a trusted pathway.220
The Federal Circuit acknowledged the argument by the USPTO
that the court should review findings by the Board using a more
deferential standard.221  The Federal Circuit panel reminded the
parties that only the court sitting en banc could answer the question of
whether a different standard of review of the Board’s findings should
apply.222  Moreover, the court appeared to encourage the suggestion
of an en banc rehearing.223
In considering the suggestion by the USPTO for rehearing en banc,
the Federal Circuit agreed that the outcome of this appeal turned on
the standard of review applied to the Board’s factual findings.224
Accordingly, the Federal Circuit agreed to consider, en banc, whether
the Board’s factual findings should be reviewed under the APA
standard of review instead of the presently applied clearly erroneous
standard.225
The Federal Circuit, en banc, determined that it would adhere to its
traditional standard of review, rather than apply the standards
prescribed by the APA.226  First, the court noted that the substantial
                                                 
217. See id. at 889, 42 U.S.P.Q.2d (BNA) at 1478-79 (citing In re Bell, 991 F.2d 781, 784, 26
U.S.P.Q.2d (BNA) 1529, 1531 (Fed. Cir. 1993)).
218. See id., 42 U.S.P.Q.2d (BNA) at 1479 (concluding that communication with the user
takes place in the UNIX only over an untrusted pathway).
219. See id., 42 U.S.P.Q.2d (BNA) at 1479 (explaining that achieving the claimed invention
in the absence of any suggestion or motivation in the cited prior art constitutes an
impermissible hindsight reconstruction).
220. See id. at 889-90, 42 U.S.P.Q.2d (BNA) at 1479 (reversing the Board’s decision because
the obviousness was not established on the record).
221. See id. at 889 n.2, 42 U.S.P.Q.2d (BNA) at 1478 n.2 (noting the request for the
application of the standard of review set forth by the APA).
222. See id., 42 U.S.P.Q.2d (BNA) at 1478 n.2 (stating that petitions appropriately suggested
an en banc rehearing so that the court could rule on the Board’s standard of review).
223. See id., 42 U.S.P.Q.2d (BNA) at 1478 n.2 (asserting that a suggestion for rehearing en
banc would be appropriate where, as in this case, a panel of the court had determined that the
Board’s decision would be reversed under a non-APA standard of review).
224. See In re Zurko, 142 F.3d 1447, 1449, 46 U.S.P.Q.2d (BNA) 1691, 1693 (Fed. Cir. 1998)
(en banc) (reversing the Board of Patent Appeals and Inferences and holding that the Board’s
decision was based on clearly erroneous findings of fact).
225. See id., 46 U.S.P.Q.2d (BNA) at 1693.
226. See id., 46 U.S.P.Q.2d (BNA) at 1693 (“We believe section 559 of the Administrative
Procedure Act permits, and stare decisis warrants, our continued application of the clearly
erroneous standard in our review of these fact-findings.”).
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evidence or arbitrary and capricious standards of reviewing agency
factual findings under the APA would require the Federal Circuit to
review the Board’s decisions on the Board’s reasoning.227  In contrast,
the clearly erroneous standard would dictate affirmance of the
Board’s findings so long as the Federal Circuit lacked a definite
conviction that a mistake had occurred.228  Moreover, such a
determination would require the court to review Board decisions on
the Federal Circuit’s reasoning.229  Thus, the present Federal Circuit
standard of review differed from those prescribed by the APA both in
character and the degree of deference contemplated.230
After discussing the history and general purposes of the APA, the
Federal Circuit noted that the USPTO had been the subject of
specific attention during the drafting and enactment of the APA.231
The Federal Circuit acknowledged that Congress had specifically
contemplated exempting the work of the Patent Office from the
purview of the APA, but ultimately did not take such action.232
Nevertheless, the Federal Circuit interpreted the history of the APA
as suggesting that Congress drafted the APA to apply to agencies
generally, but that it did not intend the APA to alter the review of
substantive USPTO decisions by the courts.233
The Federal Circuit reviewed at some length the history of patent
law, including the various mechanisms historically provided for
administrative and judicial review of decisions to grant or deny
patents.234  The court noted that no statute addressed the standard of
review to be used by courts to examine administrative decisions in
                                                 
227. See id., 46 U.S.P.Q.2d (BNA) at 1693 (referring to the substantial evidence standard of
the APA under 5 U.S.C. § 706(2)(E) and the arbitrary and capricious standard under 5 U.S.C.
§ 706(2)(E)).
228. See id., 46 U.S.P.Q.2d (BNA) at 1693 (“Currently, we affirm decisions as long as we lack
a definite and firm conviction that a mistake has been made.”).
229. See id. at 1449-50, 46 U.S.P.Q.2d (BNA) at 1693-94 (noting that the clearly erroneous
standard requires the court to review Board decisions based upon the court’s reasoning).
230. See id. at 1450, 46 U.S.P.Q.2d (BNA) at 1694 (“The substantial evidence, arbitrary and
capricious, and clear error standards differ both in character and the amount of deference they
contemplate.”).
231. See id. at 1450-51, 46 U.S.P.Q.2d (BNA) at 1694-95 (finding that Congress specifically
considered excluding the USPTO from the APA’s standard of review).
232. See id. at 1451, 46 U.S.P.Q.2d (BNA) at 1695 (suggesting that the lack of an exemption
for the USPTO in the final text of the APA is because Congress thought it redundant in light of
5 U.S.C. § 559 which allows for de novo review).
233. See id. at 1452, 46 U.S.P.Q.2d (BNA) at 1695 (“[B]ecause of existing common law
standards and the availability of trial de novo . . . Congress did not intend the APA to alter the
review of substantive Patent Office decisions.”).  The Federal Circuit construed 5 U.S.C. § 559,
as “preserving those standards of judicial review that had evolved as a matter of common law
[before the APA’s enactment in 1946], rather than compelling that all such standards of review
be displaced by the [APA].”  Id. at 1452, 46 U.S.P.Q.2d (BNA) at 1696.
234. See id. at 1452-56, 46 U.S.P.Q.2d (BNA) at 1695-99.
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patent cases.235  However, the common law apparently recognized
several standards before 1947, including “clear error and its close
cousins.”236  The more searching clear error standard of review that the
Federal Circuit has applied in lieu of the substantial evidence
standard of the APA represents an “additional requirement” noted in
the cases before 1947.237  Accordingly, the Federal Circuit concluded
that it will continue to apply the clear error standard under the
exception in section 559 of the APA.238
The court found additional support for its holding in the principle
of stare decisis.239  Through its choice of standard, the court hoped to
“encourage administrative records that more fully describe the metes
and bounds of the patent grant than would a more deferential
standard of review.”240  Finally, the Federal Circuit advocated that the
clearly erroneous standard would “preserve the confidence of
inventors who have relied on this standard in prosecuting their
patents,” “promote consistency between [the court’s] review of the
patentability decisions of the board and the district courts in
infringement litigation,” and “help avoid situations where board fact
finding on matters such as anticipation or the factual inquiries
underlying obviousness become virtually unreviewable.”241
The briefs submitted to the Supreme Court by the petitioner,
respondent, and amici generally present arguments focusing on the
                                                 
235. See id. at 1456, 46 U.S.P.Q.2d (BNA) at 1700 (finding no patent statute which sets forth
a standard for review).
236. See id. at 1457, 46 U.S.P.Q.2d (BNA) at 1700 (listing cases which prove that “[s]ince the
creation of this court, we have consistently applied the clearly erroneous standard when
reviewing factual findings of the board”).
237. See id., 46 U.S.P.Q.2d (BNA) at 1700.
238. See id., 46 U.S.P.Q.2d (BNA) at 1700.  Having concluded that there had been a “settled
practice of reviewing factual findings of the board’s patentability determinations for clear
error,” the Federal Circuit held that its “interpretation of section 559 . . . permit[ted]” it to
continue that practice, “because no statute speaks directly to a required standard, and review
for clear error was certainly recognized in the cases—though perhaps not exclusively or
intentionally—before 1947.”  Id. at 1458, 46 U.S.P.Q.2d (BNA) at 1701.  The court added that
use of a non-APA standard was “justif[ied]” by “the premises underlying review for clear error.”
Id., 46 U.S.P.Q.2d (BNA) at 1701.  The court continues:
By making it clear that we review factual findings for clear error, and thereby review
board decisions on our own reasoning, we hope the board understands that we are
more likely to appreciate and adopt reasoning similar to its reasoning when it is both
well articulated and sufficiently founded on findings of fact.
Id., 46 U.S.P.Q.2d (BNA) at 1701.
239. See id. at 1457-58, 46 U.S.P.Q.2d (BNA) at 1700 (asserting that the court finds no
reason to vacate a standard without a compelling reason to do so).
240. Id. at 1458, 46 U.S.P.Q.2d (BNA) at 1701.
241. Id., 46 U.S.P.Q.2d (BNA) at 1701.  Having concluded that “section 559 and stare decisis
together justify our continued application of . . . [a] heightened level of scrutiny to decisions by
the board,” the Federal Circuit ratified the holding of the original panel that applied such a
standard and reversed the Board’s decision in this case.  See id. at 1459, 46 U.S.P.Q.2d (BNA) at
1701.
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merits based on administrative law of compliance with the APA, or
the dangers in changing the traditionally applied standard of
review.242  Several briefs addressed the relative technical expertise of
the USPTO and the Federal Circuit.243  None, however, specifically
considered whether granting greater deference to the factual
findings of the USPTO might have the unfavorable effect of
encouraging technical adjudication of patent cases.244  The Supreme
Court heard oral argument in Zurko on March 24, 1999.245
                                                 
242. The amicus briefs filed with the Supreme Court in Zurko suggest overwhelming public
support for the perpetuation of the clearly erroneous standard of review.  The sole amicus brief
in support of the position of the USPTO takes issue with the Federal Circuit circumvention of
the APA standards through an illusory exception in § 559.  See Brief of Amicus Intellectual
Property Professors in Support of Petitioner at 23-27, Dickinson v. Zurko, 119 S. Ct. 1816 (1999)
(No. 98-377).  Furthermore, the amicus proposes that the Supreme Court, in Morgan v.
Daniels, 153 U.S. 120 (1894), essentially ratified a judicial standard of review of USPTO factual
findings more deferential than that applied in appellate review of lower courts.  See Intellectual
Property Professor Brief at 12-15, Zurko (No. 98-377), 1998 WL 876969, at *12-15 (Dec. 15,
1998).
243. In its brief filed with the Supreme Court, the USPTO argued:
[Zurko’s] argument that the PTO “does not have a better view of the facts than the
Federal Circuit” ignores both the nature of the factual questions often (and here) at
issue and the relative technical expertise of PTO examiners and federal judges.  As we
have explained, the PTO personnel assigned to review particular patent applications
are selected in important part on the basis of their expertise in relevant technical
areas.  The PTO informs us, for example, that of the three members of the Board who
rendered the final administrative decisions in this case, one holds a degree in
electrical engineering, one holds a degree in electronics and has had extensive career
experience in computer technology, and one holds an advanced degree in computer
science and two in electrical engineering.
By way of contrast, the Federal Circuit, although generally considered a relatively
specialized court, has exclusive or primary appellate jurisdiction over a variety of
matters, including not only patent cases but also government contract cases, takings
claims, federal employment controversies, and international trade cases, as well as
internal revenue cases.  Its judges are thus familiar with patent litigation, but are not
necessarily experts in patent law; and they will seldom if ever possess the sort of
expertise that the PTO’s examiners-in-chief are statutorily required to possess in the
various technical fields (such as chemistry, biology, physics, mechanical or electrical
engineering) in which an inventor may claim to have made a non-“obvious” advance
over the prior art.  Thus, far from supporting the position adopted by the court of
appeals, the complex and technical nature of patent proceedings makes doubly plain
why it is inappropriate for an appellate court to engage in more-rigorous-than-usual
review of the factual determinations made by a quintessentially expert administrative
agency.
Brief of Petitioner at 37-38, Zurko (No. 98-377) (internal citations omitted), 1998 WL 886731, at
*37-38 (Dec. 19, 1998).
244. One amicus brief provided instances of Supreme Court commentary on the expertise
of the Federal Circuit and contended that the agency-judiciary dynamic perhaps more typical
with other applications of the APA is inapposite.  See Brief of Amicus Dallas-Fort Worth
Intellectual Property Law Association in Support of Respondents at 13-16, Zurko (No. 98-377)
(“The Federal Circuit’s review of PTO decisions, therefore, does not present the usual
circumstance of a generalist court reviewing a specialist agency, with the attendant danger that
judicial review will dilute agency expertise.”).  Indeed, an equally significant danger would be a
mandate, somehow, that the Federal Circuit conduct its future appellate reviews with
independent investigations of the underlying science.  See Zurko, 1998 WL 31201, at *12-13.
245. See Victoria Slind-Flor, Court Hears Key Patent Case, NAT’L. L.J., Apr. 5, 1999, at B1.  Since
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If the Supreme Court mandates a change in the Federal Circuit
standard of review of the factual findings of the USPTO Board of
Patent Appeals and Interferences, relatively few cases are likely to
have different outcomes than they would have under the existing
standard.246  Moreover, given the apparent trend of the Federal
Circuit and the Supreme Court to encourage better disclosure by
patent applicants, the greater degree of deference to the USPTO on
factual findings related to technical concerns may be
inconsequential.247
A likely public perception of a Supreme Court ruling in favor of
the APA standard of review, however, would be the ratification of the
agency expertise of the USPTO and the undermining of the authority
of the Federal Circuit.248  Whether or not grounded in reality, the
effect of such action seemingly would buttress the notion that patent
cases turn purely on the scientific merits of the technology.249
                                                 
the submission of this Article for publication, the Supreme Court, on June 10, 1999, issued its
decision in Dickinson v. Zurko, reversing and remanding the case to the Federal Circuit.  119 S.
Ct. 1816 (1999).  In short, the Court ruled that rather than being able to overturn USPTO fact-
findings in patent cases if they are “clearly erroneous,” the Federal Circuit must employ the
more deferential APA standard of review.  Accordingly, under the APA standard, the Federal
Circuit now may overturn USPTO fact-findings only if deemed “arbitrary, capricious” or
“unsupported by substantial evidence.”
The Supreme Court based its holding principally on the rejection of the Federal
Circuit’s reasoning that the clearly erroneous standard of review with respect to USPTO fact-
findings constituted an additional requirement recognized by law under 5 U.S.C. § 559.  Id. at
1822.  Writing for the 6-3 majority of the Court, Justice Breyer further noted that:
These features of review underline the importance of the fact that, when a Federal
Circuit judge reviews PTO factfinding, he or she often will examine that finding
through the lens of patent-related experience-and properly so, for the Federal Circuit
is a specialized court.  The comparative expertise, by enabling the Circuit better to
understand the basis for the PTO’s finding of fact, may play a more important role in
assuring a proper review than would a theoretically somewhat stricter standard.
Id. at 1823.
246. This prediction is best informed by the lengthy journey taken by the USPTO to deliver
even one case in which the resolution would depend upon the difference in the standard of
review applied.  See David Malakoff, High Court to Review Standard for Appeal, 282 SCIENCE 1622,
1622 (1988) (“Any ruling that changes the appeals process is likely to affect just a handful of
cases directly.”).
247. At least one commentator, however, has noted that fact-finding in ex parte proceedings
like those before the USPTO may involve logistical problems, which may further militate against
relaxing the Federal Circuit standard of review of facts found by the Board in USPTO decisions.
See Lawrence B. Ebert, Zurko and the Optimization of Fact-finding:  Who Can You Believe?, 6 INTELL.
PROP. TODAY 32, 32 (1999).
248. See Craig Allen Nard, Deference, Defiance, and the Useful Arts, 56 OHIO ST. L.J. 1415, 1422-
23 (1995) (challenging the existing Federal Circuit standard of review of decisions by the
USPTO as a “less than optimal balance of interpretive power”).
249. See Neil A. Smith & Seong-Kun Oh, US Courts to Keep Sharp Eye on PTO, IP WORLDWIDE
Sept.-Oct. 1998, at 35, 35-37; Robert C. Scheinfeld & Parker H. Bagley, The Federal Circuit and Its
Standard of Review, N.Y. L.J., May 27, 1998, at 3, 6 (reporting the Federal Circuit decisions in
Cybor and Zurko regarding the appellate court’s standards of review and noting that the courts
confirmed that patent claim construction is a matter of law for the court, not a matter of fact
for a jury).
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Unfortunately, armed with this misbelief, interested observers will
likely mark their judicial scorecards with continuing instances of
apparent conflict between scientific reality and justice under the
patent law.250
Such perceptions are likely to persist without a more balanced
understanding of the crucial relationship between the standards of
review and the resolution of patent-related appeals at the Federal
Circuit.251
III. APPLICABLE FEDERAL CIRCUIT STANDARDS OF REVIEW
In appeals relating to patent law issues, the Federal Circuit applies
several standards of review.  First, this section provides a background
discussion regarding the applicable standards of review, including
definitions and distinctions based on the tribunal from which the
appeal arises.252  Second, this section considers the standards of review
for patent enforcement issues, including infringement and
damages.253  Third, this section surveys the standards of review of
patentability and patent invalidity issues.254  This section concludes
with the standards of review of procedural, jurisdictional, and
appellate issues.255
A. General Standards
Perhaps the earliest detailed explication in a published Federal
Circuit opinion of the generally applicable standards of review
                                                 
250. See Malakoff, supra note 246, at 1622 (noting the close scrutiny by computer and
biomedical inventors and investors on the resolution of Zurko).
251. See infra Part III (detailing the standards of review used to resolve various patent
issues).  Indeed, the Supreme Court recognized in Dickinson v. Zurko that its mandate to the
Federal Circuit to apply the APA standard of review might be a distinction without a practical
difference.  See Dickinson v. Zurko, 119 S. Ct. 1816, 1823 (1999) (“[T]he difference is a subtle
one—so fine that (apart from the present case) we have failed to uncover a single instance in
which a reviewing court conceded that use of one standard rather than the other would in fact
have produced a different outcome.”).  When considered in isolation, the requirement in
Dickinson for the Federal Circuit to apply the APA standard of review to USPTO fact-findings
arguably reigns in the Federal Circuit’s ability to question the USPTO’s assessment of the
scientific merit of the claimed technology in a patent application.  When viewed in concert with
the other standards invoked by the Federal Circuit to review USPTO decisions, however, it
becomes more apparent that the adjudication of patentability does not take a technology-based
measure.
252. See infra notes 256-78 and accompanying text (reviewing applicable standards of review,
definitions, and distinctions based upon the originating tribunal).
253. See infra notes 279-357 and accompanying text (discussing standards of review for
patent enforcement issues, infringement, and damages).
254. See infra notes 358-425 and accompanying text (surveying the standards of review of
patentability and patent invalidity).
255. See infra notes 454-558 and accompanying text (outlining standards of review for
procedural, jurisdictional, and appellate issues).
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occurred under the authorship of Judge Nies, who provided her
additional views in SSIH Equipment S.A. v. United States International
Trade Commission.256
The standards of appellate review of factual determinations, in
contrast to the quantum of proof required at the trial level, are
usually statutorily imposed.  The standards most commonly
specified are “de novo,” “clearly erroneous,” “supported by
substantial evidence” and “factual determinations, in contrast to
the quantum of proof required arbitrary or capricious,” which I
translate roughly into questions of increasingly narrow focus:  is a
finding of fact right; is it wrong; is it unreasonable; is it irrational?
A “de novo” standard provides the widest latitude for review of facts.
The court in “de novo” review must exercise its independent
judgment on the evidence of record and weigh it as a trial court.
The court is not, however, required to ignore the decision
below . . . .
With respect to “clearly erroneous,” the next level in the
hierarchy . . . :
A finding is “clearly erroneous” when although there is
evidence to support it, the reviewing court on the entire
evidence is left with the definite and firm conviction that a
mistake has been committed.
The standard commonly associated with review by an appellate
court of agency determinations is “supported by substantial
evidence.”  This standard (perhaps because of its inept name)
appears to be the least comprehended.  To begin, a “substantial
evidence” standard restricts an appellate court to a greater degree
than “clearly erroneous” review.  The Supreme
Court . . . undertook to set out the development and various
interpretations which had been given to “substantial evidence” as a
standard of review.
Beginning with its previously defined standard:
“[s]ubstantial evidence is more than a mere scintilla.  It means
such relevant evidence as a reasonable mind might accept as
adequate to support a conclusion.”  Accordingly, it “must do
more than create a suspicion of the existence of the fact to be
established . . . . it must be enough to justify, if the trial were to
a jury, a refusal to direct a verdict when the conclusion sought
to be drawn from it is one of fact for the jury . . . .”
The narrowest latitude to a reviewing court is where the
                                                 
256. 718 F.2d 365, 379-83, 218 U.S.P.Q. (BNA) 678, 690-93 (Fed. Cir. 1983) (Nies, J.,
additional views) (reviewing and distinguishing standards of proof).
1999] ECHOES OF SCIENTIFIC TRUTH 1273
court can reverse a decision only by finding it “arbitrary or
capricious”. . . .  Suffice for purposes here to say that the
standard is whether the decision was based on the relevant
factors and whether there has been a clear error of
judgment.257
B. Federal Circuit Statutory Interpretation
In reviewing the decisions of its lower tribunals, the Federal Circuit
must parse the meaning of various enabling and substantive statutes
before the court can assess compliance with such law.258  The issue of
statutory interpretation is a question of law, which the Federal Circuit
reviews de novo.259
1. Choice of law
The Federal Circuit often undertakes a choice of law inquiry to
decide whether to establish or follow its own precedent or to apply
the law of the appropriate regional circuit.260  This consideration
involves competing policy interests between “the general policy of
minimizing confusion and conflicts in the federal judicial system,”261
and the congressional intent “to bring about uniformity in the area of
                                                 
257. Id. at 381-83, 218 U.S.P.Q. (BNA) at 691-93 (Fed. Cir. 1983) (Nies, J., additional views)
(internal citations omitted).
258. As a practical matter, the relative infrequency of the Supreme Court’s review of patent-
related cases from the Federal Circuit effectively renders the Federal Circuit the final arbiter of
the legal effect of the patent statutes.  See Ian Ayres & Paul Klemperer, Limiting Patentees’ Market
Power Without Reducing Innovation Incentives:  The Perverse Benefits of Uncertainty and Non-Injunctive
Remedies, 97 MICH. L. REV. 985, 1023 (1999) (noting that the Supreme Court rarely reverses
Federal Circuit decisions, giving the court the final word on patent law statutes).  This role is
entirely consistent with the court’s legislative purpose.  See Howard T. Markey, The Court of
Appeals for the Federal Circuit:  Challenge and Opportunity, 34 AM. U. L. REV. 595, 596 (1985)
(revealing that as early as June 10, 1887, the Supreme Court appeared to approve of the
creation of a “‘national court of last resort’” to hear appeals in patent cases from all lower
courts and the USPTO).
259. See In re Portola Packaging, Inc., 110 F.3d 786, 788, 42 U.S.P.Q.2d (BNA) 1295, 1297
(Fed. Cir. 1997) (maintaining that when appellate review is based on statutory interpretation it
is a question of law, which the court reviews de novo); see also Abbott Lab. v. Novopharm Ltd.,
104 F.3d 1305, 1308, 41 U.S.P.Q.2d (BNA) 1535, 1537 (Fed. Cir. 1997) (same); Merck & Co.,
Inc. v. Kessler, 80 F.3d 1543, 1549, 38 U.S.P.Q.2d (BNA) 1347, 1351 (Fed. Cir. 1996) (same);
Bristol-Myers Squibb Co. v. Royce Labs., Inc., 69 F.3d 1130, 1134, 36 U.S.P.Q.2d (BNA) 1641,
1645 (Fed. Cir. 1995) (same); In re Chu, 66 F.3d 292, 296, 36 U.S.P.Q.2d (BNA) 1089, 1092-93
(Fed. Cir. 1995) (same); Glaxo Operations UK Ltd. v. Quigg, 894 F.2d 392, 395, 13 U.S.P.Q.2d
(BNA) 1628, 1630 (Fed. Cir. 1990) (same).
260. See Biodex Corp. v. Loredan Biomedical, Inc., 946 F.2d 850, 855-58, 20 U.S.P.Q.2d
(BNA) 1252, 1256-59 (Fed. Cir. 1991), cert. denied, 504 U.S. 980 (1992) (outlining the reasons
for determining whether Federal Circuit or regional circuit law applies).
261. Panduit Corp. v. All States Plastic Mfg. Co., 744 F.2d 1564, 1574, 223 U.S.P.Q. (BNA)
465, 471 (Fed. Cir. 1984) (stating that “the possibility of different [sets of] requirements should
be minimized especially where a dispute is totally unrelated to patent issues and the resolution
of that dispute does not impinge on the goal of patent law uniformity”).
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patent law.”262  Accordingly, the Federal Circuit defers to regional
circuit law when reviewing issues not unique to patent law.263
2. Lower tribunals
The Federal Circuit has exclusive jurisdiction to hear patent-
related appeals from the U.S. International Trade Commission
(“ITC”), the USPTO Board of Patent Appeals and Interferences, and
the U.S. District Courts.
a. United States International Trade Commission
The Federal Circuit has exclusive jurisdiction over final
determinations of the ITC relating to unfair practices in import
trade, made under section 337 of the Tariff Act of 1930.264  The court
reviews a final determination of the ITC in accordance with Chapter
7 of the APA, 5 U.S.C. §§ 701-706 (1994).265  Accordingly, the Federal
Circuit reviews factual findings of the ITC under the substantial
evidence standard.266
Although the Federal Circuit generally reviews ITC interpretations
of statutory provisions de novo, the court sometimes grants deference
to agency interpretation, especially when technical issues that require
some expertise are involved.267  The Federal Circuit will affirm the
                                                 
262. Id., 223 U.S.P.Q. (BNA) at 470.
263. See U.S. Philips Corp. v. Windmere Corp., 861 F.2d 695, 701-02, 8 U.S.P.Q.2d (BNA)
1885, 1890 (Fed. Cir. 1988), cert. denied, 490 U.S. 1068 (1989) (applying regional circuit law in
an antitrust counterclaim); see also Joan E. Schaffner, Federal Circuit “Choice of Law”:  Erie Through
the Looking Glass, 81 IOWA L. REV. 1173, 1175 n.8 (1996) (suggesting that the self-ascribed choice
of law inquiry undertaken by the Federal Circuit in confronting issues outside its exclusive
jurisdiction may be characterized more accurately as a choice between independent judgment
and deference); cf. Chrysler Motors Corp. v. Auto Body Panels of Ohio, Inc., 908 F.2d 951, 952-
53, 15 U.S.P.Q.2d (BNA) 1469, 1470 (Fed. Cir. 1990) (suggesting substantive matters not
exclusive to the Federal Circuit receive regional circuit law application and substantive
procedural issues receive application of Federal Circuit law).
264. See 28 U.S.C. § 1295(a)(6) (1994).
265. See 19 U.S.C. § 1337(c) (1994) (stating that those adversely affected by a § 337
determination may appeal to the Federal Circuit for review in accordance with chapter 7 of
Title 5); see also Fischer & Porter Co. v. United States Int’l Trade Comm’n, 831 F.2d 1574, 1576,
4 U.S.P.Q.2d (BNA) 1700, 1701 (Fed. Cir. 1987) (reviewing an ITC decision under the
jurisdiction of § 1337).
266. See 5 U.S.C. § 706(2)(E) (1994) (setting forth the substantial evidence standard of
review); see also Checkpoint Sys., Inc. v. United States Int’l Trade Comm’n, 54 F.3d 756, 759, 35
U.S.P.Q.2d (BNA) 1042, 1045 (Fed. Cir. 1995) (same); Intel Corp. v. United States Int’l Trade
Comm’n, 946 F.2d 821, 832, 20 U.S.P.Q.2d (BNA) 1161, 1171 (Fed. Cir. 1991) (same); Tandon
Corp. v. United States Int’l Trade Comm’n, 831 F.2d 1017, 1019, 4 U.S.P.Q.2d (BNA) 1283,
1284-85 (Fed. Cir. 1987) (same).  Under the substantial evidence standard, the Federal Circuit
will not disturb the Commission’s factual findings if they are supported by “such relevant
evidence as a reasonable mind might accept as adequate to support a conclusion.”  Surface
Tech., Inc. v. United States Int’l Trade Comm’n, 801 F.2d 1336, 1340-41, 231 U.S.P.Q. (BNA)
192, 196 (Fed. Cir. 1986).
267. See Farrell Corp. v. United States Int’l Trade Comm’n, 949 F.2d 1147, 1151, 20
U.S.P.Q.2d (BNA) 1912, 1916 (Fed. Cir. 1991); see also 5 U.S.C. § 706(2)(A) (1994) (stating that
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ITC’s interpretation of section 337 if it is reasonable in light of the
statute’s language, policies, and legislative history.268
b. USPTO Board of Patent Appeals and Interferences
The Federal Circuit has exclusive jurisdiction over final
determinations of the USPTO Board of Patent Appeals and
Interferences.269  The Federal Circuit generally reviews the USPTO’s
interpretations of statutory provisions de novo.270  In addition, the
Federal Circuit traditionally has reviewed factual findings of the
Board under the clearly erroneous standard,271 the propriety of which
was recently under review by the Supreme Court.272
Before appealing to the Federal Circuit, a party receiving an
adverse ruling from the Board may seek reconsideration.273  Whether
a party properly raised an issue is a question of law based on
“subsidiary factual findings.”274
c. District Court
The Federal Circuit has exclusive jurisdiction over final orders and
                                                 
such deference is limited to the clear meaning of the statute “as revealed by its language,
purpose, and history”) (citing AlTech Speciality Steel Corp. v. United States, 745 F.2d 632, 642
(1984)); YBM Magnex, Inc. v. United States Int’l Trade Comm’n, 145 F.3d 1317, 1320, 46
U.S.P.Q.2d (BNA) 1843, 1845 (Fed. Cir. 1998).
268. See Enercon GmbH v. United States Int’l Trade Comm’n, 151 F.3d 1376, 1381, 47
U.S.P.Q.2d (BNA) 1725, 1729 (Fed. Cir. 1998).
269. See 28 U.S.C. § 1295(a)(6) (1994) (noting exclusive jurisdiction over registration
applications and “other proceedings”).
270. See Astra v. Lehman, 71 F.3d 1578, 1580, 37 U.S.P.Q.2d (BNA) 1212, 1214 (Fed. Cir.
1995).  While the interpretation by the USPTO of a statute it administers is entitled to
deference, see Chevron U.S.A. v. Natural Resources Defense Council, 467 U.S. 837, 844 (1984),
“the courts are the final authorities on issues of statutory construction.  They must reject
administrative constructions of the statute, whether reached by adjudication or by rulemaking,
that are inconsistent with the statutory mandate or that frustrate the policy Congress sought to
implement.”  Ethicon, Inc. v. Quigg, 849 F.2d 1422, 1425, 7 U.S.P.Q.2d (BNA) 1152, 1154 (Fed.
Cir. 1988).
271. See In re Borden, 90 F.3d 1570, 1576, 39 U.S.P.Q.2d (BNA) 1524, 1527 (Fed. Cir. 1996)
(reviewing the factual determinations of the Board under a clearly erroneous standard); In re
GPAC, Inc., 57 F.3d 1573, 1577, 35 U.S.P.Q.2d (BNA) 1116, 1119 (Fed. Cir. 1995) (same); In re
Vaeck, 947 F.2d 488, 495, 20 U.S.P.Q.2d (BNA) 1438, 1444 (Fed. Cir. 1991) (same); In re
Woodruff, 919 F.2d 1575, 1577, 16 U.S.P.Q.2d (BNA) 1934, 1935 (Fed. Cir. 1990) (same); In re
King, 801 F.2d 1324, 1326, 231 U.S.P.Q. (BNA) 136, 137 (Fed. Cir. 1986) (same); In re Longi,
759 F.2d 887, 892, 225 U.S.P.Q. (BNA) 645, 648 (Fed. Cir. 1985) (same); In re De Blauwe, 736
F.2d 699, 703, 222 U.S.P.Q. (BNA) 191, 194 (Fed. Cir. 1984) (same); In re Kunzmann, 326 F.2d
424, 426, 140 U.S.P.Q. (BNA) 235, 237 (C.C.P.A. 1964) (same).
272. See supra note 245.
273. See Cooper v. Goldfarb, 154 F.3d 1321, 1331, 47 U.S.P.Q.2d (BNA) 1896, 1904 (Fed.
Cir. 1998) (“A party cannot wait until after the board has rendered an adverse decision then
present new arguments in a request for reconsideration.”).
274. See id., 47 U.S.P.Q.2d (BNA) at 1904 (explaining that the court will consider only those
issues raised in the parties’ briefs at the final hearing).
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judgments from the U.S. district courts nationwide.275  Patent cases
may be tried to the jury or to the district court judge sitting as the
finder of fact.  When the jury applies the law to the facts, the verdict
is viewed as having resolved the material factual issues in favor of the
verdict winner.276
In a case tried without a jury, or with an advisory jury, Federal Rule
of Civil Procedure 52(a) provides that a district court “shall find the
facts specially and state separately its conclusions of law thereon.”277
This facilitates a meaningful review of bench rulings by the appellate
court, which reviews the district court decision for errors of law and
clearly erroneous findings of fact.278
C. Patent Infringement Standards
A U.S. patent is a government grant for exclusive rights to an
invention for a limited amount of time.279  One who engages without
permission in statutorily proscribed conduct relating to a patented
invention is, subject to available defenses, a patent infringer.280
Every patent concludes with at least one numbered paragraph
called a “claim.”281  The claim defines the patented invention.282
                                                 
275. See 28 U.S.C. § 1295(a)(6) (1994).
276. See Newell Cos. v. Kenney Mfg. Co., 864 F.2d 757, 765, 9 U.S.P.Q.2d (BNA) 1417, 1423
(Fed. Cir. 1988) (“Judges must accept the factual findings, presumed from a favorable jury
verdict, which are supported under the substantial evidence/reasonable juror standard.”).
277. FED. R. CIV. P. 52(a).  But see Maureen McGirr, Panduit Corp. v. Dennison Manufacturing
Co.:  De Novo Review and the Federal Circuit’s Application of the Clearly Erroneous Standard, 36 AM. U.
L. REV. 963, 969-70 (1987) (questioning the Federal Circuit’s attendance to the clearly
erroneous standard set forth under Federal Rule of Civil Procedure 52(a)).
278. See King Instruments Corp. v. Perego, 65 F.3d 941, 945, 36 U.S.P.Q.2d (BNA) 1129,
1131 (Fed. Cir. 1995) (distinguishing the standards of review for factual findings and legal
conclusions); Interspiro USA, Inc. v. Figgie Int’l, Inc., 18 F.3d 927, 930, 30 U.S.P.Q.2d (BNA)
1070, 1072 (Fed. Cir. 1994) (same).
279. The U.S. Constitution contemplates the statutory grant of intellectual property rights.
See U.S. CONST. art. I, § 8, cl. 8 (vesting Congress with the power “[t]o promote the Progress of
Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive
Right to their respective Writings and Discoveries”).  Title 35 of the United States Code sets
forth the statutory scheme for domestic patent protection.  See generally 35 U.S.C. § 100-200
(1994) (providing for application and award of patents).  In addition, the USPTO has
promulgated regulations concerning the prosecution of patent applications.  See generally 37
C.F.R. § 1.31-1.378 (1998) (stating national processing provisions).
280. See 35 U.S.C. § 271(a), (4)(B)-(C) (stating that if there is a finding of infringement, the
court will grant injunctive relief and a damages award against the infringers).
281. The specification of a United States patent contains several parts, namely a title, an
abstract, a summary of the invention, any drawings, and one or more claims.  See 37 C.F.R.
§§ 1.71-1.77 (setting forth the required elements and order of patent application).  Although
technically part of the specification, a patent claim has heightened importance as the legally
recognized description of the invention.  See Aro Mfg. Co. v. Convertible Top Replacement Co.,
365 U.S. 336, 339 (1961) (“[T]he claims made in the patent are the sole measure of the
grant . . . .”).
282. See UNITED STATES DEPARTMENT OF COMMERCE, PATENT AND TRADEMARK OFFICE,
MANUAL OF PATENT EXAMINING PROCEDURE § 608.01(k), at 600-63 (7th ed. 1998) [hereinafter
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Moreover, the claim sets forth the scope of the patent holder’s legal
right to exclude others, during the patent term, from making, using,
offering for sale, selling the patented invention throughout the
United States, or importing that invention into the United States.283
The correct interpretation of a claim is paramount in virtually all
patent-related matters.284  Indeed, judicial determinations regarding
the patentability, validity, or infringement of a patent claim all rely on
the same claim interpretation.285
D. Claim Construction
The construction of a patent claim is within the exclusive domain
of the court.286  The Federal Circuit reviews claim interpretation de
novo, including any allegedly fact-based questions relating to claim
construction.287
The proper construction of a means-plus-function limitation
requires the court to interpret the limitation in light of the
corresponding structure, material, or acts described in the written
description, and equivalents thereof, to the extent that the written
description provides such disclosure.288  “A determination of
corresponding structure is a determination of the meaning of the
‘means’ term in the claim and is a matter of claim construction.”289
                                                 
MPEP] (“35 U.S.C. § 112 requires that the applicant shall particularly point out and distinctly
claim the subject matter which he or she regards as his or her invention.  The portion of the
application in which he or she does this forms the claim or claims.”).
283. See Zenith Lab., Inc. v. Bristol-Myers Squibb Co., 19 F.3d 1418, 1424, 30 U.S.P.Q.2d
(BNA) 1285, 1290 (Fed. Cir. 1994) (“[T]he claim . . . sets the metes and bounds of the
invention entitled to the protection of the patent system.”); see also 35 U.S.C. § 271 (1994)
(codifying Uruguay Round Agreements Act, Pub. L. No. 103-465, 108 Stat. 4809, 4983-85 (1994)
and amending § 271 to include as infringing conduct an unauthorized offer for sale of patented
invention in United States, or importation of patented invention into United States after
January 1, 1996).
284. The Federal Circuit has rejected the notion that claim construction and claim
interpretation are different.  See Markman v. Westview Instruments, Inc., 52 F.3d 967, 976 n.6,
34 U.S.P.Q.2d (BNA) 1321, 1326 n.6 (Fed. Cir. 1995) (en banc) (“[I]n our view, the terms
mean one and the same thing in patent law.”), aff’d, 517 U.S. 370 (1996).  This Article uses the
terms “claim construction” and “claim interpretation” interchangeably throughout.
285. See SmithKline Diagnostics, Inc. v. Helena Lab. Corp., 859 F.2d 878, 882, 8 U.S.P.Q.2d
(BNA) 1468, 1471 (Fed. Cir. 1988) (“[C]laims must be interpreted and given the same meaning
for purposes of both validity and infringement analyses.”).
286. See Markman, 517 U.S. at 376 (affirming the appellate court’s holding that patent claim
interpretation is solely within the province of the courts).
287. See Cybor Corp. v. FAS Techs., Inc., 138 F.3d 1448, 1456, 46 U.S.P.Q.2d (BNA) 1169,
1174 (Fed. Cir. 1998) (en banc) (asserting that claim construction is a question of law); see also
Markman, 52 F.3d at 981, 34 U.S.P.Q.2d (BNA) at 1331 (providing that construing claims is a
matter of law).
288. See In re Donaldson Co., 16 F.3d 1189, 1193, 29 U.S.P.Q.2d (BNA) 1845, 1848 (Fed. Cir.
1994) (en banc) (noting that this construction applies “regardless of the context in which the
interpretation of means plus-function language arises”).
289. See Chiuminatta Concrete Concepts, Inc. v. Cardinal Indus., Inc., 145 F.3d 1303, 1308,
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Structure disclosed in the specification, however, is only
“corresponding” structure to the claimed means under § 112, ¶ 6 if
the structure is clearly linked by the specification or the prosecution
history to the function recited in the claim.290  To determine the
specific function associated with the means limitation requires
construction of the claim language, which is a question of law that
the Federal Circuit reviews de novo.291
E. Literal Infringement
Patent infringement liability arises with the unauthorized
manufacture, use, offer for sale, or sale in the United States of a
patented invention, or importation of that invention into the United
States.292  The determination of infringement is a two-step inquiry,
beginning with a proper claim construction.293  The second step of
the infringement analysis involves the comparison of the accused
product or process to the properly construed claim.294  A patent
holder who alleges infringement has the burden of proving at trial,
by a preponderance of the evidence, that the accused infringer’s
                                                 
46 U.S.P.Q.2d (BNA) 1752, 1755-56 (Fed. Cir. 1998) (characterizing the “means” term as a
“general reference for the corresponding structure disclosed in the publication”); B. Braun
Med., Inc. v. Abbott Lab., 124 F.3d 1419, 1424, 43 U.S.P.Q.2d (BNA) 1896, 1990 (Fed. Cir.
1997) (explaining that the patent description is reviewed to find correspondence between the
structure and the means); see also Pennwalt Corp. v. Durand-Wayland, Inc., 833 F.2d 931, 934, 4
U.S.P.Q.2d (BNA) 1737, 1739 (Fed. Cir. 1987) (en banc) (“To determine whether a claim
limitation is met literally, where expressed as a means for performing a stated function, the
court must compare the accused structure with the disclosed structure, and must find
equivalent structure as well as identity of claimed function for that structure.”).
290. See Chiuminatta, 145 F.3d at 1308, 46 U.S.P.Q.2d (BNA) at 1755 (determining
correspondence to the means limitation by comparing the “accused structure” with the
“disclosed structure”).
291. See Mas-Hamilton Group v. LaGard, Inc., 156 F.3d 1206, 1213-14, 48 U.S.P.Q.2d (BNA)
1010, 1016-17 (Fed. Cir. 1998) (discussing the means-plus-function claim construction analysis);
B. Braun Med., 124 F.3d at 1424-25, 43 U.S.P.Q.2d (BNA) at 1899-1900 (advancing the
“adequate disclosure” requirement mandated when patent claims are drafted in a “means-plus
function format”); cf. Markman, 52 F.3d at 977 n.8, 34 U.S.P.Q.2d (BNA) at 1327 n.8 (reserving
only the question whether a determination of equivalence under § 112, ¶ 6 is a question of law
or fact).
292. See 35 U.S.C. § 271(a) (1994).  For a statistical study of the Federal Circuit’s
dispositions in appeals from infringement findings, see Donald R. Dunner et al., A Statistical
Look at the Federal Circuit’s Patent Decisions:  1982-1994, 5 FED. CIR. B.J. 151, 176 tbl. 5 (1995),
which covers the period from October 1, 1982 to March 15, 1994.
293. See Carroll Touch, Inc. v. Electro Mechanical Sys., Inc., 15 F.3d 1573, 1576, 27
U.S.P.Q.2d (BNA) 1836, 1839 (Fed. Cir. 1993) (stating that the patent claim must be properly
construed to determine its scope and meaning).
294. See North Am. Vaccine, Inc. v. American Cyanamid Co., 7 F.3d 1571, 1574, 28
U.S.P.Q.2d (BNA) 1333, 1335 (Fed. Cir. 1993) (noting that the second step of the analysis is an
issue of fact); see also Lemelson v. General Mills, Inc., 968 F.2d 1202, 1206, 23 U.S.P.Q.2d (BNA)
1284, 1287 (Fed. Cir. 1992) (indicating that step two of the analysis determines “whether a
particular claim ‘reads on’ the accused structure or process”); W.L. Gore & Assocs., Inc. v.
Garlock, Inc., 842 F.2d 1275, 1280, 6 U.S.P.Q.2d (BNA) 1277, 1282 (Fed. Cir. 1988) (illustrating
the application of step two in an infringement analysis case).
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product or process contains every limitation of at least one of the
asserted claims of the patent, either literally or by equivalence.295
Where a jury or the ITC makes a finding of fact that a patent
infringement has occurred, the Federal Circuit will review the finding
under the substantial evidence standard.296  The Federal Circuit
reviews infringement questions under the clearly erroneous standard
when the trial judge acted as the fact-finder.297
In order to meet a means-plus-function limitation, an accused
device must first perform the identical function recited in the means
limitation and second, perform that function using the structure
disclosed in the specification or an equivalent structure.298  The
Federal Circuit reviews this factual determination for substantial
evidence to support the jury’s verdict,299 or the ITC’s findings for
clear error where the trial judge was the fact-finder.
F. Infringement Under the Doctrine of Equivalents
A literal infringement results when every limitation recited in a
patent claim is present exactly in an accused product or process.300  A
                                                 
295. See Conroy v. Reebok Int’l Ltd., 14 F.3d 1570, 1573, 29 U.S.P.Q.2d (BNA) 1373, 1374-
75 (Fed. Cir. 1994) (“[T]he patentee must prove that the accused device embodies every
limitation in the claim, either literally or by a substantial equivalent.”); Key Mfg. Group, Inc. v.
Microdot, Inc., 925 F.2d 1444, 1449, 17 U.S.P.Q.2d (BNA) 1806, 1810 (Fed. Cir. 1991) (“To
support an infringement determination, an accused device must embody exactly each claim
limitation or its equivalent.”); Envirotech Corp. v. Al George, Inc., 730 F.2d 753, 758, 221
U.S.P.Q. (BNA) 473, 477 (Fed. Cir. 1984) (providing that infringement is found when “the
accused device falls within the scope of the asserted claims as properly interpreted”).
296. See Lemelson, 968 F.2d at 1207, 23 U.S.P.Q.2d at 1288 (“[The substantial evidence test]
requires us to decide for ourselves whether reasonable jurors viewing the evidence as a whole
could have found the facts needed to support the verdict in light of the applicable law.”).
297. See Young Dental Mfg. Co. v. Q3 Special Prods., Inc., 112 F.3d 1137, 1141, 42
U.S.P.Q.2d (BNA) 1589, 1592 (Fed. Cir. 1997) (using a clear error standard of review to
determine whether all claim limitations were present either literally or equivalently); see also
Hilton-Davis Chem. Co. v. Warner-Jenkinson Co., 62 F.3d 1512, 1520-21, 35 U.S.P.Q.2d (BNA)
1641, 1657 (Fed. Cir. 1995) (en banc); Pennwalt Corp. v. Durand-Wayland, Inc., 833 F.2d 931,
936, 4 U.S.P.Q.2d (BNA) 1737, 1740 (Fed. Cir. 1987) (en banc) (explaining that clear error
occurs when the reviewing court, after examining all the evidence, is convinced that a mistake
has been committed); SRI Int’l v. Matsushita Elec. Corp. of Am., 775 F.2d 1107, 1125, 227
U.S.P.Q. (BNA) 577, 589 (Fed. Cir. 1985) (en banc).
298. See Intellicall, Inc. v. Phonometrics, Inc., 952 F.2d 1384, 1388-89, 21 U.S.P.Q.2d (BNA)
1383, 1387 (Fed. Cir. 1992).
299. See Young Dental Mfg., 112 F.3d at 1141, 42 U.S.P.Q.2d (BNA) at 1592; see also Texas
Instruments Corp. v. United States Int’l Trade Comm’n, 805 F.2d 1558, 1562, 231 U.S.P.Q.
(BNA) 833, 834-35 (Fed. Cir. 1986) (affirming the ITC noninfringement finding based on the
existence of substantial evidence in the record).
300. See Strattec Sec. Corp. v. General Automotive Specialty Co., 126 F.3d 1411, 1418, 44
U.S.P.Q.2d (BNA) 1030, 1036 (Fed. Cir. 1997) (restating literal infringement as “when the
properly construed claim reads on the accused device exactly”).  For illustrations of how courts
have analyzed literal infringement cases, see Key Mfg. Group, 925 F.2d at 1449, 17 U.S.P.Q.2d
(BNA) at 1810; Johnston v. IVAC Corp., 885 F.2d 1574, 1580, 12 U.S.P.Q.2d (BNA) 1382, 1384
(Fed. Cir. 1989); ZMI v. Cardiac Resuscitator Corp., 844 F.2d 1576, 1582, 6 U.S.P.Q.2d (BNA)
1557, 1562 (Fed. Cir. 1988); Uniroyal, Inc. v. Rudkin-Wiley Corp., 837 F.2d 1044, 1054, 5
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finding of infringement, however, does not require that the accused
product or process literally embody every limitation of the claim.301
Even when a patent holder cannot prove literal infringement, a
finding of infringement may be appropriate under the doctrine of
equivalents.302
                                                 
U.S.P.Q.2d (BNA) 1434, 1441 (Fed. Cir. 1988); Stewart-Warner Corp. v. City of Pontiac, 767
F.2d 1563, 1570, 226 U.S.P.Q. (BNA) 676, 681 (Fed. Cir. 1985).
301. See Pennwalt Corp. v. Durand-Wayland, Inc., 833 F.2d 931, 934-35, 4 U.S.P.Q.2d (BNA)
1737, 1739-40 (Fed. Cir. 1987) (en banc) (explaining that the doctrine of equivalents allows a
finding of infringement if the accused product performs substantially the same function in
substantially the same way to obtain the same result as the claimed device); see also Corning
Glass Works v. Sumitomo Elec. U.S.A., Inc., 868 F.2d 1251, 1259, 9 U.S.P.Q.2d (BNA) 1962,
1967 (Fed. Cir. 1989) (clarifying that each claim limitation need not be “literally” found in the
accused product—an equivalent of the stated limitation found in the accused product is
sufficient to support a verdict of infringement); Mannesmann Demag Corp. v. Engineered
Metal Prods. Co., 793 F.2d 1279, 1282, 230 U.S.P.Q. (BNA) 45, 46 (Fed. Cir. 1986) (same).
In Graver Tank & Manufacturing Co. v. Linde Air Products Co., 339 U.S. 605 (1950), the
Supreme Court set forth a tripartite test to decide infringement under the doctrine of
equivalents. See id. at 608.  The Court held that the absence of literal infringement did not
preclude a finding of infringement under the doctrine of equivalents when the accused device
“performs substantially the same function in substantially the same way to obtain the same
result.”  Id. (stating that the essence of the doctrine is that one may not practice fraud on the
patent).  This holding soon received shorthand reference as the function-way-result test of
Graver Tank.  Cf. International Visual Corp. v. Crown Metal Mfg., 991 F.2d 768, 774, 26
U.S.P.Q.2d (BNA) 1588, 1593 (Fed. Cir. 1993) (stating that there may be instances in which the
function-way-result test is satisfied, but when the facts may not justify application of the doctrine
of equivalents).
The present touchstone for determining whether an element in an accused device is
equivalent to a claimed limitation is the substantiality of their differences.  See Dawn Equip. Co.
v. Kentucky Farms Inc., 140 F.3d 1009, 1015-16, 46 U.S.P.Q.2d (BNA) 1109, 1114-15 (Fed. Cir.
1998).  In order to infringe under the doctrine of equivalents, the element must differ only
insubstantially from the asserted claim limitation.  See Dawn Equip., 140 F.3d at 1015-16
(acknowledging the inadequacies of the “insubstantial differences” test and how the function-
way-result test provides “additional guidance” on the issue of equivalence); see also Hilton Davis
Chem. Co. v. Warner-Jenkinson Co., 62 F.3d 1512, 1518, 35 U.S.P.Q.2d (BNA) 1641, 1645 (Fed.
Cir. 1995) (en banc) (applying the function-way-result test to deduce the substantiality of
differences), rev’d on other grounds, 520 U.S. 17 (1997).
302. In other cases, however, the Federal Circuit indicates circumstances where a patentee
may otherwise lose the right to assert coverage of allegedly equivalent structure or matter by
making statements during prosecution of a patent application that essentially disclaimed the
asserted equivalent.  See, e.g., Gentry Gallery, Inc. v. Berkline Corp., 134 F.3d 1473, 1475, 45
U.S.P.Q.2d (BNA) 1498, 1501 (Fed. Cir. 1998) (stating that arguments made in Petition to
Make Special limit the range of equivalents); Tanabe Seiyaku Co. v. United States Int’l Trade
Comm’n, 109 F.3d 726, 732, 41 U.S.P.Q.2d (BNA) 1976, 1981-82 (Fed. Cir. 1997) (noting that
statements made during prosecution demonstrated that ketone solvents other than acetone
could not be asserted as equivalents); Ekchian v. Home Depot, Inc., 104 F.3d 1299, 1304, 41
U.S.P.Q.2d (BNA) 1364, 1368 (Fed. Cir. 1997) (grounding denial of asserted equivalent on
statement made in information disclosure statement); Maxwell v. J. Baker, Inc., 86 F.3d 1098,
1107, 39 U.S.P.Q.2d (BNA) 1001, 1006 (Fed. Cir. 1996) (explaining that doctrine of equivalents
should not extend to disclosed, but unclaimed, subject matter); Applied Materials, Inc. v.
Advanced Semiconductor Materials Am., Inc., 98 F.3d 1563, 1574, 40 U.S.P.Q.2d (BNA) 1481,
1489-90 (Fed. Cir. 1996) (explaining that written description demonstrated that a certain
function must be performed by claimed process, and accused process that did not perform that
function could not be asserted as an equivalent); Texas Instruments, Inc. v United States Int’l
Trade Comm’n, 988 F.2d 1162, 1174, 26 U.S.P.Q.2d (BNA) 1018, 1025 (noting that
unmistakable assertions made by the applicant preclude assertion of equivalency).
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G. Prosecution History Estoppel
The prosecution history of a patent consists of the entire record of
proceedings before the USPTO.303  In Markman, the Federal Circuit
held that proper claim construction requires consideration of, inter
alia, arguments and amendments made during the prosecution of a
patent application.304  The prosecution history also may be relevant to
an infringement analysis under the doctrine of equivalents.305
Prosecution history estoppel limits the scope of protection
available under the doctrine of equivalents.306  Prosecution history
estoppel thus precludes a patent holder from asserting a range of
equivalency in an infringement suit encompassing subject matter that
it disclaimed during prosecution of the patent application to obtain
allowance of the claims in their issued form.307  Prosecution history
estoppel is a question of law that the Federal Circuit reviews de novo.308
                                                 
303. See Standard Oil Co. v. American Cyanamid Co., 774 F.2d 448, 452, 227 U.S.P.Q.
(BNA) 293, 296 (Fed. Cir. 1985) (stating that “prosecution history (sometimes called file
wrapper and contents) of [patents] consists of the entire record of proceedings” before
USPTO); see also Autogiro Co. of Am. v. United States, 384 F.2d 391, 397, 155 U.S.P.Q. (BNA)
697, 702 (Ct. Cl. 1967) (holding that patent’s prosecution history, or file wrapper, is part of
patent); cf. Jonsson v. Stanley Works, 903 F.2d 812, 818, 14 U.S.P.Q.2d (BNA) 1863, 1869 (Fed.
Cir. 1990) (providing that prosecution history of original application is also relevant to
understanding scope of claims issuing from continuation-in-part application).
304. See Markman v. Westview Instruments, Inc., 52 F.3d 967, 980, 34 U.S.P.Q.2d (BNA)
1321, 1330 (Fed. Cir. 1995) (en banc) (stating that claim should be construed upon
consideration of patent’s prosecution history).
305. See Moleculon Research Corp. v. CBS, Inc., 793 F.2d 1261, 1270, 229 U.S.P.Q. (BNA)
805, 811 (Fed. Cir. 1986) (“While it is true that the effect of prosecution history arises as an
estoppel when applying infringement analysis under the doctrine of equivalents, the
prosecution history can and should, where relevant, be assessed (along with claim language and
specification) in properly interpreting claim language.”); McGill Inc. v. John Zink Co., 736 F.2d
666, 673, 221 U.S.P.Q. (BNA) 944, 949 (Fed. Cir. 1984) (“Prosecution history may be used not
only in an estoppel context but also as a claim construction tool.”).
306. See Pall Corp. v. Micron Separations, Inc., 66 F.3d 1211, 1218, 36 U.S.P.Q.2d (BNA)
1225, 1230 (Fed. Cir. 1995) (noting that prosecution history estoppel applies even if there is a
factual finding that the devices are equivalent).
307. See Sage Prods., Inc. v. Devon Indus., Inc., 126 F.3d 1420, 1432, 44 U.S.P.Q.2d (BNA)
1103, 1113 (Fed. Cir. 1997) (“A patentee is not free to retrade or renege on a deal struck with
the PTO during patent prosecution.”); see also Mark I Mktg. Corp. v. R.R. Donnelley & Sons Co.,
66 F.3d 285, 291, 36 U.S.P.Q.2d (BNA) 1095, 1099-1100 (Fed. Cir. 1995) (recognizing that
prosecution history estoppel “serves as a check on the applicability of the doctrine of
equivalents”); Southwall Techs., Inc. v. Cardinal IG Co., 54 F.3d 1570, 1580, 34 U.S.P.Q.2d
(BNA) 1673, 1680 (Fed. Cir. 1995) (proffering that when the doctrine of prosecution history
estoppel is applied, courts must analyze what subject matter was surrendered and the reason for
the surrender).
308. See, e.g., Wang Lab., Inc. v. Mitsubishi Elecs. Am., Inc., 103 F.3d 1571, 1577, 41
U.S.P.Q.2d (BNA) 1263, 1269 (Fed. Cir. 1997) (explaining how the reviewing court examines
the patent actions and statements to determine “what a competitor reasonably may conclude
the patentee surrendered to gain issuance of the patent”); Southwall Techs, 54 F.3d at 1579, 34
U.S.P.Q.2d (BNA) at 1679; Wang Lab., Inc. v. Toshiba Corp., 993 F.2d 858, 867, 26 U.S.P.Q.2d
(BNA) 1767, 1775 (Fed. Cir. 1993); LaBounty Mfg., Inc. v. United States Int’l Trade Comm’n,
867 F.2d 1572, 1576, 9 U.S.P.Q.2d (BNA) 1995, 1998 (Fed. Cir. 1989).
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H. Design Patent Infringement
A design patent protects the nonfunctional aspects of a claimed
ornamental design.309  Design patent infringement liability attaches if,
visually, the accused design is substantially the same as the patented
design310 and if the accused design appropriates the novelty in the
patented design that distinguishes the patented design from the prior
art.311  The relevant comparison is between the accused design and
the claimed design, not the commercial embodiment of the claimed
design.312
Similar to the infringement determination for utility patents, this
determination for design patents is a two-step inquiry involving a
proper claim construction followed by the comparison of the accused
design for overall visual similarity.313  A design patent holder must
prove infringement by a preponderance of the evidence.314  The
                                                 
309. See 35 U.S.C. § 171 (1994); see also OddzOn Prods., Inc. v. Just Toys, Inc., 122 F.3d 1396,
1405, 43 U.S.P.Q.2d (BNA) 1641, 1647 (Fed. Cir. 1997) (agreeing with the lower court’s
interpretation of looking at the ornamental visual impression rather than the broader concept
of the item); KeyStone Retaining Wall Sys., Inc. v. Westrock, Inc., 997 F.2d 1444, 1450, 27
U.S.P.Q.2d (BNA) 1297, 1302 (Fed. Cir. 1993) (noting that the appearance of the design as a
whole is controlling in determining questions of patentability and infringement).
310. In Gorham Manufacturing Co. v. White, 81 U.S. (14 Wall.) 511, 528 (1872), the Court
stated:
[I]n the eye of an ordinary observer, giving such attention as a purchaser usually gives,
two designs are substantially the same, if the resemblance is such as to deceive such an
observer, inducing him to purchase one supposing it to be the other, the first patented
is infringed by the other.
Id. at 528; see also L.A. Gear, Inc. v. Thom McAnn Shoe Co., 988 F.2d 1117, 1125, 25 U.S.P.Q.2d
(BNA) 1913, 1918 (Fed. Cir. 1993) (requiring a determination as to whether the designs are
substantially the same); Lee v. Dayton-Hudson Corp., 838 F.2d 1186, 1187, 5 U.S.P.Q.2d (BNA)
1625, 1625 (Fed. Cir. 1988) (applying the test set forth in Gorham); Litton Sys., Inc. v. Whirlpool
Corp., 728 F.2d 1423, 1444, 221 U.S.P.Q. (BNA) 97, 109 (Fed. Cir. 1984) (same).
311. See Oakley, Inc. v. International Tropic-Cal, Inc., 923 F.2d 167, 169, 17 U.S.P.Q.2d
(BNA) 1401, 1403 (Fed. Cir. 1991) (observing that the fact-finder must consider the overall
similarity of the design as well as whether the accused device appropriates the novelty in the
patented design that distinguishes it from the prior art); see also Avia Group Int’l, Inc. v. L.A.
Gear Cal., Inc., 853 F.2d 1557, 1565, 7 U.S.P.Q.2d (BNA) 1548, 1554 (Fed. Cir. 1988) (stating
that in addition to Gorham’s similarity test, the accused device must also evidence aspects of the
patented device which separate it from the prior art).  For a more detailed discussion of the
applicable standards for design patent infringement, see Harry C. Marcus & Mark J. Abate,
Design Patent Infringement Put to Sea Without Guiding Charts, 22 AM. INTELL. PROP. L. ASS’N Q.J.
135 (1994).
312. See Payless Shoesource, Inc. v. Reebok Int’l Ltd., 998 F.2d 985, 990, 27 U.S.P.Q.2d
(BNA) 1516, 1520-21 (Fed. Cir. 1993) (stating that the proper application of the Gorham test
requires comparison of the accused design to the claimed design and not to the commercial
embodiment).
313. See Elmer v. ICC Fabricating, Inc., 67 F.3d 1571, 1577, 36 U.S.P.Q.2d (BNA) 1417, 1420
(Fed. Cir. 1995) (describing the two-step analysis for determining whether a design patent has
been infringed); Braun, Inc. v. Dynamics Corp. of Am., 975 F.2d 815, 820, 24 U.S.P.Q.2d (BNA)
1121, 1125 (Fed. Cir. 1992) (noting that the two products involved met the test set forth in
Gorham requiring such similarity).
314. See L.A. Gear, Inc., 988 F.2d at 1124, 25 U.S.P.Q.2d (BNA) at 1918 (stating that design
infringement is a question of fact and must be proven by a preponderance of the evidence).
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Federal Circuit applies the same standards of review with respect to
infringement of design patents as it does for utility patents.315
I. Plant Patent Infringement
One who discovers and asexually reproduces a distinct and new
variety of plant may obtain plant patent protection.316  In general, the
same patent rights and remedies pertain to both utility patents and
plant patents.317  The Federal Circuit applies the same standards of
review with respect to infringement of plant patents as it does for
utility patents.318
J. Remedies
A prevailing plaintiff patent holder has several available statutory
remedies, including damages,319 injunctive relief,320 and reasonable
attorney fees.321  A patent holder prevailing in an infringement action
is entitled to recover damages, interest, and costs.322  In general, such
damages must be adequate to compensate for infringement.323
However, damages may not be less than a reasonable royalty.324  One
measure of damages depends on the sales and profits that the patent
holder lost because of the infringement.325  If the prevailing patent
                                                 
315. See Elmer, 67 F.3d at 1577, 36 U.S.P.Q.2d (BNA) at 1420-21 (explaining that, like utility
patents, claims for design patent infringement must be properly construed and then the claim
may be compared to the accused design for a determination of similarity).
316. See 35 U.S.C. § 161 (1994).
317. See id. (stating that provisions of Title 35 regarding invention patents shall be
applicable to plants as well).
318. See Imazio Nursery, Inc. v. Dania Greenhouses, 69 F.3d 1560, 1568, 36 U.S.P.Q.2d
(BNA) 1673, 1680 (Fed. Cir. 1995) (stating that where Congress uses the same statutory
construction in separate statutes, the courts presume that Congress intended similar
interpretation of the statutes).
319. See 35 U.S.C. §§ 284-285 (1994).
320. See id. § 283.
321. See id. § 285.
322. See id. § 284.
323. See id. (requiring courts to award adequate damages).
324. Id. (requiring damages to be not less than a reasonable royalty, plus interest and costs
fixed by the court).  A reasonable royalty is what a licensee would be willing to pay the inventor
while still making a reasonable profit from the use of the patented invention.
325. To recover lost profits, the patent holder must show that the infringer actually caused
the economic harm for which the patentee seeks compensation. See Rite-Hite Corp. v. Kelley
Co., 56 F.3d 1538, 1545, 35 U.S.P.Q.2d (BNA) 1065, 1069 (Fed. Cir. 1995) (en banc) (noting
that a patent holder must show that, but for infringing sales, the patent holder would not have
suffered the loss).  In the context of lost profits, causation requires evidence of “a reasonable
probability that [the patent holder] would have made the asserted profits absent infringement.”
King Instruments Corp. v. Perego, 65 F.3d 941, 952, 36 U.S.P.Q.2d (BNA) 1129, 1137 (Fed. Cir.
1995).  The Federal Circuit reviews a trial court’s finding of causation for clear error.  See
SmithKline Diagnostics, Inc. v. Helena Lab. Corp., 926 F.2d 1161, 1165, 17 U.S.P.Q.2d (BNA)
1922, 1925 (Fed. Cir. 1991) (upholding the trial court’s rejection of a claim for lost profits
because the decision was not clearly erroneous).  In addition to causation, the patent holder
bears the burden of proving the amount of the award. See id. at 1164, 17 U.S.P.Q.2d (BNA) at
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holder cannot establish lost profits, then the court may determine a
reasonable royalty by using a hypothetical royalty negotiation
between the patent holder and a willing licensee at the time of the
alleged infringement.326  In addition, where the patent holder’s
product embodies unpatented and patented components, the court
must assess whether the reasonable royalty may derive from the entire
market value of the combination.327
K. Patent Marking
Patent law provides for infringement damages from the time the
patentee either marked the product (i.e., providing constructive
notice)328 or notified the accused infringer of its infringement,
whichever was earlier.329  The patentee bears the burden of pleading
and proving compliance with the statutory marking requirement.330
The Federal Circuit reviews this issue as a question of fact, examining
the record for substantial evidence to support the jury’s verdict or for
clear error where the trial judge is the fact-finder.331
L. Damages
The Federal Circuit reviews a district court’s damages award for
substantial evidence to support the jury’s verdict,332 or for clear error
                                                 
1925 (agreeing with the trial court that damages are a finding of fact to be proven by a
preponderance of the evidence).  Quantum is an issue of fact, which the Federal Circuit reviews
for clear error.  See Mahurkar v. C.R. Bard, Inc., 79 F.3d 1572, 1579, 38 U.S.P.Q.2d (BNA) 1288,
1292 (Fed. Cir. 1996) (stating that the trial court has discretion for the method and calculation
of the damage award and such discretion will review the amount only for clear error).
326. See Hanson v. Alpine Valley Ski Area, Inc., 718 F.2d 1075, 1078, 219 U.S.P.Q. (BNA)
679, 682 (Fed. Cir. 1983) (articulating the use of a hypothetical licensee/licensor agreement for
an infringing ski resort showing no profits); Georgia-Pacific Corp. v. United States Plywood
Corp., 318 F. Supp. 1116, 1120, 166 U.S.P.Q. (BNA) 235, 238 (S.D.N.Y. 1970) (setting forth a
comprehensive, albeit nonexclusive, list of relevant factors in determining a reasonable royalty),
modified and aff’d sub nom., Georgia-Pacific Corp. v. Plywood-Champion Papers, Inc., 446 F.2d
295, 170 U.S.P.Q. (BNA) 369 (2d Cir. 1971).
327. See Leesona Corp. v. United States, 599 F.2d 958, 974, 202 U.S.P.Q. (BNA) 424, 439
(Ct. Cl. 1979) (holding that compensation included market value royalties).
328. See 35 U.S.C. § 287(a) (1994).
329. See id.; American Med. Sys., Inc. v. Medical Eng’g Corp., 6 F.3d 1523, 1537, 28
U.S.P.Q.2d (BNA) 1321, 1331 (Fed. Cir. 1993) (stating that damages are available either from
the time the patent holder began marking its product or when it notified the infringer of the
infringement, whichever was earlier).
330. See Dunlap v. Schofield, 152 U.S. 244, 248 (1894) (“[T]he duty of alleging, and the
burden of proving, either [actual or constructive notice] is upon the patent holder.”); see also
Motorola, Inc. v. United States, 729 F.2d 765, 770, 221 U.S.P.Q. (BNA) 297, 300-01 (Fed. Cir.
1984) (requiring patent owner to show that he complied with the marking requirement of the
statute).
331. See Maxwell v. J. Baker, Inc., 86 F.3d 1098, 1111, 39 U.S.P.Q.2d (BNA) 1001, 1010 (Fed.
Cir. 1996) (stating that the determination of compliance with the marking requirements is a
question of fact to be reviewed for substantial evidence).
332. See SmithKline Diagnostics, Inc. v. Helena Lab. Corp., 926 F.2d 1161, 1165, 17
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where the trial judge is the fact-finder.333  The Federal Circuit,
however, reviews the district court’s award by an abuse of discretion
standard.334
M. Reasonable Royalty
The amount of a reasonable royalty is a question of fact that the
Federal Circuit reviews for substantial evidence to support the jury’s
verdict,335 or for clear error where the trial judge is the finder of
fact.336
N. Prejudgment Interest
The patent law provides for the award of prejudgment interest to
ensure adequate compensation for the infringement.337  Prejudgment
                                                 
U.S.P.Q.2d (BNA) 1922, 1925 (Fed. Cir. 1991).  In SmithKline, the Federal Circuit addressed an
ambiguity in its precedent:
We have reviewed our precedent and find some confusing, if not conflicting,
statements with respect to the nature of damage issues and the standard of review.
The conflict/confusion has not been directly addressed in any prior decision.  Faced
with this situation, the panel has been able to reconcile some statements in prior
decisions as indicated in the text.  In this situation, the authority we have chosen to
follow, namely, that damages are reviewed as a question of fact, accords with our
earliest precedent.  It is also in line with the rule of decision in other fields, i.e., the
amount of damages is a question of fact.  There is no reason to adopt a special rule for
patent cases.  The damage award, thus, is reviewed under the clearly erroneous
standard when fixed by the court and under the more restrictive substantial evidence
standard when we review a denial of a motion for JNOV.
More particularly, we reject an interpretation of our precedent holding that a judge
has “discretion” to choose the “methodology” in determining an award to mean that
the judge may choose between basing an award on “lost profits” damages or on a
reasonable royalty.  That is not choosing methodology.  If a winning patentee seeks
and proves lost profits, he is entitled to an award reflecting that amount.  A judge,
however, may choose between reasonable alternative accounting methods for
determining the amount of lost profits or may adopt in its discretion a reasonable way
to determine the number of infringing units.  Such subsidiary choices are left to the
court’s sound discretion under our precedent.
Id. at 1164-65 n.2, 17 U.S.P.Q.2d (BNA) at 1925 n.2 (internal citations omitted).
333. See id., 17 U.S.P.Q.2d (BNA) at 1925 n.2 (explaining that reversal of the trial judge’s
holding is reviewed according to the clearly erroneous standard).
334. See Unisplay, S.A. v. American Elec. Sign Co., 69 F.3d 512, 517 n.8, 36 U.S.P.Q.2d
(BNA) 1540, 1544 n.8 (Fed. Cir. 1995) (stating that there was no intention by the court to
overrule the distinction in SmithKline between the clearly erroneous review of the damages
amount and the abuse of discretion review of methodology); State Indus., Inc. v. Mor-Flo
Indus., Inc., 883 F.2d 1573-77, 12 U.S.P.Q.2d (BNA) 1026, 1028 (Fed. Cir. 1989) (same).
335. See Fonar Corp. v. General Elec. Co., 107 F.3d 1543, 1552-53, 41 U.S.P.Q.2d (BNA)
1801, 1808 (Fed. Cir. 1997) (upholding as reasonable the jury’s decision to base a royalty in the
value of the entire accused machines).
336. See SmithKline, 926 F.2d at 1164-65 n.2, 17 U.S.P.Q.2d (BNA) at 1925 n.2.
337. See 35 U.S.C. § 284 (1994); see also General Motors Corp. v. Devex Corp., 461 U.S. 648,
655-56 (1983) (noting that an award of interest from the time royalty payments should have
been received serves only to make the patent holder whole); Underwater Devices, Inc. v.
Morrison-Knudsen Co., 717 F.2d 1380, 1389, 219 U.S.P.Q. (BNA) 569, 576 (Fed. Cir. 1983)
(holding the prejudgment interest may only be applied to the actual damages, not to punitive
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interest has no punitive purpose, but merely seeks to compensate the
patent owner for the use of its money between the date of injury and
the date of judgment.338  The Federal Circuit reviews the grant or
denial of prejudgment interest under an abuse of discretion
standard.339
O. Willful Infringement
Deliberate disregard of another’s patent rights, as opposed to
actions taken by an accused infringer under a reasonable belief that it
did not infringe the patent, may support a finding of willful
infringement.340  A plaintiff patent holder must prove by clear and
convincing evidence that, based on the totality of the circumstances,
the defendant’s infringement was willful.341  Willfulness is a question
of fact that the Federal Circuit reviews for substantial evidence to
support the jury’s verdict,342 or for clear error where the trial judge
                                                 
damages that may also be charged).
338. See Bio-Rad Lab., Inc. v. Nicolet Instrument Corp., 807 F.2d 964, 969, 1 U.S.P.Q.2d
(BNA) 1191, 1195 (Fed. Cir. 1986), cert. denied, 482 U.S. 915 (1987) (explaining that the court’s
discretion regarding the rate of the prejudgment interest must be guided by the underlying
principle that the award of such interest strictly serves to make the patent holder whole, rather
than to provide for punitive damages).
339. See Lummus Indus., Inc. v. D.M. & E. Corp., 862 F.2d 267, 274, 8 U.S.P.Q.2d (BNA)
1983, 1988 (Fed. Cir. 1988) (stating that the trial judge has discretion in determining
prejudgment interest awards and therefore, any award decision will be reviewed for abuse of
discretion).
340. See Stickle v. Heublein, Inc., 716 F.2d 1550, 1565, 219 U.S.P.Q. (BNA) 377, 388 (Fed.
Cir. 1983) (noting that the deliberate disregard, as opposed to inadvertence, indicated
willfulness).  An important factor in determining whether infringement was willful is whether
the infringer obtained a competent opinion by independent counsel of noninfringement,
invalidity, or unenforceability.  See Ortho Pharm. Corp. v. Smith, 959 F.2d 936, 944, 22
U.S.P.Q.2d (BNA) 1119, 1126 (Fed. Cir. 1992) (explaining that an opinion letter by counsel
may be an important factor in a determination of willful infringement).  Prudent behavior
generally requires that competent legal advice was obtained before the commencement of the
infringing activity.  See Minnesota Mining & Mfg. Co. v. Johnson & Johnson Orthopedics, Inc.,
976 F.2d 1559, 1580, 24 U.S.P.Q.2d (BNA) 1321, 1339 (Fed. Cir. 1992) (noting that an opinion
of counsel is a factor but does not guarantee protection from a funding of willfulness); see also
Spindelfabrik Suessen-Schurr, Stahlecker & Grill GmbH v. Schubert & Salzer Maschinenfabrik
Aktiengesellschaft, 829 F.2d 1075, 1084, 4 U.S.P.Q.2d (BNA) 1044, 1051 (Fed. Cir. 1987)
(stating that an opinion from counsel is generally within the affirmative duty of care owed by a
potential infringer).
341. See SRI Int’l, Inc. v. Advanced Tech. Labs., Inc., 127 F.3d 1462, 1465, 44 U.S.P.Q.2d
(BNA) 1422, 1424 (Fed. Cir. 1997) (upholding the trial court’s conclusion that defendants’
reliance on several general legal opinions was not justified and defendants were aware of such
infringement); see also BIC Leisure Prods., Inc. v. Windsurfing Int’l, Inc., 1 F.3d 1214, 1222, 27
U.S.P.Q.2d (BNA) 1671, 1678 (Fed. Cir. 1993) (noting that a separate, three-day trial was held
to make full inquiry into the issue of willfulness); Read Corp. v. Portec, Inc., 970 F.2d 816, 829,
23 U.S.P.Q.2d (BNA) 1426, 1437 (Fed. Cir. 1992) (rejecting the jury’s finding of willfulness
based on a variety of factors, including advice of counsel); E.I. du Pont de Nemours & Co. v.
Phillips Petroleum Co., 849 F.2d 1430, 1440, 7 U.S.P.Q.2d (BNA) 1129, 1137 (Fed. Cir.)
(rejecting the argument that willfulness need only be proven by a preponderance of the
evidence), cert. denied, 488 U.S. 986 (1988).
342. See Hoechst Celanese Corp. v. BP Chems. Ltd., 78 F.3d 1575, 1583, 38 U.S.P.Q.2d
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sits as the finder of fact.343  Furthermore, a finding of willful
infringement may form the basis for an exceptional case
determination.344
P. Exceptional Case
A district court may award attorneys’ fees and costs in an
exceptional case.345  A party must prove an exceptional case by clear
and convincing evidence.346  The Federal Circuit reviews the factual
determination that a case is exceptional under the clearly erroneous
standard.347
Q. Enhanced Damages
A district court’s decision to enhance damages for willful
infringement and the extent of the enhancement is reviewed for an
abuse of discretion.348
                                                 
(BNA) 1126, 1132 (Fed. Cir. 1996) (noting if substantial evidence supports a verdict of
willfulness, the verdict will not be reversed on appeal); see also Orthokinetics, Inc. v. Safety
Travel Chairs, Inc., 806 F.2d 1565, 1581, 1 U.S.P.Q.2d (BNA) 1081, 1091 (Fed. Cir. 1986)
(explaining that a determination of willfulness is based on the totality of the circumstances and
that a jury determination of willfulness will be upheld if there is substantial evidence to support
the finding).
343. See Slimfold Mfg. Co. v. Kinkead Indus., Inc., 932 F.2d 1453, 1459, 18 U.S.P.Q.2d
(BNA) 1842, 1847 (Fed. Cir. 1991) (asserting that findings of willful infringement and
exceptional circumstances are both questions of fact to be revised only if clearly erroneous); see
also Spindelfabrik Suessen-Schurr v. Schubert & Salzer Maschinenfabrik Aktiengesellschaft, 829
F.2d 1075, 1083, 4 U.S.P.Q.2d (BNA) 1044, 1051 (Fed. Cir. 1987) (explaining that the question
on review is whether the finding of willful infringement is clearly erroneous in light of the
underlying facts), cert. denied, 484 U.S. 1063 (1988).
344. See S.C. Johnson & Son, Inc. v. Carter-Wallace, Inc., 781 F.2d 198, 201, 228 U.S.P.Q.
(BNA) 367, 369 (Fed. Cir. 1986) (willful infringement may support a finding of exceptional
circumstances, but it is not a guarantee of a finding of exceptional circumstances); cf. Standard
Oil Co. v. American Cyanamid Co., 774 F.2d 448, 455, 227 U.S.P.Q. (BNA) 293, 298 (Fed. Cir.
1985) (enumerating other circumstances, such as inequitable conduct, litigation misconduct,
vexatious litigation, and frivolity, that are appropriate grounds for an exceptional case finding).
345. See 35 U.S.C. § 285 (1994) (“The court in exceptional cases may award reasonable
attorney fees to the prevailing party.”); see also Gentry Gallery, Inc. v. Berkline Corp., 134 F.3d
1473, 1480, 45 U.S.P.Q.2d (BNA) 1498, 1504 (Fed. Cir. 1998) (rejecting a claim for attorney’s
fees by the non-prevailing party).
346. See Reactive Metals & Alloys Corp. v. ESM, Inc., 769 F.2d 1578, 1582, 226 U.S.P.Q.
(BNA) 821, 824 (Fed. Cir. 1985) (stating that the award of attorney’s fees is at the discretion of
the trial judge only after proof demonstrated by the patent holder, by clear and convincing
evidence, that exceptional circumstances exist).
347. See L.A. Gear, Inc. v. Thom McAnn Shoe Co., 988 F.2d 1117, 1128, 25 U.S.P.Q.2d
(BNA) 1913, 1921 (Fed. Cir. 1993) (explaining that whether or not a case is exceptional is a
factual question reviewed only for clear error); see also Revlon, Inc. v. Carson Prods. Co., 803
F.2d 676, 679, 231 U.S.P.Q (BNA) 472, 474 (Fed. Cir. 1986) (upholding the trial judge’s finding
that the case was exceptional, absent any clear error).
348. See SRI Int’l, Inc. v. Advanced Tech. Labs., Inc., 127 F.3d 1462, 1469, 44 U.S.P.Q.2d
(BNA) 1422, 1427 (Fed. Cir. 1997) (upholding trebling of the three percent royalty award for
punitive damages granted by the trial court because such an award was within the court’s
discretion); see also Graco, Inc. v. Binks Mfg. Co., 60 F.3d 785, 792, 35 U.S.P.Q.2d (BNA) 1255,
1260 (Fed. Cir. 1995) (stating that willfulness of infringement is the sole basis for the court’s
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R. Attorney Fees and Costs
In addition, a district court has inherent authority to assess
attorney fees as a sanction against a party for bad faith litigation
conduct.349  The Federal Circuit reviews the propriety of a district
court’s award of attorney fees and costs for abuse of discretion.350
S. Injunctive Relief
In a patent infringement suit, the district court may grant a
preliminary injunction pending trial and a permanent injunction
after a full determination on the merits.351  The grant of a preliminary
injunction depends on the likelihood of success on the merits,
irreparable harm, balance of hardships, and the public interest.352
The moving party bears the burden of showing that these elements
support the award of a preliminary injunction.353
The Federal Circuit generally has viewed the grant of a preliminary
injunction as a matter of procedural law not unique to the exclusive
                                                 
enhancement of damages); Rite-Hite Corp. v. Kelley Co., 819 F.2d 1120, 1126, 2 U.S.P.Q.2d
(BNA) 1915, 1919 (Fed. Cir. 1987) (finding no basis for lower court’s discretion to award
attorney’s fees where no willfulness or exceptional circumstances were shown).  “[W]hen a trial
court denies attorney fees in spite of a finding of willful infringement, the court must explain
why the case is not ‘exceptional’ within the meaning of the statute.”  Modine Mfg. Co. v. Allen
Group, Inc., 917 F.2d 538, 543, 16 U.S.P.Q.2d (BNA) 1622, 1626 (Fed. Cir. 1990) (citing S.C.
Johnson & Son, Inc., 781 F.2d at 201, 228 U.S.P.Q. (BNA) at 369 (Fed. Cir. 1986)).  Where such
an explanation is provided, the Federal Circuit reviews the decision not to award attorney fees
for an abuse of discretion.  See National Presto Indus., Inc. v. West Bend Co., 76 F.3d 1185,
1197, 37 U.S.P.Q.2d (BNA) 1685, 1693 (Fed. Cir. 1996) (granting the trial judge discretion over
attorney fees allows the judge latitude to consider a variety of factors, such as culpability of the
infringer and litigation behavior, that will assist on the issuance of justice).
349. See FED. R. CIV. P. 11, 37; see also Refac Int’l, Ltd. v. Hitachi, Ltd., 921 F.2d 1247, 1256,
16 U.S.P.Q.2d (BNA) 1347, 1354 (Fed. Cir. 1990) (awarding attorney fees as a sanction for the
frivolous nature of the appeal).
350. See Shatterproof Glass Corp. v. Libbey-Owens Ford Co., 758 F.2d 613, 629, 225 U.S.P.Q.
(BNA) 634, 644 (Fed. Cir.) (noting that an award of attorney fees is a discretionary decision to
be exercised only in cases involving exceptional circumstances), cert. denied, 474 U.S. 976
(1985).
351. See 35 U.S.C. § 283 (1994) (providing for the grant in equity of injunctions of a
reasonable scope to prevent the violation of patent rights).
352. See Reebok Int’l, Ltd. v. J. Baker, Inc., 32 F.3d 1552, 1555, 31 U.S.P.Q.2d (BNA) 1781,
1783 (Fed. Cir. 1994) (determining that the trial court’s decision to issue a preliminary
injunction was discretionary); see also New England Braiding Co. v. A.W. Chesterton Co., 970
F.2d 878, 882, 23 U.S.P.Q.2d (BNA) 1622, 1625 (Fed. Cir. 1992) (setting standard for movant in
order to obtain “extraordinary relief” or an injunction prior to trial); Nutrition 21 v. United
States, 930 F.2d 867, 869, 18 U.S.P.Q.2d (BNA) 1347, 1348-49 (Fed. Cir. 1991) (discussing the
four factors that the moving party must show to obtain a preliminary injunction); Hybritech,
Inc. v. Abbott Lab., 849 F.2d 1446, 1451, 7 U.S.P.Q.2d (BNA) 1191, 1195 (Fed. Cir. 1988)
(explaining that the four factors are not dispositive; rather the district court must weigh and
measure each factor against the others and against the “form and magnitude of requested
relief”).
353. See H.H. Robertson Co. v. United Steel Deck, Inc., 820 F.2d 384, 388, 2 U.S.P.Q.2d
(BNA) 1926, 1928 (Fed. Cir. 1987) (establishing that the burden is always on the moving party
to show entitlement to a preliminary injunction).
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jurisdiction of the court and therefore, has applied the procedural
law of the appropriate regional circuit.354  The Federal Circuit reviews
the district court’s grant of a preliminary or permanent injunction
for an abuse of discretion.355
The district court may require the posting of a supersedeas bond to
preserve the status quo while protecting the non-appealing party’s
rights pending appeal.356  The conditions that trigger a surety’s
obligations under a supersedeas bond depends on the interpretation
of the terms of the bond, which is a matter of law that the Federal
Circuit reviews de novo.357
T. Patentability Standards
To obtain patent protection, the claimed invention must involve
statutory subject matter that is useful, novel, and nonobvious.358  In
addition, the applicant must satisfy the statutory disclosure
requirements.359  A defendant to an infringement suit may raise, as an
                                                 
354. See National Presto Indus., Inc. v. West Bend Co., 76 F.3d 1185, 1185 n.2, 37 U.S.P.Q.2d
(BNA) 1685, 1686 n.2 (Fed. Cir. 1996); Abbott Lab. 849 F.2d at 1449, 7 U.S.P.Q.2d (BNA) at
1194 (applying procedural law of the District of Columbia).
355. See Novo Nordisk of N. Am., Inc. v. Genentech, Inc., 77 F.3d 1364, 1367, 37 U.S.P.Q.2d
(BNA) 1773, 1775 (Fed. Cir. 1996) (holding that granting or denying a preliminary injunction
pursuant to 35 U.S.C. § 283 is within the district court’s discretion); Joy Techs., Inc. v. Flakt,
Inc., 6 F.3d 770, 772, 28 U.S.P.Q.2d (BNA) 1378, 1380 (Fed. Cir. 1993) (“An abuse of discretion
may be established by showing that the district court either made a clear error of judgement in
weighing relevant factors, or exercised its discretion based on an error of law or in findings
which were clearly erroneous.”); Ortho Pharm. Corp. v. Smith, 959 F.2d 936, 945, 22 U.S.P.Q.2d
(BNA) 1119, 1127 (Fed. Cir. 1992) (claiming Federal Circuit reviews a district court’s decision
to grant an injunction and the scope of that injunction for abuse of discretion); Abbott Lab., 849
F.2d at 1449, 7 U.S.P.Q.2d (BNA) at 1194 (stating that a review of a district court’s grant of a
preliminary injunction is limited to determining whether the district court abused its discretion,
committed an error of law, or seriously misjudged the evidence); Smith Int’l, Inc. v. Hughes
Tool Co., 718 F.2d 1573, 1579, 219 U.S.P.Q. (BNA) 686, 691 (Fed. Cir. 1983) (reiterating that a
party denied a preliminary injunction must meet the “heavy burden” of showing that a lower
court abused its discretion).
356. See Beatrice Foods Co. v. New England Printing & Lithographing Co., 930 F.2d 1572,
1574, 18 U.S.P.Q.2d (BNA) 1548, 1550 (Fed. Cir. 1991) (ordering New England to increase the
supersedeas bond to $52 million if it wanted to continue to stay the judgment pending a further
appeal).
357. See id., 18 U.S.P.Q.2d (BNA) at 1550 (stating that the interpretation of a bond’s term is
a “unique task”).
358. See 35 U.S.C. §§ 101-103 (1994) (discussing the patentability of inventions).
359. See id. § 112.  The statute provides in relevant part:
[T]he specification shall contain a written description of the invention, and of the
manner and process of making and using it, in such full, clear, concise, and exact
terms as to enable any person skilled in the art to which it pertains, or with which it is
most nearly connected, to make and use the same, and shall set forth the best mode
contemplated by the inventor of carrying out his invention.
The specification shall conclude with one or more claims particularly pointing out and
distinctly claiming the subject matter which the applicant regards as his invention.
Id.
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affirmative defense, patent invalidity based on these grounds.360  An
issued patent, however, carries a statutory presumption of validity.361
A party must overcome this presumption by proving invalidity with
clear and convincing evidence.362
U. Statutory Subject Matter
Patent protection extends only to certain types of inventions as set
forth by statute.363  Such inventions include “new and useful
processes, machines, manufactures, compositions of matter, or any
new and useful improvement.”364  In recent years, the patentability of
computer-related technology, for example, has been the focus of the
Federal Circuit’s inquiries into patentable subject matter.365
V. Utility
To receive patent protection, the invention must have utility and
must be capable of being used to effect the object proposed.366
                                                 
360. The statute sets out the following affirmative defenses:
The following shall be defenses in any action involving the validity infringement of a
patent and shall be pleaded:
(1) Noninfringement, absence of liability for infringement or unenforceability,
(2) Invalidity of the patent or any claim in suit on ground specified in part II of this
title as a condition for patentability,
(3) Invalidity of the patent or any claim in suit for failure to comply with any
requirement of sections 112 or 251 of this title,
(4) Any other fact or act made a defense by this title.
Id. § 282.
361. See id. (presuming validity of patent independently of other claims).
362. See Hybritech Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1375, 231 U.S.P.Q.
(BNA) 81, 87 (Fed. Cir. 1986) (“Notwithstanding that the introduction of prior art not before
the examiner may facilitate the challenger’s meeting the burden of proof on invalidity, the
presumption remains intact and on the challenger throughout the litigation, and the clear and
convincing standard does not change.”), cert. denied, 480 U.S. 947 (1987).  For a statistical study
of the Federal Circuit’s dispositions in appeals from the USPTO regarding §§ 102, 103, and 112
rejections, see Dunner, supra note 292, at Charts 1C, 2C, and 3C.
363. See 35 U.S.C. § 101 (1994).
364. Id. (assuming conditions and requirements of the title are met); see also Diamond v.
Chakrabarty, 447 U.S. 303, 309 (1980) (holding that availability of patent protection applies to
“anything under the sun that is made by man”) (quoting S. REP. NO. 82-1979, at 5 (1952) and
H.R. REP. NO. 82-1923, at 6 (1952)).
365. See State Street Bank & Trust Co. v. Signature Fin. Group, Inc., 149 F.3d 1368, 47
U.S.P.Q.2d (BNA) 1596 (Fed. Cir. 1998) (holding that computer algorithms and business
methods are not unpatentable per se); In re Alappat, 33 F.3d 1526, 1545, 31 U.S.P.Q.2d (BNA)
1545, 1588 (Fed. Cir. 1994) (en banc) (reversing the rejection of claims to computer operating
pursuant to software as nonstatutory subject matter under § 101).
366. See Brenner v. Manson, 383 U.S. 519, 534 (1966) (“The basic quid pro quo
contemplated by the Constitution and the Congress for granting a patent monopoly is the
benefit derived by the public from an invention with substantial utility.”); see also Cross v. Iizuka,
753 F.2d 1040, 1044, 224 U.S.P.Q. (BNA) 739, 742 (Fed. Cir. 1985) (claiming that a patent may
not be granted to an invention unless substantial or practical utility for the invention has been
discovered and disclosed).
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Whether an invention claimed in a patent lacks utility is a question of
fact, which the Federal Circuit reviews under the clearly erroneous
standard.367
W. Novelty
To receive patent protection, the invention must be novel, i.e., not
anticipated by the prior art.368  An invention is anticipated, and
therefore invalid, if a single prior art reference expressly or
inherently discloses each and every limitation of the claimed
invention.369  A party must prove anticipation by clear and convincing
evidence.370  Anticipation is a question of fact that the Federal Circuit
                                                 
367. See Raytheon Co. v. Roper Corp., 724 F.2d 951, 956, 220 U.S.P.Q. (BNA) 592, 596 (Fed.
Cir. 1983).
368. See 35 U.S.C. § 102(a)-(b) (1994) (describing conditions of patentability, novelty, and
loss of right to patent).
369. See, e.g., Glaxo, Inc. v. Novopharm, Ltd., 52 F.3d 1043, 1047, 34 U.S.P.Q.2d (BNA)
1565, 1567 (Fed. Cir. 1995) (holding that the invention was not anticipated); Electro Med. Sys.
S.A. v. Cooper Life Sciences, 34 F.3d 1048, 1052, 32 U.S.P.Q.2d (BNA) 1017, 1019 (Fed. Cir.
1994) (stating that anticipation must be proven by clear and convincing evidence); Minnesota
Mining & Mfg. Co. v. Johnson & Johnson Orthopedics, Inc., 976 F.2d 1559, 1565, 24 U.S.P.Q.2d
(BNA) 1321, 1326 (Fed. Cir. 1992) (assessing that a party alleging an anticipation claim must
demonstrate identity of invention); Shearing v. Iolab Corp., 975 F.2d 1541, 1544-45, 24
U.S.P.Q.2d (BNA) 1133, 1136 (Fed. Cir. 1992) (suggesting that defendant must convince jury
that a third party disclosed each and every element of plaintiff’s invention in order to prove
anticipation); see also Scripps Clinic & Research Found. v. Genentech, Inc., 927 F.2d 1565, 1576,
18 U.S.P.Q.2d (BNA) 1001, 1010 (Fed. Cir. 1991) (“Invalidity for anticipation requires that all
of the elements and limitation of the claim are found within a single prior art reference.”); In re
Spada, 911 F.2d 705, 708, 15 U.S.P.Q.2d (BNA) 1655, 1657 (Fed. Cir. 1990) (indicating that the
first step in an inquiry for anticipation requires that all elements of claimed invention be
described in a single preference); In re Bond, 910 F.2d 831, 832, 15 U.S.P.Q.2d (BNA) 1566,
1567 (Fed. Cir. 1990) (finding that every element of a claimed invention must be “identically
shown in a single reference”); Richardson v. Suzuki Motor Co., 868 F.2d 1226, 1236, 9
U.S.P.Q.2d (BNA) 1913, 1920 (Fed. Cir. 1989) (holding that a district court correctly instructed
the jury that an invention is anticipated if the device, including all the claim limitations, is
shown in a single prior art reference); Carella v. Starlight Archery & Pro Line Co., 804 F.2d 135,
138, 231 U.S.P.Q. (BNA) 644, 646 (Fed. Cir. 1986) (requiring every element of the claimed
invention to be literally present as arranged in the claim); Kloster Speedsteel AB v. Crucible,
Inc., 793 F.2d 1565, 1571, 230 U.S.P.Q. (BNA) 81, 84 (Fed. Cir. 1986) (affirming the district
court’s finding that the patent claim was not anticipated pursuant to § 102); Perkin-Elmer Corp.
v. Computervision Corp., 732 F.2d 888, 894, 221 U.S.P.Q. (BNA) 669, 673 (Fed. Cir. 1984)
(presuming that the jury found no anticipation because of the differences between the claimed
invention and the prior art); RCA Corp. v. Applied Digital Data Sys., Inc., 730 F.2d 1440, 1444,
221 U.S.P.Q. (BNA) 385, 388 (Fed. Cir. 1984) (involving expressed disclosure of each element
of claimed invention); Kalman v. Kimberly Clark Corp., 713 F.2d 760, 772, 218 U.S.P.Q.(BNA)
781, 789 (Fed. Cir. 1983) (“[t]o be an anticipation a prior patent must include all the teachings
necessary to accomplish what the allegedly invented patent succeeds in doing.”).
370. See Verdegaal Bros. v. Union Oil Co., 814 F.2d 628, 631, 2 U.S.P.Q.2d (BNA) 1051,
1053 (Fed. Cir. 1987) (reasoning that the precise issue in the case is whether Union Oil’s
evidence is so clear and convincing that reasonable jurors could only conclude that the claims
were invalid); American Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F.2d 1350, 1360, 220
U.S.P.Q. (BNA) 763, 770 (Fed. Cir. 1984) (arguing that convincing a court of invalidity by clear
and convincing evidence is a constant and never changing burden).
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reviews for substantial evidence to support the jury’s verdict,371 or
otherwise for clear error.372
X. Statutory Bars to Patentability:  Public Use and On-Sale
The patent law bars patent protection of an invention that was in
public use or on-sale more than one year before the filing date of the
United States patent application for that invention.373  The public use
and on-sale bars to patentability derive from the same public policy.374
                                                 
371. See C.R. Bard, Inc. v. M3 Sys., Inc., 157 F.3d 1340, 1361, 48 U.S.P.Q.2d (BNA) 1225,
1231 (Fed. Cir. 1998) (reversing jury’s verdict of invalidity for anticipation claim).
372. See, e.g., In re Graves, 69 F.3d 1147, 1151, 36 U.S.P.Q.2d (BNA) 1697, 1700 (Fed. Cir.
1995) (establishing that prior art reference is a question of fact that is reviewed under the
clearly erroneous standard); Glaverbel Societe Anonyme v. Northlake Mktg. & Supply, 45 F.3d
1550, 1554, 33 U.S.P.Q.2d (BNA) 1496, 1498 (Fed. Cir. 1995) (holding that the district court’s
finding with respect to anticipation is reviewed for clear error); In re Baxter Travenol Lab., 952
F.2d 388, 390, 21 U.S.P.Q.2d (BNA) 1281, 1283 (Fed. Cir. 1991) (affirming the Board’s decision
because clear error was not found); Scripps Clinic & Research Found., 927 F.2d at 1576, 18
U.S.P.Q.2d (BNA) at 1010 (discussing clear and convincing standard as applied to anticipation
claims in a summary judgment proceeding); Chester v. Miller, 906 F.2d 1574, 1576, 15
U.S.P.Q.2d (BNA) 1333, 1335 (Fed. Cir. 1990) (finding no clear error in the Board’s decision
that applicant’s claim was unpatentable due to anticipation by prior art); Diversitech Corp. v.
Century Steps, Inc., 850 F.2d 675, 677, 7 U.S.P.Q.2d (BNA) 1315, 1317 (Fed. Cir. 1988) (“A
patent challenger must show by clear and convincing evidence that a claim is anticipated.”);
Hybritech, Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1379, 321 U.S.P.Q. (BNA) 81, 90
(Fed. Cir. 1986) (same); In re King, 801 F.2d 1324, 1326, 231 U.S.P.Q. (BNA) 136, 138 (Fed.
Cir. 1986) (claiming that review of a finding of anticipation is the same whether it was made by
district court or the Board); Ralston Purina Co. v. Far-Mar-Co. Inc., 772 F.2d 1570, 1574, 227
U.S.P.Q. (BNA) 177, 179 (Fed. Cir. 1985) (“A finding is clearly erroneous when although there
is evidence to support it, the reviewing court on the entire evidence is left with definite and firm
conviction that a mistake has been committed.”); Lindemann Maschinenfabrik GmbH v.
American Hoist & Derrick Co., 730 F.2d 1452, 1458, 221 U.S.P.Q. (BNA) 481, 485 (Fed. Cir.
1984) (concluding district court’s finding of anticipation was clearly erroneous); see also In re
Napier, 55 F.3d 610, 613, 34 U.S.P.Q.2d (BNA) 1782, 1784 (Fed. Cir. 1995) (recognizing that
what a prior art reference teaches is also a question of fact that the Federal Circuit reviews
under the clearly erroneous standard); Continental Can Co. v. Monsanto Co., 948 F.2d 1264,
1268, 20 U.S.P.Q.2d (BNA) 1746, 1749 (Fed. Cir. 1991) (holding that whether a claim
limitation is inherent in a prior art reference is a factual issue on which evidence may be
introduced).
373. See 35 U.S.C. § 102(b) (1994).
A person shall be entitled to a patent unless-
(b) the invention was patented or described in a printed publication in this or a
foreign country or in public use or on sale in this country, more than one year prior to
the date of the application for patent in the United States.
Id.
374. Compare Tone Bros., Inc. v. Sysco Corp., 28 F.3d 1192, 1198, 31 U.S.P.Q.2d (BNA)
1321, 1324 (Fed. Cir. 1994) (discussing public policy rationale underlying public use), with
Envirotech Corp. v. Westech Eng’g, Inc., 904 F.2d 1571, 1574, 15 U.S.P.Q.2d (BNA) 1230, 1232
(Fed. Cir. 1990) (describing policies and purposes underlying the on-sale bar).  The policies
underlying § 102(b) are as follows:
(1) discouraging the removal, from the public domain, of inventions that the public
reasonably has come to believe are freely available;
(2) favoring the prompt and widespread disclosure of inventions;
(3) allowing the inventor a reasonable amount of time following sales activity to
determine the potential economic value of a patent; and
(4) prohibiting the inventor from commercially exploiting his invention beyond the
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The rationales for these patentability bars include the
encouragement of prompt disclosure of inventions to the public and
the discouragement of commercial exploitation of the invention
while deferring the start of the patent protection term.375
A party asserting patent invalidity based on public use must prove
by clear and convincing evidence that the invention was used in
public before the critical date and primarily for purposes other than
experimentation.376  Factors relevant to a public use inquiry include
public access to, and awareness of, the activity, the degree of
confidentiality imposed on observers, indicia of bona fide
experimentation, and the financial aspects of the activity.377  The
Federal Circuit reviews de novo the district court’s ultimate conclusion
of public use, and reviews for clear error the underlying factual
findings.378
A party asserting patent invalidity based on on-sale activity must
prove by clear and convincing evidence that a definite sale or offer to
sell occurred before the critical date and that the subject matter of
the sale or offer to sell either anticipated the claimed invention or
would have rendered the claimed invention obvious.379  The Federal
Circuit reviews de novo a district court’s conclusion of on-sale activity
and reviews for clear error the underlying factual findings.380
                                                 
statutorily prescribed time.
King Instrument Corp. v. Otari Corp., 767 F.2d 853, 860, 226 U.S.P.Q. (BNA) 402, 406 (Fed.
Cir. 1985), cert. denied, 475 U.S. 1016 (1986).
375. See Envirotech, 904 F.2d at 1574, 15 U.S.P.Q.2d (BNA) at 1232 (claiming that none of
the policy reasons support the on-sale bar in this case).
376. See Moleculon Research Corp. v. CBS, Inc., 793 F.2d 1261, 1266, 229 U.S.P.Q. (BNA)
805, 808 (Fed. Cir. 1986) (finding that the district court’s conclusions on public use was
consistent with policies underlying the bar and therefore, the decision should be affirmed), cert.
denied, 479 U.S. 1030 (1987).
377. See Baker Oil Tools, Inc. v. Geo Vann, Inc., 828 F.2d 1558, 1564, 4 U.S.P.Q.2d (BNA)
1210, 1214 (Fed. Cir. 1987) (determining that underlying facts of each case must be considered
in light of all circumstances).
378. See Manville Sales Corp. v. Paramount Sys., Inc., 917 F.2d 544, 549, 16 U.S.P.Q.2d
(BNA) 1587, 1591 (Fed. Cir. 1990) (suggesting that to determine whether an invention was in
public use, the court must consider how the totality of the circumstances comports with the
policies underlying the public use bar).
379. See UMC Elecs. Co. v. United States, 816 F.2d 647, 656, 2 U.S.P.Q.2d (BNA) 1465, 1472
(Fed. Cir.) (noting that the party asserting patent invalidity based on on-sale activity must prove
that there was definite sale or offer to sell one year prior to filing for subject patent), cert. denied,
484 U.S. 1025 (1987).
380. See Pfaff v. Wells Elec., Inc., 124 F.3d, 1429, 1432, 43 U.S.P.Q.2d (BNA) 1928, 1931
(Fed. Cir. 1997) (determining that because there were no facts in dispute, the only question
remaining was whether the § 102 on-sale bar invalidates the patent, which is reviewed de novo);
Kolmes v. World Fibers Corp., 107 F.3d 1534, 1540, 41 U.S.P.Q.2d (BNA) 1829, 1832 (Fed. Cir.
1997) (concluding that relevant fact-findings by the district court were not clearly erroneous);
Micro Chem., Inc. v. Great Plains Chem. Co., 103 F.3d 1538, 1544, 41 U.S.P.Q.2d (BNA) 1238,
1243-44 (Fed. Cir. 1997) (“Application of the on-sale bar under Section 102 is a question of law
based upon underlying issues of fact.”); Ferag AG v. Quipp, Inc., 45 F.3d 1562, 1566, 33
U.S.P.Q.2d (BNA) 1512, 1514-15 (Fed. Cir. 1995) (reviewing ultimate determination de novo
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Y. Inventorship
Under the patent law, an inventor is the person who conceived the
patented invention.381  A party asserting patent invalidity based on
incorrect inventorship must prove this claim by clear and convincing
evidence.382  The Federal Circuit reviews inventorship de novo as a
question of law based on underlying factual findings.383
Z. Derivation
Derivation is a basis for patent invalidity premised on the assertion
that the designated inventor did not actually invent the subject
matter of the patent because that person derived the invention from
another.384  The Federal Circuit reviews a finding of derivation as a
question of fact and requires acceptance of the district court’s
findings, unless clearly erroneous or predicated on an improper legal
foundation.385  To show derivation, the party asserting invalidity must
                                                 
and subsidiary fact-findings for clear error); Keystone Rataining Wall Sys., Inc. v. Westrock, Inc.,
997 F.2d 1444, 1453, 27 U.S.P.Q.2d (BNA) 1297, 1303 (Fed. Cir. 1993); Atlantic Thermoplastics
Co. v. Faytex Corp., 970 F.2d 834, 836, 23 U.S.P.Q.2d (BNA) 1481, 1483 (Fed. Cir. 1992)
(emphasizing that appellate review of an on-sale bar proceeds as a question of law); Baker Oil
Tools, Inc. v. Geo Vann, Inc., 828 F.2d 1558, 1562-64, 4 U.S.P.Q.2d (BNA) 1210, 1213-14 (Fed.
Cir. 1987).
381. See Collar Co. v. Van Dusen, 90 U.S. (23 Wall.) 530, 563-64 (1874); Burroughs
Wellcome Co. v. Barr Lab., Inc., 40 F.3d 1223, 1227-18, 32 U.S.P.Q.2d (BNA) 1915, 1919 (Fed.
Cir. 1994) (“Conception is the touchstone of inventorship.”).
382. See Hess v. Advanced Cardiovascular Sys., Inc., 106 F.3d 976, 980, 41 U.S.P.Q.2d (BNA)
1782, 1785 (Fed. Cir. 1997) (holding that the burden of proving misjoinder or nonjoinder of
inventors is by clear and convincing evidence because there is a strong temptation for witnesses
to reconstruct their testimony in a light more favorable to their own position so that they can
gain some credit for the invention); cf. 35 U.S.C. § 256 (1994) (stating that an error in
“omitting inventors or naming persons who are not inventors” does not invalidate the patent if
the error is correctable and there was not deceptive intent).
383. See Sewall v. Walters, 21 F.3d 411, 415, 30 U.S.P.Q.2d (BNA) 1356, 1358 (Fed. Cir.
1994) (maintaining that factual findings based on the question of inventorship, who conceived
the subject matter and whether the subject matter is stated in an application or in a count in an
interference, are reviewed by the clearly erroneous standard).
384. See 35 U.S.C. § 102(f) (1994) (stating that a patent should be issued unless the person
seeking the patent did not invent that which he or she is trying to patent); Price v. Symsek, 988
F.2d 1187, 1190, 26 U.S.P.Q.2d (BNA) 1031, 1033 (Fed. Cir. 1993) (clarifying that although
derivation and priority of invention are similar in that both focus on inventorship and both may
be resolved by the Board, the two are different concepts).  A claim that a patentee derived an
invention addresses originality-- who invented the subject matter before the court, rather than
which of two self-proclaimed inventors actually was first.  See Price v. Symsek, 988 F.2d 1187,
1190, 26 U.S.P.Q.2d (BNA) 1031, 1033 (Fed. Cir. 1993).
385. See Hess, 106 F.3d at 980, 41 U.S.P.Q.2d (BNA) at 1785 (finding that, although there
was some conflict in the question of co-inventorship, the district court’s finding that the
plaintiff was not a co-inventor was not clearly erroneous); see also Price, 988 F.2d at 1190, 26
U.S.P.Q.2d (BNA) at 1033 (requiring that the party attacking the patent must establish prior
conception of the claimed subject matter and communication of the conception to the adverse
claimant); Raytheon Co. v. Roper Corp., 724 F.2d 951, 956, 220 U.S.P.Q. (BNA) 592, 596 (Fed.
Cir. 1983) (stating that district court determinations must be accepted unless they are
predicated on an improper legal foundation).
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prove by clear and convincing evidence both prior conception of the
invention by another and communication of that conception to the
patentee.386  The Federal Circuit reviews a determination of proper
inventorship as a question of law based on underlying factual findings
relating to conception.387
AA. Abandonment, Suppression, or Concealment
The abandonment, suppression, or concealment of an invention
may preclude an inventor from obtaining patent protection.388  No
particular period of delay is unreasonable per se.389  The Federal
Circuit reviews the question of abandonment for substantial evidence
to support the jury’s verdict of the ITC’s determination;390 or
otherwise for clear error.391  On the other hand, suppression or
concealment is a question of law, which the Federal Circuit reviews de
novo.392
BB. Nonobvious
To receive patent protection, an invention must be nonobvious at
the time of the invention to one of ordinary skill in the relevant art.393
An accused infringer must prove obviousness by clear and convincing
evidence.394  Obviousness is a question of law that the Federal Circuit
                                                 
386. See Amax Fly Ash Corp. v. United States, 514 F.2d 1041, 1047, 182 U.S.P.Q. (BNA) 210,
215 (Ct. Cl. 1975) (maintaining plaintiff’s assertion that the evidence must be “clear and
convincing”).
387. See Advanced Cardiovascular Sys., 106 F.3d at 980, 41 U.S.P.Q.2d (BNA) at 1786
(establishing de novo review for residuary questions of law).
388. See 35 U.S.C. § 102(g) (1994) (stating that “[a] person shall be entitled to a patent
unless— . . . (g) before the applicant’s invention thereof, the invention was made in this
country by another who had not abandoned, suppressed, or concealed it”).
389. See Paulik v. Rizkalla, 760 F.2d 1270, 1273, 226 U.S.P.Q. (BNA) 224, 226 (Fed. Cir.
1985) (stating that the determination of abandonment rests on the application of equitable
principles and public policy to the facts of the case); Shindelar v. Holdeman, 628 F.2d 1337,
1343, 207 U.S.P.Q. (BNA) 112, 117 (C.C.P.A. 1980), cert. denied, 451 U.S. 984 (1981) (noting
that because each case must be considered on its own facts, no established time frame exists for
determining when abandonment occurs).
390. See Checkpoint Sys., Inc. v. United States Int’l Trade Comm’n, 54 F.3d 756, 759-60, 35
U.S.P.Q.2d (BNA) 1042, 1044 (Fed. Cir. 1995) (indicating that the Federal Circuit will not
disturb the ITC’s factual findings if they are supported by “such relevant evidence as a
reasonable mind might accept as adequate to support a conclusion”).
391. See Electric Storage Battery Co. v. Shimadzu, 307 U.S. 5, 15 (1939) (describing various
issues of fact, such as negligence or delayed application, that can lead to a determination of
abandonment).
392. See Brokaw v. Vogel, 429 F.2d 476, 480, 166 U.S.P.Q. (BNA) 428, 431 (C.C.P.A. 1970)
(disagreeing with appellee, the court asserted that whether there was suppression or
concealment under the statute is a conclusion of law based on facts of record).
393. See 35 U.S.C. § 103 (1994) (describing conditions of patentability, including
nonobvious subject matter).
394. See Ryko Mfg. Co. v. Nu-Star, Inc., 950 F.2d 714, 716, 21 U.S.P.Q.2d (BNA) 1053, 1055
(Fed. Cir. 1991) (stating the court’s obviousness test as:  (1) scope and content of previous art;
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reviews de novo.395  Nonetheless, the conclusion of obviousness is
subject to underlying factual findings.396  These findings include the
scope and content of the prior art, the level of ordinary skill in the art
at the time of the invention, objective evidence of nonobviousness,
and differences between the prior art and the claimed invention.397
Relevant secondary considerations of nonobviousness include
commercial success, long felt but unsolved needs, failures of others,
and copying.398  The Federal Circuit reviews the underlying factual
findings for clear error.399
An obviousness determination takes into account analogous art.400
                                                 
(2) variations between pieces in conflict; and (3) degree of skill); Polaroid Corp. v. Eastman
Kodak Co., 789 F.2d 1556, 1558, 229 U.S.P.Q. (BNA) 561, 562-63 (Fed. Cir.) (concluding that
judges must carry out a totality of evidence test in determining the obvious/nonobvious
question), cert. denied, 479 U.S. 850 (1986).
395. See In re Lueders, 111 F.3d 1569, 1571, 42 U.S.P.Q.2d (BNA) 1481, 1482 (Fed. Cir.
1997) (noting that courts will utilize a de novo review for all legal conflicts of obviousness);
Roton Barrier, Inc. v. Stanley Works, 79 F.3d 1112, 1127, 37 U.S.P.Q.2d (BNA) 1816, 1828 (Fed.
Cir. 1996) (same); B.F. Goodrich Co. v. Aircraft Braking Sys. Corp., 72 F.3d 1577, 1582, 37
U.S.P.Q.2d (BNA) 1314, 1317-18 (Fed. Cir. 1996) (same); In re Donaldson Co., 16 F.3d 1189,
1192, 29 U.S.P.Q.2d (BNA) 1845, 1848 (Fed. Cir. 1994) (en banc) (same); Minnesota Mining &
Mfg. Co. v. Johnson & Johnson Orthopedics, Inc., 976 F.2d 1559, 1572-73, 24 U.S.P.Q.2d (BNA)
1321, 1332-33 (Fed. Cir. 1992) (same); In re Vaeck, 947 F.2d 488, 493, 20 U.S.P.Q.2d (BNA)
1438, 1442 (Fed. Cir. 1991) (same); Stiftung v. Renishaw PLC, 945 F.2d 1173, 1182, 20
U.S.P.Q.2d (BNA) 1094, 1102 (Fed. Cir. 1991) (same); Specialty Composites v. Cabot Corp.,
845 F.2d 981, 989, 6 U.S.P.Q.2d (BNA) 1601, 1606 (Fed. Cir. 1988) (same); Ashland Oil, Inc. v.
Delta Resins & Refractories, Inc., 776 F.2d 281, 297 n.24, 227 U.S.P.Q. (BNA) 657, 667 n.24
(Fed. Cir. 1985) (same); Jervis B. Webb Co. v. Southern Sys., Inc., 742 F.2d 1388, 1393, 222
U.S.P.Q. (BNA) 943, 946 (Fed. Cir. 1984) (same); Gardner v. TEC Sys., Inc., 725 F.2d 1338,
1344, 220 U.S.P.Q. (BNA) 777, 782 (Fed. Cir. 1984) (same).
396. See Richardson-Vicks, Inc. v. Upjohn Co., 122 F.3d 1476, 1479, 44 U.S.P.Q.2d (BNA)
1181, 1183 (Fed. Cir. 1997) (contrasting the notion that obviousness necessitates an analysis of
the facts, but is still a conclusion of law); Miles Lab., Inc. v. Shandon Inc., 997 F.2d 870, 877, 27
U.S.P.Q.2d (BNA) 1123, 1128 (Fed. Cir. 1993) (defining the court’s review of obviousness facts
under a “clearly erroneous” standard); Panduit Corp. v. Dennison Mfg. Co., 810 F.2d 1561,
1566-68, 1 U.S.P.Q.2d (BNA) 1593, 1595-97 (Fed. Cir. 1987).
397. See Monarch Knitting Mach. Corp. v. Sulzer Morat GmbH, 139 F.3d 877, 881, 45
U.S.P.Q.2d (BNA) 1977, 1981 (Fed. Cir. 1998) (basing the court’s holding on the scope of the
prior art); see also In re Oetiker, 977 F.2d 1443, 1447, 24 U.S.P.Q.2d (BNA) 1443, 1445-46 (Fed.
Cir. 1992) (deciding that simplicity is not correlative to ordinary skill); In re Gorman, 933 F.2d
982, 986-87, 18 U.S.P.Q.2d (BNA) 1885, 1888 (Fed. Cir. 1991) (questioning ordinary skill as a
solitary factor, rather than a collective factor); Continental Can Co. USA, Inc. v. Monsanto Co.,
948 F.2d 1264, 1270, 20 U.S.P.Q.2d (BNA) 1746, 1750 (Fed. Cir. 1991) (affirming the four basic
factors utilized by the courts to determine obviousness); In re Young, 927 F.2d 588, 591, 18
U.S.P.Q.2d (BNA) 1089, 1091 (Fed. Cir. 1991); Panduit Corp., 810 F.2d at 1566-68, 1 U.S.P.Q.2d
(BNA) at 1595-97.
398. See Graham v. John Deere Co., 383 U.S. 1, 17-18 (1966) (emphasizing the significance
of additional factors).
399. See In re Woodruff, 919 F.2d 1575, 1577, 16 U.S.P.Q.2d (BNA) 1934, 1935 (Fed. Cir.
1990) (utilizing de novo review for legal analysis and a clearly erroneous standard for fact-
finding); In re Beattie, 974 F.2d 1309, 1311, 24 U.S.P.Q.2d (BNA) 1040, 1041 (Fed. Cir. 1992)
(same); Uniroyal, Inc. v. Rudkin-Wiley Corp., 837 F.2d 1044, 1050, 5 U.S.P.Q.2d (BNA) 1434,
1438 (Fed. Cir. 1988) (same); Panduit Corp., 810 F.2d at 1565-66, 1 U.S.P.Q.2d (BNA) at 1594-95
(same).
400. See In re Clay, 966 F.2d 656, 658-59, 23 U.S.P.Q.2d (BNA) 1058, 1060 (Fed. Cir. 1992)
(maintaining that there are two criteria for determining whether prior art is analogous).
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Two criteria have evolved for determining whether prior art is
analogous:  “(1) whether the art is from the same field of endeavor,
regardless of the problem addressed, and (2) if the reference is not
within the field of the inventor’s endeavor, whether the reference still
is reasonably pertinent to the particular problem with which the
inventor is involved.”401  Whether a reference in the prior art is
analogous is a factual question, which the Federal Circuit reviews for
substantial evidence to support the jury’s verdict, or otherwise for
clear error.402
CC. Obviousness-type Double Patenting
Obviousness-type double patenting is a judge-made doctrine that
prevents an extension of the patent right beyond the statutory time
limit.403  This doctrine requires rejection of an application claim when
the claimed subject matter is not patentably apart from the subject
matter claimed in a commonly owned patent.404  Its purpose is to
prevent an unjustified extension of the term of the right to exclude
granted by a patent by allowing a second patent claiming an obvious
variant of the same invention to issue to the same owner.405  The
Federal Circuit reviews de novo a rejection under the doctrine of
obviousness-type double patenting as a legal conclusion,406 and
reviews for clear error any factual findings underlying that decision.407
DD. Written Description
To obtain patent protection, an inventor must set forth an
adequate written description of the invention.408  This statutory
requirement ensures that the subject matter of a claim presented
after the filing date of the patent application sufficiently was disclosed
at the time of filing, and thus, the prima facie date of invention can
                                                 
401. Id., 23 U.S.P.Q.2d (BNA) at 1060 (stating that under the clearly erroneous standard
the analogous argument is two-fold).
402. See Panduit Corp., 810 F.2d at 1568 n.9, 1 U.S.P.Q.2d (BNA) at 1597 n.9 (differentiating
factors falling under fact analysis from those under legal review).
403. See In re Braat, 937 F.2d 589, 592, 19 U.S.P.Q.2d (BNA) 1289, 1291-92 (Fed. Cir. 1991)
(establishing the difficult judicial standard for ensuring that additional patents are not given for
“merely an obvious variation”).
404. See id., 19 U.S.P.Q.2d (BNA) at 1291-92.
405. See In re Goodman, 11 F.3d 1046, 1052, 29 U.S.P.Q.2d (BNA) 2010, 2015 (Fed. Cir.
1993) (describing the two part test for determining double patenting as:  “1) is the same
invention claimed twice, and 2) is one claim merely an obvious variation of the earlier”).
406. See Texas Instruments, Inc. v. United States Int’l Trade Comm’n, 988 F.2d 1165, 1179,
26 U.S.P.Q.2d (BNA) 1018, 1029 (Fed. Cir. 1993); General Foods v. Studiengesellschaft Kohl
MbH, 972 F.2d 1272, 1277, 23 U.S.P.Q.2d (BNA) 1839, 1843 (Fed. Cir. 1992).
407. See In re Caveney, 761 F.2d 671, 674, 226 U.S.P.Q. (BNA) 1, 3 (Fed. Cir. 1985) (noting
that the court’s review of facts is clearly erroneous, rather than de novo).
408. See 35 U.S.C. § 112, ¶ 1 (1994).
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fairly be held to be the filing date of the application.409  This issue
arises, for example, out of an assertion of entitlement to the filing
date of a previously filed application under 35 U.S.C. § 120.410  The
adequacy of a written description is a question of fact that the Federal
Circuit reviews for substantial evidence to support the jury’s verdict411
or otherwise for clear error.412
EE. Indefiniteness
To obtain patent protection, an inventor must set forth a claim that
reasonably apprises those of skill in the art of its scope.413  Whether a
claim is invalid for its indefiniteness depends upon “whether those
skilled in the art would understand what is claimed when the claim is
read in light of the specification.”414  Indefiniteness is a legal
conclusion that the Federal Circuit reviews de novo.415
FF. Enablement
In addition, an inventor must provide a disclosure sufficient to
enable any person skilled in the art to practice the invention.416  The
specification of a patent must teach those skilled in the art how to
make and use the full scope of the claimed invention without undue
                                                 
409. See Hyatt v. Boone, 146 F.3d 1348, 1354-55, 47 U.S.P.Q.2d (BNA) 1128, 1132 (Fed. Cir.
1998) (holding that not only is the subject matter critical, but clarity and specificity are integral
to the court carrying out such analysis); Vas-Cath, Inc. v. Mahurkar, 935 F.2d 1555, 1563, 19
U.S.P.Q.2d (BNA) 1111, 1116 (Fed. Cir. 1991) (relying on the clarity factor); In re Smith, 481
F.2d 910, 914, 178 U.S.P.Q. (BNA) 620, 623-24 (C.C.P.A. 1973) (focusing on the specificity
factor).
410. See Lockwood v. American Airlines, Inc., 107 F.3d 1565, 1571, 41 U.S.P.Q.2d (BNA)
1961, 1965-66 (Fed. Cir. 1997) (explaining the importance of the written description
requirement in relation to the filing date).
411. See Wang Lab., Inc. v. Toshiba Corp., 993 F.2d 858, 865, 26 U.S.P.Q.2d (BNA) 1767,
1774 (Fed. Cir. 1993) (defining the standard for the written description requirement).
412. See Vas-Cath, Inc., 935 F.2d at 1563, 19 U.S.P.Q.2d (BNA) at 1116 (maintaining that
compliance with the written description requirement is a question of fact that is reviewed under
the clearly erroneous standard); In re Gosteli, 872 F.2d 1008, 1012, 10 U.S.P.Q.2d (BNA) 1614,
1618 (Fed. Cir. 1989) (same); see also Utter v. Hiraga, 845 F.2d 993, 998, 6 U.S.P.Q.2d (BNA)
1709, 1714 (Fed. Cir. 1988) (clarifying distinctions between court choice of analysis); Ralston
Purina Co. v. Far-Mar-Co., 772 F.2d 1570, 1575, 227 U.S.P.Q. (BNA) 177, 179 (Fed. Cir. 1985)
(describing analysis that can be used by court during a written description requirement review).
413. See 35 U.S.C. § 112, ¶ 2 (1994) (requiring that the patent “particularly [point] out and
distinctly [claim] the subject matter which the applicant regards as his invention”).
414. See Orthokinetics, Inc. v. Safety Travel Chairs, Inc., 806 F.2d 1565, 1576, 1 U.S.P.Q.2d
(BNA) 1081, 1088 (Fed. Cir. 1986).
415. See North Am. Vaccine, Inc. v. American Cyanamid Co., 7 F.3d 1571, 1579, 28
U.S.P.Q.2d (BNA) 1333, 1339 (Fed. Cir. 1993) (establishing the court’s standard of review);
Carl Zeiss Stiftung v. Renishaw plc, 945 F.2d 1173, 1181, 20 U.S.P.Q.2d (BNA) 1094, 1101 (Fed.
Cir. 1991) (same).
416. Cf. Genentech, Inc. v. Novo Nordisk A/S, 108 F.3d 1361, 1365-66, 42 U.S.P.Q.2d (BNA)
1001, 1004 (Fed. Cir. 1997) (noting that lack of disclosure alone does not result in a failure of
the enabling requirement).
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experimentation.417  A party must prove lack of enablement by clear
and convincing evidence.418  Enablement is a question of law that the
Federal Circuit reviews de novo.419  The court reviews for clear error
any underlying facts to the enablement conclusion.420
GG. Best Mode
To obtain patent protection, an inventor must disclose the best
mode of carrying out the invention personally known at the time of
filing the application.421  The best mode inquiry focuses on the
inventor’s state of mind based on personal knowledge of available
facts.422  A party must prove a best mode violation by clear and
convincing evidence.423  Compliance with the best mode requirement
is a factual question that the Federal Circuit reviews for substantial
evidence to support the jury’s verdict,424 or otherwise for clear error.425
                                                 
417. See Hybritech, Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1384, 231 U.S.P.Q.
(BNA) 81, 94 (Fed. Cir. 1986) (specifying degree of experimentation necessary).
418. See Morton Int’l Co. v. Cardinal Chem. Co., 5 F.3d 1464, 1469, 28 U.S.P.Q.2d (BNA)
1190, 1194 (Fed. Cir. 1993) (assessing the amount of evidence necessary to prove
infringement).
419. See PPG Indus., Inc. v. Guardian Indus. Corp., 75 F.3d 1558, 1564, 37 U.S.P.Q.2d
(BNA) 1618, 1623 (Fed. Cir. 1996) (stating the court’s standard of review); In re Wands, 858
F.2d 731, 735-37, 8 U.S.P.Q.2d (BNA) 1400, 1402-04 (Fed. Cir. 1988) (same); Moleculon
Research Corp. v. CBS, Inc., 793 F.2d 1261, 1268, 229 U.S.P.Q. (BNA) 805, 811 (Fed. Cir. 1986)
(same); Quaker City Gear Works, Inc. v. Skil Corp., 747 F.2d 1446, 1453-54, 223 U.S.P.Q. (BNA)
1161, 1166 (Fed. Cir. 1984) (same).
420. See Gould v. Quigg, 822 F.2d 1074, 1077, 3 U.S.P.Q.2d (BNA) 1302, 1303-04 (Fed. Cir.
1987) (noting the court’s use of a clearly erroneous test for factual determinations).
421. See 35 U.S.C. § 112, ¶ 1 (1994) (requiring that the patent specification “set forth the
best mode contemplated by the inventor of carrying out his invention”).
422. See Chemcast Corp. v. Arco Indus. Corp., 913 F.2d 923, 927, 16 U.S.P.Q.2d (BNA)
1033, 1036 (Fed. Cir. 1990) (stating that the fact-finder must consider not only the inventor’s
state of mind at the time the application is filed, but also the level of skill in art and the scope of
the claimed invention); see also Spectra-Physics, Inc. v. Coherent, Inc., 827 F.2d 1524, 1535, 3
U.S.P.Q.2d (BNA) 1737, 1745 (Fed. Cir. 1987) (noting that there is no clear objective standard
to judge the adequacy of the best mode disclosure, but that evidence of accidental or
intentional concealment is considered); Hybritech Inc., 802 F.2d at 1384-85, 231 U.S.P.Q. (BNA)
at 94.
423. See Transco Prods., Inc. v. Performance Contracting, Inc., 38 F.3d 551, 560, 32
U.S.P.Q.2d (BNA) 1077, 1084 (Fed. Cir. 1994) (stating that in determining the best mode
requirement the court must consider:  “(1) whether the inventor knew of a mode of practicing
the claimed invention that he considered to be better than any other at the time he filed his
application; and (2) to compare what he knew with what he disclosed . . . .”); see also Railroad
Dynamics, Inc. v. A. Stucki Co., 727 F.2d 1506, 1517, 220 U.S.P.Q. (BNA) 929, 939-40 (Fed. Cir.
1984) (setting forth the burden of proving facts in relation to the best mode requirement upon
the offering party).
424. See generally Fonar Corp. v. General Elec. Co., 107 F.3d 1543, 1550, 41 U.S.P.Q.2d
(BNA) 1801, 1806 (Fed. Cir. 1997) (describing the court’s use of the evidence to review the
jury’s verdict in regards to the best mode requirement); Wang Lab., Inc. v. Mitsubishi Elecs.
Am., Inc., 103 F.3d 1571, 1583, 41 U.S.P.Q.2d (BNA) 1263, 1273 (Fed. Cir. 1997) (same); Great
N. Corp. v. Henry Molded Prods., Inc., 94 F.3d 1569, 1572, 39 U.S.P.Q.2d (BNA) 1997, 2000
(Fed. Cir. 1996); Therma-Tru Corp. v. Peachtree Doors, Inc., 44 F.3d 988, 993, 33 U.S.P.Q.2d
(BNA) 1274, 1277 (Fed. Cir. 1995); In re Hayes Microcomputer Prods., Inc., 982 F.2d 1527,
1536, 25 U.S.P.Q.2d (BNA) 1241, 1248 (Fed. Cir. 1992); Shearing v. Iolab Corp., 975 F.2d 1541,
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HH.  Noninfringement Defense Standards
In addition to patent invalidity, noninfringement is another
affirmative defense available to an accused infringer.426
1. Repair versus reconstruction
Infringement liability does not attach to the repair of a patented
combination of unpatented components.427  The distinction between
permissible repair and impermissible reconstruction does not
depend on whether the replaced element is an essential or
distinguishing part of the claimed combination.428  Permissible repair
includes any repair necessary for the maintenance or use of the
whole patented combination, such as the replacement of spent,
unpatented elements.429  Whether defendant’s actions constitute a
permissible repair or an infringing reconstruction is a question of
law, which the Federal Circuit reviews de novo.430
2. License and implied license
A defense to an infringement charge may involve the existence of a
license agreement relating to the otherwise unauthorized activity.431
The proper construction of the parties’ license agreement is a
question of contract interpretation under state law, which the Federal
Circuit reviews de novo.432
In addition, when a patent holder sells or authorizes a sale of the
                                                 
1545-46, 24 U.S.P.Q.2d (BNA) 1133, 1137-38 (Fed. Cir. 1992).
425. See generally Amgen, Inc. v. Chugai Pharm. Co., 927 F.2d 1200, 1209, 18 U.S.P.Q.2d
(BNA) 1016, 1024 (Fed. Cir. 1991) (noting the court’s use of the clearly erroneous standard for
fact-findings); Spectra-Physics, Inc. v. Coherent, Inc., 827 F.2d 1524, 1535-36, 3 U.S.P.Q.2d
(BNA) 1737, 1745 (Fed. Cir. 1987) (same); DeGeorge v. Bernier, 768 F.2d 1318, 1324, 226
U.S.P.Q. (BNA) 758, 763 (Fed. Cir. 1985) (same); Coleman v. Dines, 754 F.2d 353, 356, 224
U.S.P.Q. (BNA) 758, 763 (Fed. Cir. 1985) (same); McGill, Inc. v. John Zink Co., 736 F.2d 666,
676, 221 U.S.P.Q. (BNA) 944, 951 (Fed. Cir. 1984) (same).
426. See 35 U.S.C. § 282, ¶ 1 (1994) (stating that noninfringement, absence of liability for
infringement, or unenforceability shall be defenses in actions involving the validity or
infringement of a patent).
427. See Aro Mfg. Co. v. Convertible Top Replacement Co., 365 U.S. 336, 346 (1961)
(describing the replacement of individual parts after the original is spent as the owners’ “lawful
right” to repair their own property).
428. See Dawson Chem. Co. v. Rohm & Haas Co., 448 U.S. 176, 217 (1980) (discussing
distinction between repair and reconstruction) (citing Aro Mfg., 365 U.S. at 344).
429. See Aro Mfg., 365 U.S. at 346.
430. See Dawson Chem., 448 U.S. at 217 (utilizing the de novo standard for a distinctly legal,
rather than factual, question); Sage Prods., Inc. v. Devon Indus., Inc., 45 F.3d 1575, 33
U.S.P.Q.2d (BNA) 1765, 1766-67 (Fed. Cir. 1995) (same).
431. See Studiengesellschaft Kohle M.B.H. v. Hercules, Inc., 105 F.3d 629, 633, 41
U.S.P.Q.2d (BNA) 1518, 1521 (Fed. Cir. 1997) (discussing the “free” license versus the “paying”
license as protection from infringement violations).
432. See Cyrix Corp. v. Intel Corp., 77 F.3d 1381, 1384, 37 U.S.P.Q.2d (BNA) 1884, 1887
(Fed. Cir. 1996) (holding that contract interpretation is a question of law deserving de novo
review).
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patented product, a court may recognize an implied license.433  The
Federal Circuit reviews the existence of an implied license de novo, as
a question of law.434
II. Unenforceability
1. Inequitable conduct
Patent applicants and their representatives have a duty of candor,
good faith, and honesty in their dealings with the USPTO.435  Breach
of this duty constitutes inequitable conduct.436  A party alleging
inequitable conduct must prove by clear and convincing evidence
that the patent applicant intentionally misrepresented or withheld
material information from the patent examiner.437  Information is
material if a substantial likelihood exists that a reasonable examiner
would have considered it necessary to a proper patentability
assessment of an invention.438  Circumstantial evidence may allow the
court to infer an intent to deceive the USPTO.439  Evidence of gross
negligence alone, however, cannot support a finding of deceptive
intent.440
                                                 
433. See United States v. Univis Lens Co., 316 U.S. 241, 250-51 (1942) (noting that the
patent holder’s sale of an unfinished patented item constituted both a transfer of ownership
and a license to complete the patented procedure without further payment).
434. See Guinn v. Kopf, 96 F.3d 1419, 1421, 40 U.S.P.Q.2d (BNA) 1157, 1159 (Fed. Cir.
1996) (noting that the single issue, whether the commissioner properly promulgated 37 C.F.R.
§ 1.662(c) under the authority of Congress, involves only contract interpretation); Met-Coil Sys.
Corp. v. Korners Unlimited, Inc., 803 F.2d 684, 687, 231 U.S.P.Q. (BNA) 474, 476 (Fed. Cir.
1986) (stating that the issue is a question of law).
435. See Precision Instrument Mfg. Co. v. Automotive Maintenance Mach. Co., 324 U.S. 806,
818 (1945) (stating that persons with pending applications at the Patent Office have an
“uncompromising duty to report to it all facts concerning possible fraud or inequitableness
underlying the applications in issue”).
436. See id. (explaining that only through requiring disclosure can the USPTO prevent
inequitable conduct, thereby protecting the public from “fraudulent patent monopolies”); 37
C.F.R. § 1.555 (1998) (describing the intentional failure to report material information as
inequitable conduct).
437. See Glaverbel Societe Anonyme v. Northlake Mktg. & Supply, Inc., 45 F.3d 1550, 1556-
57, 33 U.S.P.Q.2d (BNA) 1496, 1500 (Fed. Cir. 1995) (citing Kingsdown Med. Consultants, Ltd.
v. Hollister, Inc., 863 F.2d 867, 872, 9 U.S.P.Q.2d (BNA) 1384, 1389 (Fed. Cir. 1988)) (both
cases discussing the standard for proving inequitable conduct).
438. See 37 C.F.R. § 1.555 (1998) (delineating duties to disclose information material to
patentability).
439. See Paragon Podiatry Lab., Inc. v. KLM Lab., Inc., 984 F.2d 1182, 1189-90, 25
U.S.P.Q.2d (BNA) 1561, 1567 (Fed. Cir. 1993) (noting that there is no requirement of
“smoking gun” evidence to prove intent to deceive); see also Kansas Jack, Inc. v. Kuhn, 719 F.2d
1144, 1151, 219 U.S.P.Q. (BNA) 857, 861 (Fed. Cir. 1983) (stating that the presumption that
one intends the natural consequences of one’s acts can be used to prove the intent element of
fraud).
440. See Kingsdown Med. Consultants, 863 F.2d at 876, 9 U.S.P.Q.2d (BNA) at 1392 (clarifying
that all evidence, including good faith evidence, is necessary in determining the intent to
deceive).
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The Federal Circuit reviews the district court’s determination of
inequitable conduct for abuse of discretion.441  Misrepresentation,
materiality, and intent to deceive are underlying questions of fact that
the Federal Circuit reviews for clear error.442
2. Laches and equitable estoppel
Laches and equitable estoppel are defenses to an allegation of
patent infringement.443  An accused infringer invoking a laches
defense must prove by a preponderance of the evidence that the
plaintiff’s unreasonable delay in bringing suit resulted in material
prejudice to the defendant.444  Similarly, an accused infringer
invoking equitable estoppel must prove by a preponderance of the
evidence that:  (1) the plaintiff misled the defendant into reasonably
believing that the plaintiff had foregone enforcement of its patent
rights against the defendant; (2) that the defendant relied on this
belief; and (3) that material prejudice would result from survival of
the claim.445  The Federal Circuit reviews for an abuse of discretion
the district court’s decision whether to apply the equitable defenses
of laches or equitable estoppel.446
JJ. Claim and Issue Preclusion
Claim preclusion, or res judicata, bars the relitigation of claims
already adjudicated.447  Similarly, issue preclusion, or collateral
estoppel, bars the relitigation of issues already adjudicated.448  A party
                                                 
441. See Kolmes v. World Fibers Corp., 107 F.3d 1534, 1541, 41 U.S.P.Q.2d (BNA) 1829,
1834 (Fed. Cir. 1997) (articulating the standard of review).
442. See Kingsdown Med. Consultants, 863 F.2d at 872, 9 U.S.P.Q.2d (BNA) at 1389 (stating
that the findings on these issues will not be disturbed unless the Federal Circuit firmly believes
that there has been a mistake).
443. See Hemstreet v. Computer Entry Sys. Corp., 972 F.2d 1290, 1292, 23 U.S.P.Q.2d (BNA)
1860, 1862 (Fed. Cir. 1992) (noting that both defenses are based on factual determinations
made at the trial court’s discretion).
444. See Advanced Cardiovascular Sys., Inc. v. SciMed Life Sys., Inc., 988 F.2d 1157, 1161, 26
U.S.P.Q.2d (BNA) 1038, 1041 (Fed. Cir. 1993) (stating that the period of delay is measured
from the time the plaintiff had actual notice of the claim or would reasonably have made an
inquiry about the issue).
445. See A.C. Aukerman Co. v. R.L. Chaides Constr. Co., 960 F.2d 1020, 1041, 22 U.S.P.Q.2d
(BNA) 1321, 1335-36 (Fed. Cir. 1992) (en banc) (noting that equitable estoppel, unlike laches,
is not factually limited).
446. See id. at 1028, 22 U.S.P.Q.2d (BNA) at 1325 (articulating the standard of review);
Adelberg Lab., Inc. v. Miles, Inc., 921 F.2d 1267, 1274, 17 U.S.P.Q.2d (BNA) 1111, 1116 (Fed.
Cir. 1990) (finding no such abuse where the lower court granted the defendant’s motion for
summary judgment on the grounds of estoppel and laches).
447. See Young Eng’rs, Inc. v. United States Int’l Trade Comm’n, 721 F.2d 1305, 1316, 219
U.S.P.Q. (BNA) 1142, 1152 (Fed. Cir. 1983) (finding a second infringement action was barred
when the issues were litigated previously).
448. Cf. Mother’s Restaurant, Inc. v. Mama’s Pizza, Inc., 723 F.2d 1566, 1569-70, 221
U.S.P.Q. (BNA) 394, 397 (Fed. Cir. 1983) (holding that a trademark cancellation proceeding
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to a subsequent action invoking collateral estoppel regarding issue
preclusion must prove that the prior action:  (1) involved the same
controlling facts and applicable law; (2) involved actual litigation of
the identical issue; (3) concluded with a final judgment to which the
identical issue was essential; and (4) permitted a “full and fair
opportunity” to litigate that issue.449
As claim and issue preclusion are not matters unique to patent
cases, the Federal Circuit applies the applicable law of the
appropriate regional circuit rather than its own jurisprudence.450  The
Federal Circuit likely would review de novo the propriety of the
application of claim or issue preclusion.451
KK. Patent Misuse
Patent misuse is an affirmative defense to an accusation of patent
infringement, the successful assertion of which “requires that the
alleged infringer show that the patentee has impermissibly
broadened the ‘physical or temporal scope’ of the patent grant with
anticompetitive effect.”452  The Federal Circuit reviews de novo the
conclusion of patent misuse and the underlying facts for substantial
evidence where resolved by a jury.453
LL. Interference Proceedings
When a patent application claims the same subject matter as
another pending application or an unexpired patent, the
Commissioner of the USPTO may declare an interference to
determine which party has priority, i.e., who was the first to invent the
                                                 
that adjudicated the issue of similar service marks prevents further adjudication on the same
issue).
449. See In re Freeman, 30 F.3d 1459, 1465-67, 31 U.S.P.Q.2d (BNA) 1444, 1449-50 (Fed. Cir.
1994) (describing and applying these conditions to determine whether a reissue claim,
amended during a reexamination hearing, is subject to issue preclusion).
450. See Epic Metals Corp. v. H.H. Robertson Co., 870 F.2d 1574, 1576, 10 U.S.P.Q.2d
(BNA) 1296, 1298-99 (Fed. Cir. 1989) (noting that the application of res judicata principles is
not exclusive to Federal Circuit jurisdiction) (citing Hartley v. Mentor Corp., 869 F.2d 1469,
1471 n.1, 10 U.S.P.Q.2d (BNA) 1138, 1139 n.1 (Fed. Cir. 1989)).
451. See United Techs. Corp. v. Chromalloy Gas Turbine Corp., 189 F.3d 1338, 1342-43, 51
U.S.P.Q.2d (BNA) 1838, 1840-41 (Fed. Cir. 1999) (“Whether, based on the facts of the case, a
claim is barred by the doctrine of res judicata is a question of law that we review de novo.”);
Pharmacia & Upjohn Co. v. Mylan Pharms., Inc., 170 F.3d 1373, 1376, 50 U.S.P.Q.2d (BNA)
1033,1036 (Fed. Cir. 1999) (reviewing the district court’s application of collateral estoppel de
novo).
452. Windsurfing Int’l, Inc. v. AMF, Inc., 782 F.2d 995, 1001, 228 U.S.P.Q. (BNA) 562, 566
(Fed. Cir. 1986) (quoting Blonder-Tongue Lab., Inc. v. University of Ill. Found., 402 U.S. 313,
343 (1971)).
453. See Virginia Panel Corp. v. MAC Panel Co., 133 F.3d 860, 868, 45 U.S.P.Q.2d (BNA)
1225, 1231-32 (Fed. Cir. 1997).
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claimed subject matter.454  An initial step in the interference
proceeding is defining an interference count, the interpretation of
which is a question of law that the Federal Circuit reviews de novo.455
In determining priority of invention, the USPTO Board of Patent
Appeals and Interferences must consider the “respective dates of
conception and reduction to practice of the invention . . . [as well as]
the reasonable diligence of one who was first to conceive and last to
reduce to practice, from a time prior to conception by the other.”456
Accordingly, priority of invention “goes to the first party to reduce an
invention to practice unless the other party can show that it was the
first to conceive the invention and that it exercised reasonable
diligence in later reducing that invention to practice.”457
The Federal Circuit reviews the issue of priority de novo and reviews
the Board’s factual findings underlying that determination for clear
error.458  Likewise, the Federal Circuit reviews the issue of conception
de novo and reviews the Board’s factual findings underlying that
determination for clear error.459
Conception is the touchstone to determining inventorship.460
Conception is the formation in the mind of the inventor of a definite
and permanent idea of the complete and operative invention,
including every feature or limitation of the claimed invention.461
                                                 
454. See 35 U.S.C. § 135(a) (1994) (outlining the interference procedure); Hahn v. Wong,
892 F.2d 1028, 1030, 13 U.S.P.Q.2d (BNA) 1313, 1315 (Fed. Cir. 1989) (setting forth a brief
description of the procedures and practices of the USPTO in conducting interference
proceedings under its new rules).
455. See Davis v. Loesch, 998 F.2d 963, 967, 27 U.S.P.Q.2d (BNA) 1440, 1444 (Fed. Cir.
1993) (reviewing the interpretation of an interference count de novo); DeGeorge v. Bernier, 768
F.2d 1318, 1321, 226 U.S.P.Q. (BNA) 758, 760 (Fed. Cir. 1985) (same).
456. 35 U.S.C. § 102(g) (1994).
457. Price v. Symsek, 988 F.2d 1187, 1190, 26 U.S.P.Q.2d (BNA) 1031, 1033 (Fed. Cir.
1993).
458. See Holmwood v. Sugavanam, 948 F.2d 1236, 1238, 20 U.S.P.Q.2d (BNA) 1712, 1714
(Fed. Cir. 1991) (“Reduction to practice is a legal determination subject to de novo review.”);
Hybritech Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1376, 231 U.S.P.Q. (BNA) 81, 87
(Fed. Cir. 1986) (same).
459. See Bosies v. Benedict, 27 F.3d 539, 542, 30 U.S.P.Q.2d (BNA) 1862, 1864 (Fed. Cir.
1994) (noting that the legal question of conception is reviewed de novo).
460. See Burroughs Wellcome Co. v. Barr Lab., Inc., 40 F.3d 1223, 1227-28, 32 U.S.P.Q.2d
(BNA) 1915, 1919 (Fed. Cir. 1994) (articulating the test for conception as whether the inventor
had an idea that was “definite and permanent” enough that one skilled in the art could
understand the invention).
461. See Coleman v. Dines, 754 F.2d 353, 359, 224 U.S.P.Q. (BNA) 857, 862 (Fed. Cir. 1985)
(setting forth the burden of proof for conception).  Conception must be proven by
corroborating evidence showing that the inventor disclosed to others his complete thought
expressed in such clear terms as to enable those skilled in the art to make the invention.  See id.,
224 U.S.P.Q. (BNA) at 862.  The sufficiency of corroborative evidence is determined by the
“rule of reason,” which requires a reasonable analysis of all of the pertinent evidence to
determine whether the inventor’s testimony is credible.  See Price, 988 F.2d at 1195, 26
U.S.P.Q.2d (BNA) at 1037.
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To prove a reduction to practice, an applicant must show that the
embodiment relied upon as evidence of priority actually worked for
its intended purpose.462  The Federal Circuit applies the “rule of
reason” standard when reviewing the sufficiency of evidence about
reduction to practice.463  Reduction to practice is a legal conclusion
subject to de novo review.464  The Federal Circuit reviews the Board’s
factual findings supporting its legal conclusions regarding reduction
to practice for clear error.465
The Board or the Examiner-in-Chief may impose an appropriate
sanction, including granting judgment in an interference, against a
party who fails to comply with the rules governing interferences,
including filing deadlines.466  The Federal Circuit reviews a Board’s
decision pursuant to the permissive rules governing an interference
for abuse of discretion.467
MM. Reissue
The patent law provides for the reissue of a patent deemed wholly
or partly inoperative or invalid as a result of error without any
                                                 
462. See Estee Lauder, Inc. v. L’Oreal S.A., 129 F.3d 588, 593, 44 U.S.P.Q.2d (BNA) 1610,
1614 (Fed. Cir. 1997) (noting that there is no reduction to practice until an inventor has
knowledge that the invention will serve its intended purpose); see also Burroughs Wellcome, 40
F.3d at 1228, 32 U.S.P.Q.2d (BNA) at 1919 (“[T]he discovery that an invention actually works is
part of its reduction to practice.”); Hahn v. Wong, 892 F.2d 1028, 1032, 13 U.S.P.Q.2d (BNA)
1313, 1317 (Fed. Cir. 1989) (stating that reduction to practice of a chemical compound is
established by a showing that the inventor prepared the compound knowing it would work);
Mikus v. Wachtel, 542 F.2d 1157, 1159, 191 U.S.P.Q. (BNA) 571, 573 (C.C.P.A. 1976)
(explaining the need for independent corroboration of reduction to practice); see also UMC
Elec. Co. v. United States, 816 F.2d 647, 652, 2 U.S.P.Q.2d (BNA) 1465, 1468 (Fed. Cir. 1987)
(“[T]here cannot be a reduction to practice of the invention . . . without a physical
embodiment which includes all limitations of the claim.”).
463. See Holmwood, 948 F.2d at 1238-39, 20 U.S.P.Q.2d (BNA) at 1714 (noting that the “rule
of reason” analysis “requires the Patent & Trademark Office to examine, analyze, and evaluate
reasonably all pertinent evidence when weighing the credibility of an inventor’s story”).
464. See Fujikawa v. Wattanasin, 93 F.3d 1559, 1564, 39 U.S.P.Q.2d (BNA) 1895, 1899 (Fed.
Cir. 1996); Hybritech, Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1376, 231 U.S.P.Q.
(BNA) 81, 87 (Fed. Cir. 1986).
465. See Conservolite, Inc. v. Widmayer, 21 F.3d 1098, 1100, 30 U.S.P.Q.2d (BNA) 1626,
1628 (Fed. Cir. 1994).
466. See 37 C.F.R. § 1.616 (1998) (setting forth sanctions for failure to comply with
interference regulations or orders).
467. See Abrutyn v. Giovanniello, 15 F.3d 1048, 1050-51, 29 U.S.P.Q.2d (BNA) 1615, 1617
(Fed. Cir. 1994) (describing four situations where there is abuse of discretion); see also Gerritsen
v. Shirai, 979 F.2d 1524, 1527-28, 24 U.S.P.Q.2d (BNA) 1912, 1915-16 (Fed. Cir. 1992) (stating
that decisions made under a permissive statute that concern only USPTO practices are reviewed
for abuse of discretion).  Abuse of discretion will be found where a decision:  “(1) is clearly
unreasonable, arbitrary, or fanciful; (2) is based on an erroneous conclusion of law; (3) rests on
clearly erroneous fact-findings; or (4) involves a record that contains no evidence on which the
Board could rationally base its decision.”  Abrutyn, 15 F.3d at 1050-51, 29 U.S.P.Q.2d (BNA) at
1617.
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deceptive intention.468  Reissue error may include an attorney’s failure
to appreciate the full scope of the invention, but does not give the
patentee a second bite at the apple.469  “The deliberate cancellation of
a claim of an original application in order to secure a patent . . .
[may] prevent the applicant from obtaining the cancelled claim by
reissue,” but is not dispositive.470  This “recapture” rule bars the
patentee from acquiring, through reissue, claims that are of the same
or of broader scope than those claims that were cancelled from the
original application.471
Whether the statutory requirement of “error” has been met is an
issue of law, which the Federal Circuit reviews de novo.472  This legal
conclusion is based on underlying factual inquiries, which the
Federal Circuit reviews for substantial evidence to support the jury’s
verdict, or for clear error where the trial judge sits as the fact-finder.473
To the extent that its claims are identical with the original patent, a
reissued patent constitutes a continuation of the original patent.474
Claims are identical if they are without substantive change.475  Thus,
the scope of the claim must be identical, but the words need not be
identical.476  A determination of whether the scope of a reissue claim
is identical with the scope of the original claim is a question of law
that the Federal Circuit reviews de novo.477
                                                 
468. See 35 U.S.C. § 251 (1994).  The inoperativity or invalidity may arise by reason of a
defective specification or drawing, or by reason of the patentee claiming more or less than he
had a right to claim in the patent.  See id.
469. See In re Wilder, 736 F.2d 1516, 1519, 222 U.S.P.Q. (BNA) 369, 370-71 (Fed. Cir. 1984)
(noting that such attorney error is a common source of patent defects).
470. Mentor Corp. v. Coloplast, Inc., 998 F.2d 992, 995-96, 27 U.S.P.Q.2d (BNA) 1521, 1524-
25 (Fed. Cir. 1993) (quoting In re Wilingham, 282 F.2d 353, 357, 127 U.S.P.Q. (BNA) 211, 215
(C.C.P.A. 1960)); Seattle Box Co. v. Industrial Crating & Packing, Inc., 731 F.2d 818, 826, 221
U.S.P.Q. (BNA) 568, 574 (Fed. Cir. 1984) (same); Ball Corp. v. United States, 729 F.2d 1429,
1438, 221 U.S.P.Q. (BNA) 289, 296 (Fed. Cir. 1984) (same).
471. But see Mentor Corp., 998 F.2d at 996, 27 U.S.P.Q.2d (BNA) at 1525 (noting that reissue
claims may avoid the effect of the recapture rule if they are narrower in certain respects and
broader in others).
472. See In re Clement, 131 F.3d 1464, 1468, 45 U.S.P.Q.2d (BNA) 1161, 1163 (Fed. Cir.
1997) (stating that the Board’s findings are sustained unless clearly erroneous); Mentor Corp.,
998 F.2d at 994, 27 U.S.P.Q.2d (BNA) at 1524 (same).
473. See In re Kemps, 97 F.3d 1427, 1430, 40 U.S.P.Q.2d (BNA) 1309, 1312 (Fed. Cir. 1996)
(rejecting the arbitrary and capricious standard of review).
474. See 35 U.S.C. § 252 (1994).
475. See Seattle Box Co., 731 F.2d at 827-28, 221 U.S.P.Q. (BNA) at 574-75 (interpreting
“identical” as “without substantive change” rather than the stricter standard of “essentially
identical”).
476. See Slimfold Mfg. Co. v. Kinkead Indus., Inc., 810 F.2d 1113, 1115, 1 U.S.P.Q.2d (BNA)
1563, 1565 (Fed. Cir. 1987) (stating that “identical” does not exclude a minor word change).
477. See Tillotson, Ltd. v. Walbro Corp., 831 F.2d 1033, 1037, 4 U.S.P.Q.2d (BNA) 1450,
1452 (Fed. Cir. 1987) (holding that the scope of a claim is a “legal issue” that is reviewed de
novo).
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NN.Reexamination
Patent law provides a procedural mechanism in the USPTO, known
as a reexamination proceeding, which allows for the amendment of,
or addition to, the claims in an issued U.S. patent.478  A patentee of a
reexamined patent is entitled to infringement damages, inter alia, for
the period between the date of issuance of the original claims and the
date of issuance of the reexamined claims, if the original and
reexamined claims are “identical.”479
Reexamined claims are “identical” to their original counterparts if
they are “without substantive change.”480  If substantive changes have
been made to the original claims, the patentee is entitled to
infringement damages only for the period following the issuance of
the reexamination certificate.481  The Federal Circuit reviews without
deference the district court’s conclusion that the reexamined claims
remained identical in scope.482
OO.Federal Court Jurisdiction
The procedural aspects of patent enforcement in the district courts
and the Federal Circuit include jurisdiction, disposition, and control
of cases.483  As courts vested under Article III, section 2 of the U.S.
Constitution, the district courts and the Federal Circuit must remain
cognizant of their limited jurisdiction.484  The failure of the parties at
                                                 
478. See 35 U.S.C. § 305 (1994) (“No proposed amended or new claim enlarging the scope
of a claim of the patent will be permitted in a reexamination proceeding . . . .”).
479. See 35 U.S.C. §§ 252, 307(b) (1994) (describing the legal effects of a reissued patent);
Tennant Co. v. Hako Minuteman, Inc., 878 F.2d 1413, 1417, 11 U.S.P.Q.2d (BNA) 1303, 1306
(Fed. Cir. 1989) (stating that amended claims identical to the original claims are given an
effective date of the original patent).
480. See Seattle Box, 731 F.2d at 827-28, 221 U.S.P.Q. (BNA) at 574-75.  In determining
whether substantive changes have been made, the courts discern whether the scope of the
claims are identical, not merely whether different words are used.  See Slimfold Mfg., 810 F.2d at
1115, 1 U.S.P.Q.2d (BNA) at 1565.
481. See Bloom Eng’g Co. v. North Am. Mfg. Co., 129 F.3d 1247, 1249-50, 44 U.S.P.Q.2d
(BNA) 1859, 1861 (Fed. Cir. 1997) (stating that infringement damages are available only if the
amended claims are identical to the original claims).
482. See Minco, Inc. v. Combustion Eng’g, Inc., 95 F.3d 1109, 1115, 40 U.S.P.Q.2d (BNA)
1001, 1005 (Fed. Cir. 1996) (holding that claim construction is subject to independent review).
483. See 28 U.S.C. § 1338(a) (1994) (granting to federal district courts original jurisdiction
over any civil action arising under a congressional act relating to patents); 28 U.S.C.
§ 1295(a)(1) (establishing U.S. Courts of Appeals for the Federal Circuit as having exclusive
jurisdiction over any appeal based on a § 1338 claim).
484. See Kimberly-Clark Corp. v. Procter & Gamble Distrib. Co., 973 F.2d 911, 913, 23
U.S.P.Q.2d (BNA) 1921, 1923 (Fed. Cir. 1992) (stating that federal courts are limited to
enumerated cases and controversies).  Original jurisdiction in the federal courts depends upon
both constitutional and congressional mandate.  To satisfy the first prerequisite, Article III of
the U.S. Constitution requires a case or controversy.  See Aetna Life Ins. Co. v. Haworth, 300
U.S. 227, 239-41 (1937) (delineating the limited extent of the federal judicial powers).  Second,
Article III empowers federal courts to hear cases “arising under” federal law.  See U.S. CONST.
art. III, § 2, cl. 1.  With respect to patent subject matter jurisdiction, “[t]he district courts shall
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any time during the litigation to satisfy the requirements of Article III
divests the federal courts of jurisdiction to hear the case.485  In
addition, the district courts and the Federal Circuit may dispose of
and control their cases as appropriate under the applicable federal
rules.486
PP. Subject Matter Jurisdiction
The Federal Circuit applies its own precedent, rather than the law
of the relevant regional circuit, in reviewing the propriety of a district
court’s dismissal for lack of subject matter jurisdiction.487  Whether a
trial court properly granted a motion to dismiss for lack of subject
matter jurisdiction is a question of law, which the Federal Circuit
reviews de novo.488
Only a patentee may bring an action for patent infringement.489
The patent law recognizes a patentee as any party to which the patent
issued, or as any successors in title to the patentee.490  A licensee is not
entitled to bring suit in its own name as a patentee, unless the
licensee holds “all substantial rights” under the patent, which
effectively renders it an “assignee,” and thus, a patentee.491
Thus, although a patentee has standing to sue in its own name, an
exclusive licensee that does not have all substantial rights has
standing to sue third parties only as a co-plaintiff in conjunction with
the patentee.492  One exception to this general rule arguably exists
                                                 
have original  jurisdiction of any civil action arising under any Act of Congress relating to
patents . . . .  Such jurisdiction shall be exclusive of the courts of the states in patent . . . cases.”
28 U.S.C. § 1338(a) (1994).  The appellate jurisdiction of the Federal Circuit derives in turn
from the proper jurisdiction of the district court.  See id. § 1295(a)(1) (stating that the Federal
Circuit has exclusive jurisdiction over appeals from federal district courts whose jurisdiction was
based on § 1338).
485. See Preiser v. Newkirk, 422 U.S. 395, 401 (1975) (stating that a case or controversy must
exist at all stages of a litigation for a federal court to have jurisdiction) (quotation omitted).
486. See infra notes 506-58 and accompanying text.
487. See Sanders Assocs., Inc. v. Summagraphics Corp., 2 F.3d 394, 395, 27 U.S.P.Q.2d
(BNA) 1853, 1854 (Fed. Cir. 1993) (holding that where the issue on appeal is jurisdiction, the
Federal Circuit will determine its jurisdiction independently); Woodard v. Sage Prods., Inc., 818
F.2d 841, 844, 2 U.S.P.Q.2d (BNA) 1649, 1651 (Fed. Cir. 1987) (en banc) (stating that
deference to the district court is inappropriate where the issue on appeal is jurisdiction).
488. See GAF Bldg. Materials Corp. v. Elk Corp., 90 F.3d 479, 481, 39 U.S.P.Q.2d (BNA)
1463, 1465 (Fed. Cir. 1996) (stating that the proper standard for reviewing for § 1338(a)
jurisdiction is de novo); BP Chems., Ltd. v. Union Carbide Corp., 4 F.3d 975, 978, 28 U.S.P.Q.2d
(BNA) 1124, 1127 (Fed. Cir. 1993) (holding that whether a case or controversy exists is a
question of law).
489. See 35 U.S.C. § 281 (1994).
490. See id. § 100(d).
491. See Vaupel Textilmaschinen KG v. Meccanica Euro Italia S.P.A., 944 F.2d 870, 875-76,
20 U.S.P.Q.2d (BNA) 1045, 1048-50 (Fed. Cir. 1991) (holding that an assignment of the full
“bundle of rights” included in a patent confers standing to sue on an assignee).
492. See Abbott Lab. v. Diamedix Corp., 47 F.3d 1128, 1130-33, 33 U.S.P.Q.2d (BNA) 1771,
1773-76 (Fed. Cir. 1995) (holding that patentee must be joined before the licensee has right to
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where such an exclusive licensee has standing to sue in its own name
when “necessary to prevent an absolute failure of justice.”493  The
question of standing to sue for patent infringement is one that the
Federal Circuit reviews de novo.494
When reviewing a conclusion of the district court that the causes of
action in a case are not ripe for adjudication, the Federal Circuit
applies the law of the regional circuit in which the district court sits.495
QQ.Declaratory Judgment Jurisdiction
The Declaratory Judgment Act496 established a procedural
mechanism for the resolution of actual controversies between
interested parties.497  A determination of an actual controversy
requires the existence of a reasonable apprehension of immediate
harm.498  The party seeking a declaratory judgment has the burden of
establishing the existence of an actual case or controversy.499
Declaratory judgment jurisdiction is a question of law that the
                                                 
sue for infringement).
493. See Waterman v. Mackenzie, 138 U.S. 252, 255 (1891); Littlefield v. Perry, 88 U.S. (21
Wall.) 205, 223 (1874) (conferring standing on a licensee where the infringer of the patent was
the patentee itself); Ortho Pharm. Corp. v. Genetics Inst., Inc., 52 F.3d 1026, 1030, 34
U.S.P.Q.2d (BNA) 1444, 1446 (Fed. Cir. 1995) (stating that remedies normally available to the
licensee are unavailable absent extraordinary circumstances).
494. See Rite-Hite Corp. v. Kelley Co., 56 F.3d 1538, 1551, 35 U.S.P.Q.2d (BNA) 1065, 1074
(Fed. Cir. 1995) (en banc) (stating that standing is a jurisdictional issue subject to de novo
review by the appellate court).
495. See Cedars-Sinai Med. Ctr. v. Watkins, 11 F.3d 1573, 1580, 29 U.S.P.Q.2d (BNA) 1188,
1194 (Fed. Cir. 1993) (stating that the law of the regional circuit applies where ripeness of
claims is the issue); Molins PLC v. Quigg, 837 F.2d 1064, 1066, 5 U.S.P.Q.2d (BNA) 1526, 1527
(Fed. Cir. 1988) (holding that the regional circuit law applies to ripeness issues because
ripeness focuses on justiciability in district courts, not the Federal Circuit).
496. 28 U.S.C. §§ 2201-2202 (1994).
497. See generally Lawrence M. Sung, Comment, Intellectual Property Protection or Protectionism?
Declaratory Judgment Use By Patent Owners Against Prospective Infringers, 42 AM. U. L. REV. 239, 249-
56 (1992) (discussing the Declaratory Judgment Act, 28 U.S.C. §§ 2201-2202 (1988), and the
application of declaratory judgment jurisprudence to patent cases).
498. An actual controversy requires:  “(1) an explicit threat or other action by the patentee,
which creates a reasonable apprehension on the part of the declaratory plaintiff that it will face
an infringement suit, and (2) present activity which could constitute infringement or concrete
steps taken with the intent to conduct such activity.”  BP Chems. Ltd. v. Union Carbide Corp., 4
F.3d 975, 978, 28 U.S.P.Q.2d (BNA) 1124, 1126 (Fed. Cir. 1993).  In this inquiry, the “first
prong looks to [the patentholder’s] conduct; [the] second to that of [the declaratory
judgment] plaintiff.”  Arrowhead Indus. Water, Inc. v. Ecolochem, Inc., 846 F.2d 731, 736, 6
U.S.P.Q.2d (BNA) 1685, 1689 (Fed. Cir. 1988).
499. See Aetna Life Ins. Co. v. Haworth, 300 U.S. 227, 240-41 (1937) (stating that a
declaratory judgment action requires an actual controversy); EMC Corp. v. Norand Corp., 89
F.3d 807, 810, 39 U.S.P.Q.2d (BNA) 1451, 1453 (Fed. Cir. 1996) (stating that the facts alleged
in a declaratory judgment proceeding must show the presence of a controversy), cert. denied, 519
U.S. 1101 (1997); Phillips Plastics Corp. v. Kato Hatsujou Kabushiki Kaisha, 57 F.3d 1051, 1053,
35 U.S.P.Q.2d (BNA) 1222, 1223 (Fed. Cir. 1995) (holding that declaratory judgment actions
require an “objectively reasonable apprehension that suit will be brought”); Spectronics Corp.
v. H.B. Fuller Co., 940 F.2d 631, 634, 19 U.S.P.Q.2d (BNA) 1545, 1547 (Fed. Cir. 1991) (stating
that an actual controversy must be established by the declaratory judgment plaintiff).
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Federal Circuit reviews de novo.500  The Federal Circuit, however,
reviews for an abuse of discretion the district court’s refusal to accord
jurisdiction under the Declaratory Judgment Act.501
RR. Personal Jurisdiction
Personal jurisdiction over an out-of-state defendant is appropriate
if the relevant state’s long-arm statute permits the assertion of
jurisdiction without violating federal due process.502  The existence of
personal jurisdiction is a question of law that the Federal Circuit
reviews de novo.503  This conclusion may be based on subordinate
questions of fact that the Federal Circuit reviews for clear error.504
Furthermore, the Federal Circuit applies its own precedent, rather
than the law of the relevant regional circuit, to review a district
court’s decision concerning personal jurisdiction.505
                                                 
500. See Super Sack Mfg. Corp. v. Chase Packaging Corp., 57 F.3d 1054, 1058, 35 U.S.P.Q.2d
(BNA) 1139, 1142 (Fed. Cir. 1995) (holding that whether an actual controversy exists in a
declaratory judgment action is subject to plenary review); BP Chems., 4 F.3d at 978, 28
U.S.P.Q.2d (BNA) at 1127 (same).
501. See Glaxo, Inc. v. Novopharm, Ltd., 110 F.3d 1562, 1570, 42 U.S.P.Q.2d (BNA) 1257,
1264 (Fed. Cir. 1997) (applying a deferential standard of review to declaratory action once an
actual controversy is established); Serco Servs. Co. v. Kelley Co., 51 F.3d 1037, 1039, 34
U.S.P.Q.2d (BNA) 1217, 1218 (Fed. Cir. 1995) (stating that an abuse of discretion standard
requires the lower court to make a reasoned judgment concerning whether to allow the action
to proceed).
502. See Graphic Controls Corp. v. Utah Med. Prods., Inc., 149 F.3d 1382, 1385, 47
U.S.P.Q.2d (BNA) 1622, 1625 (Fed. Cir. 1998) (“Determining whether jurisdiction exists over
an out-of-state defendant involves two inquiries:  whether a forum state’s long-arm statute
permits the assertion of jurisdiction and whether assertion of personal jurisdiction violates
federal due process.”); Dainippon Screen Mfg. Co., v. CFMT, Inc., 142 F.3d 1266, 1269-70, 46
U.S.P.Q.2d (BNA) 1616, 1619 (Fed. Cir. 1998) (same); Genetic Implant Sys., Inc. v. Core-Vent
Corp., 123 F.3d 1455, 1458, 43 U.S.P.Q.2d (BNA) 1786, 1788 (Fed. Cir. 1997) (same); Viam
Corp. v. Iowa Export-Import Trading Co., 84 F.3d 424, 427, 38 U.S.P.Q.2d (BNA) 1833, 1834
(Fed. Cir. 1996) (same); Akro Corp. v. Luker, 45 F.3d 1541, 1543, 33 U.S.P.Q.2d (BNA) 1505,
1507 (Fed. Cir. 1995) (same); North Am. Philips Corp. v. American Vending Sales, Inc., 35 F.3d
1576, 32 U.S.P.Q.2d (BNA) 1203, 1204 (Fed. Cir. 1994) (same).
503. See Graphic Controls, 149 F.3d at 1384, 47 U.S.P.Q.2d (BNA) at 1624; Dainippon Screen
Mfg., 142 F.3d at 1269, 46 U.S.P.Q.2d (BNA) at 1619 (same); Genetic Implant Sys., 123 F.3d at
1457, 43 U.S.P.Q.2d (BNA) at 1788 (same).
504. See Dainippon Screen Mfg., 142 F.3d at 1270, 46 U.S.P.Q.2d (BNA) at 1620 (noting that
underlying questions of fact concerning personal jurisdiction are reviewed for clear error).
Specific jurisdiction exists when a non-resident defendant purposefully establishes minimum
contacts with the forum state, the cause of action arises out of those contacts, and jurisdiction is
constitutionally reasonable.  See Burger King Corp. v. Rudzewicz, 471 U.S. 462, 472, 476-77
(1985) (discussing requirements for personal jurisdiction).  The Federal Circuit employs a
three-prong minimum contacts test for determining if specific jurisdiction exists:  (1) whether
the defendant purposefully directed its activities at residents of the forum; (2) whether the
claim arises out of or relates to those activities; and (3) whether assertion of personal
jurisdiction is reasonable and fair.  See Dainippon Screen Mfg., 142 F.3d at 1270 n.2, 46 U.S.P.Q.2d
(BNA) at 1620 n.2; Genetic Implant Sys., 123 F.3d at 1458, 43 U.S.P.Q.2d (BNA) at 1789.
505. See Akro, 45 F.3d at 1543, 33 U.S.P.Q.2d (BNA) at 1506 (stating that jurisdiction over an
out-of-state infringer presents a question of Federal Circuit law); Beverly Hills Fan Co. v. Royal
Sovereign Corp., 21 F.3d 1558, 1564-65, 30 U.S.P.Q.2d (BNA) 1001, 1006 (Fed. Cir. 1994)
(noting that the application of Federal Circuit law to jurisdictional issues promotes “national
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SS. District Court Practice
1. Defenses
A defendant may move, before filing a responsive pleading, to
dismiss the complaint.506  The court must deny such a motion unless it
appears beyond doubt that the plaintiff will be unable to prove any
set of facts in support of its claim entitling it to relief.507  Whether a
complaint states a claim upon which relief can be granted is a
conclusion of law, which the Federal Circuit reviews de novo by
applying the relevant law of the appropriate regional circuit.508
2. Amendment of pleadings
Federal Rule of Civil Procedure 15 provides that leave to amend a
party’s pleadings “shall be freely given when justice so requires.”509
The grant or denial of leave to amend the complaint is within the
discretion of the district court and the Federal Circuit will reverse this
decision only for an abuse of discretion.510  In reviewing an order
denying a motion to amend, a subject that is not unique to patent
law, the Federal Circuit defers to the law of the regional circuit.511
3. Indispensable party
Whether a party is indispensable under Federal Rule of Civil
Procedure 19(b) is a matter of regional circuit law and is reviewed for
abuse of discretion.512
4. Intervention
Federal Rule of Civil Procedure 24 governs party intervention.513
                                                 
uniformity in the field of patent law”).
506. See FED. R. CIV. P. 12(b)(6) (stating that a defendant may move for dismissal before
filing a responsive pleading on the grounds that the complaint stated no claim upon which
relief could be granted).
507. See Advanced Cardiovascular Sys., Inc. v. SciMed Life Sys., Inc., 988 F.2d 1157, 1160, 26
U.S.P.Q.2d (BNA) 1038, 1041 (Fed. Cir. 1993) (noting the requirements to prevail on a motion
to dismiss).
508. See id. (stating that no deference is given to the district court’s decision concerning a
motion to dismiss) (citing Eades v. Thompson, 823 F.2d 1055, 1060 (7th Cir. 1987)).
509. FED. R. CIV. P. 15.
510. See Senza-Gel Corp. v. Seiffhart, 803 F.2d 661, 666, 231 U.S.P.Q. (BNA) 363, 367 (Fed.
Cir. 1986) (stating that the abuse of discretion standard of review comports with the policy of
permitting the amending of pleadings) (citing Howey v. United States, 481 F.2d 1187, 1190 (9th
Cir. 1973)).
511. See Senza-Gel, 803 F.2d at 666, 231 U.S.P.Q. (BNA) at 367 (applying Ninth Circuit law);
Cornwall v. United States Constr. Mfg., Inc., 800 F.2d 250, 252, 231 U.S.P.Q. (BNA) 64, 66 (Fed.
Cir. 1986) (deferring to Eleventh Circuit law).
512. See In re Cambridge Biotech Corp., 186 F.3d 1356, 1368-69, 51 U.S.P.Q.2d (BNA) 1321,
1329 (Fed. Cir. 1999) (applying First Circuit law).
513. See FED. R. CIV. P. 24.
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The denial of a motion to intervene constitutes a procedural matter
not unique to patent law, and thus, the Federal Circuit applies the
relevant law of the appropriate regional circuit.514  The standard of
review for a motion for permissive intervention is an abuse of
discretion.515
5. Discovery matters
Because an order compelling discovery is not unique to patent law,
the Federal Circuit applies the relevant regional circuit law with
respect to the standard of review.516  The Federal Circuit reviews a
district court’s rulings regarding pre-trial discovery for a clear
showing of an abuse of discretion.517
The decision to admit or exclude evidence is within the sound
discretion of the trial court and will be reversed on appeal only for a
clear abuse of that discretion.518  In patent-related cases, to show that
a district court abused its discretion in excluding the prior art
evidence, the affected party must demonstrate that the exclusion
prejudiced its substantive rights.519
6. Sanctions
A district court has inherent authority to control its docket, which
may involve imposing sanctions on the parties.520  Severe sanctions,
such as taking allegations as established and awarding judgment on
that basis, dismissal, and default judgment are authorized under
Federal Rule of Civil Procedure 37 only in extreme circumstances,
which include willfulness, bad faith, or fault.521  The Federal Circuit
                                                 
514. See Haworth, Inc. v. Steelcase, Inc., 12 F.3d 1090, 1092, 29 U.S.P.Q.2d (BNA) 1368,
1370 (Fed. Cir. 1993) (applying Sixth Circuit law).
515. See id. (describing the standard of appellate review) (citing Bradley v. Milliken, 828
F.2d 1186, 1193-94 (6th Cir. 1987)).
516. See American Standard, Inc. v. Pfizer, Inc., 828 F.2d 734, 739, 3 U.S.P.Q.2d (BNA)
1817, 1819 (Fed. Cir. 1987) (applying Seventh Circuit law to motion to compel discovery);
Truswal Sys. Corp. v. Hydro-Air Eng’g, Inc., 813 F.2d 1207, 1209, 2 U.S.P.Q.2d (BNA) 1034,
1036 (Fed. Cir. 1987) (deferring to Eighth Circuit law on reviewing order quashing subpoena);
Heat & Control, Inc. v. Hester Indus., Inc., 785 F.2d 1017, 1022 n.4, 228 U.S.P.Q. (BNA) 926,
929 n.4 (Fed. Cir. 1986) (applying Fourth Circuit law to review an order quashing subpoena).
517. See Dorf & Stanton Communications, Inc. v. Molson Breweries, 100 F.3d 919, 922-23, 40
U.S.P.Q.2d (BNA) 1761, 1764 (Fed. Cir. 1996) (applying an abuse of discretion standard under
Second Circuit law).
518. See Kearns v. Chrysler Corp., 32 F.3d 1541, 1547, 31 U.S.P.Q.2d (BNA) 1746, 1750
(Fed. Cir. 1994) (applying the abuse of discretion standard to order excluding prior art
evidence).
519. See DMI, Inc. v. Deere & Co., 802 F.2d 421, 428, 231 U.S.P.Q. (BNA) 276, 280-81 (Fed.
Cir. 1986) (stating that a party must show that its substantive rights have been affected).
520. See Landis v. North Am. Co., 299 U.S. 248, 254 (1936) (stating that there is an inherent
power in every court to control its docket).
521. See Refac Int’l, Ltd. v. Hitachi, Ltd., 921 F.2d 1247, 1253, 16 U.S.P.Q.2d (BNA) 1347,
1352 (Fed. Cir. 1990) (holding that “[t]he district court must take into account:  (1) the
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reviews for an abuse of discretion the propriety of the district court’s
sanctions.522  In addition, the Federal Circuit applies the relevant law
of the appropriate regional circuit.523
7. Subpoena
The Federal Rules of Civil Procedure allow examination of a
deponent concerning any matter, not privileged, which is relevant to
the subject matter involved in the pending action.524  Rule 45 allows a
person served with a discovery subpoena to move for a protective
order, an order to quash, or an order to modify the subpoena.525  The
Federal Circuit reviews the district court’s order to quash a subpoena
under an abuse of discretion standard and applies the appropriate
regional circuit law.526
8. Judgment as a matter of law (“JMOL”)
The Federal Rules of Civil Procedure permit a district court to
grant a motion for judgment as a matter of law on an issue where no
legally sufficient evidentiary basis exists for a reasonable jury to find
for the moving party on that issue.527  In reviewing rulings under
Federal Rule of Civil Procedure 50, the Federal Circuit generally
defers to the law of the appropriate regional circuit.528
The Federal Circuit reviews a district court’s grant of JMOL under
Rule 50(a) de novo, reapplying the JMOL standard.529  The Federal
                                                 
public’s interest in expeditious resolution of litigation; (2) the court’s need to manage its
docket; (3) the risk of prejudice to the defendants; (4) the public policy favoring disposition of
cases on their merits; and (5) the availability of less drastic sanctions”).
522. See Cooter & Gell v. Hartmarx Corp., 496 U.S. 384, 405 (1990) (stating that an
appellate court should use an abuse of discretion standard when reviewing sanctions); S. Bravo
Sys., Inc. v. Containment Techs. Corp., 96 F.3d 1372, 1374-75, 40 U.S.P.Q.2d (BNA) 1140, 1142-
43 (Fed. Cir. 1996) (stating that sanctions are to be reviewed under an abuse of discretion
standard); Refac Int’l, 921 F.2d at 1253-54, 16 U.S.P.Q.2d (BNA) at 1352 (“In reviewing Rule 37
sanctions, the question is whether the district court abused its discretion.”); cf. Gerritsen v.
Shirai, 979 F.2d 1524, 1528, 24 U.S.P.Q.2d (BNA) 1912, 1915 (Fed. Cir. 1992) (adopting an
abuse of discretion standard for reviewing a sanction imposed by the USPTO).
523. See Refac Int’l, 921 F.2d at 1253-54, 16 U.S.P.Q.2d (BNA) at 1352 (applying the law of
the Ninth Circuit).
524. See FED. R. CIV. P. 26(b).
525. See FED. R. CIV. P. 45(d)(1).
526. See Truswal Sys. Corp. v. Hydro-Air Eng’g, Inc., 813 F.2d 1207, 1209, 2 U.S.P.Q.2d
(BNA) 1034, 1035-36 (Fed. Cir. 1987) (reviewing the quashing of a subpoena under an abuse of
discretion standard and stating that applying regional circuit law is appropriate); Heat &
Control, Inc. v. Hester Indus., Inc., 785 F.2d 1017, 1022 & n.4, 228 U.S.P.Q. (BNA) 926, 929 &
n.4 (Fed. Cir. 1986) (deferring to Fourth Circuit law).
527. See FED. R. CIV. P. 50(a).
528. Cf. Sjolund v. Musland, 847 F.2d 1573, 1576, 6 U.S.P.Q.2d (BNA) 2020, 2023 (Fed. Cir.
1988) (applying Ninth Circuit law to the review of the entry of judgment notwithstanding the
verdict).
529. See Texas Instruments, Inc. v. Cypress Semiconductor Corp., 90 F.3d 1558, 1563, 39
U.S.P.Q.2d (BNA) 1492, 1496 (Fed. Cir. 1996) (stating that a court reviews the JMOL de novo by
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Circuit will reverse a denial of a motion for JMOL only if the jury’s
factual determinations are not supported by substantial evidence or
the legal conclusions implied from the verdict cannot be supported
in law by those findings.530
9. Special master
A district court has the inherent discretion to appoint, without the
consent of the parties, a special master to assist the court in a case.531
The Federal Rules of Civil Procedure define authority of a district
court to assign issues to a special master.532  The Federal Circuit
reviews this reference for an abuse of discretion.533
                                                 
reapplying the JMOL standard); Markman v. Westview Instruments, Inc., 52 F.3d 967, 975, 34
U.S.P.Q.2d (BNA) 1321, 1326 (Fed. Cir. 1995) (en banc) (stating that factual findings made by
a jury “are to be upheld unless the party moving for JMOL shows that . . . there is not substantial
evidence to support a finding in favor of the nonmovant”); Read Corp. v. Portec, Inc., 970 F.2d
816, 821, 23 U.S.P.Q.2d (BNA) 1426, 1431 (Fed. Cir. 1992) (stating that a JNOV should be
reviewed de novo by reapplying the JNOV standard); Dana Corp. v. IPC, Ltd. Partnership, 860
F.2d 415, 417, 8 U.S.P.Q.2d (BNA) 1692, 1694 (Fed. Cir. 1988) (stating that a court must
determine if there is substantial evidence to support the JNOV and if the jury’s findings are
legally sufficient to warrant the JNOV).
530. See United States Surgical Corp. v. Ethicon, Inc., 103 F.3d 1554, 1559, 41 U.S.P.Q.2d
(BNA) 1225, 1228-29 (Fed. Cir. 1997) (stating that the court determines whether there was
substantial evidence to support the jury’s verdict); Markman, 52 F.3d at 975, 34 U.S.P.Q.2d
(BNA) at 1325-26 (stating that on review the court determines whether the jury’s verdict is
supported by substantial evidence and in law)(en banc); Kearns v. Chrysler Corp., 32 F.3d 1541,
1547-48, 31 U.S.P.Q.2d (BNA) 1746, 1751 (Fed. Cir. 1994) (same); Richardson v. Suzuki Motor
Co., 868 F.2d 1226, 1235, 9 U.S.P.Q.2d (BNA) 1913, 1919 (Fed. Cir. 1989) (stating that on
review a court should apply the reasonable jury/substantial evidence standard); Unidisco, Inc.
v. Schattner, 824 F.2d 965, 967, 3 U.S.P.Q.2d (BNA) 1439, 1441 (Fed. Cir. 1987) (stating that
the court determines whether the jury’s verdict and legal conclusions are supported by
substantial evidence when reviewing a JNOV standard); DMI, Inc. v. Deere & Co., 802 F.2d 421,
425, 231 U.S.P.Q. (BNA) 276, 278-79 (Fed. Cir. 1986) (same); Perkin-Elmer Corp. v.
Computervision Corp., 732 F.2d 888, 893, 221 U.S.P.Q. (BNA) 669, 673 (Fed. Cir. 1984)
(noting that the standard of review for a JNOV is whether the jury’s verdict is supported by
substantial evidence that supports its legal conclusions); Railroad Dynamics, Inc. v. A. Stucki
Co., 727 F.2d 1506, 1512-13, 220 U.S.P.Q. (BNA) 929, 936 (Fed. Cir. 1984) (stating that on
review of a JNOV the court must determine whether there is evidence to support the jury’s
verdict, and if the evidence supports the jury’s legal conclusions); see also Shatterproof Glass
Corp. v. Libbey-Owens Ford Co., 758 F.2d 613, 619, 225 U.S.P.Q. (BNA) 634, 636 (Fed. Cir.
1985) (“In reviewing a decision denying a motion for judgment notwithstanding the verdict, we
do not approach the issues as if there had been no trial.  We review the evidence as a whole,
and ascertain whether the verdict is in accordance with law, and whether there was substantial
evidence in support of the jury’s verdict.”).
531. See Ex parte Peterson, 253 U.S. 300, 311-12 (1920) (appointing an auditor as the special
master to parse out issues for trial); see also Constant v. Advanced Micro-Devices, Inc., 848 F.2d
1560, 1566-67, 7 U.S.P.Q.2d (BNA) 1057, 1060-61 (Fed. Cir. 1988) (stating that a court has the
inherent power to appoint a special master).
532. See FED. R. CIV. P. 53.
533. See Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 72 F.3d 857, 867, 37
U.S.P.Q.2d (BNA) 1161, 1166 (Fed. Cir. 1995) (finding that the court did not abuse its
discretion in appointing a special master).
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10. Summary judgment
A district court must enter summary judgment in the absence of a
genuine dispute of material fact.534  The propriety of summary
judgment is a question of law that the Federal Circuit reviews de
novo.535  In addition, the Federal Circuit applies the relevant law of the
appropriate regional circuit based on the underlying claim.536
11. New trial
The Federal Rules of Civil Procedure permit a district court to
grant a new trial on all or part of the issues already tried.537  The
Federal Circuit generally defers to the law of the appropriate regional
circuit on such a consideration.538  The denial of a motion for new
trial can be reversed only if the district court abused its discretion.539
                                                 
534. Summary judgment is proper “if the pleadings, depositions, answers to interrogatories,
and admissions on file, together with the affidavits, . . . show that there is no genuine issue as to
any material fact and that the moving party is entitled to a judgment as a matter of law.”  FED. R.
CIV. P. 56(c).  Summary judgment is improper “if the evidence is such that a reasonable jury
could return a verdict for the nonmoving party.”  Anderson v. Liberty Lobby, Inc., 477 U.S. 242,
248 (1986).  When ruling on a motion for summary judgment, all of the nonmovant’s evidence
is to be believed,and all justifiable inferences are to be drawn in its favor.  See id. at 255.
535. See Aktiebolag v. E.J. Co., 121 F.3d 669, 672, 43 U.S.P.Q.2d (BNA) 1620, 1622 (Fed. Cir.
1997) (stating that a grant of summary judgment is reviewed de novo); Young Dental Mfg. Co. v.
Q3 Special Prods., Inc., 112 F.3d 1137, 1141, 42 U.S.P.Q.2d (BNA) 1589, 1592 (Fed. Cir. 1997)
(same); Ekchian v. Home Depot Inc., 104 F.3d 1299, 1302, 41 U.S.P.Q.2d (BNA) 1364, 1366
(Fed. Cir. 1997) (same); Cole v. Kimberly-Clark Corp., 102 F.3d 524, 528, 41 U.S.P.Q.2d (BNA)
1001, 1004 (Fed. Cir. 1996) (same); Petrolite Corp. v. Baker Hughes, Inc., 96 F.3d 1423, 1425,
40 U.S.P.Q.2d (BNA) 1201, 1203 (Fed. Cir. 1996) (same); Astra v. Lehman, 71 F.3d 1578, 1580,
37 U.S.P.Q.2d (BNA) 1212, 1214 (Fed. Cir. 1995) (same); Gasser Chair Co. v. Infanti Chair
Mfg. Corp., 60 F.3d 770, 773, 34 U.S.P.Q.2d (BNA) 1822, 1824 (Fed. Cir. 1995) (same);
Lantech, Inc. v. Keip Mach. Co., 32 F.3d 542, 545, 31 U.S.P.Q.2d (BNA) 1666, 1669 (Fed. Cir.
1994) (same); Stark v. Advanced Magnetics, Inc., 29 F.3d 1570, 1572-73, 31 U.S.P.Q.2d (BNA)
1290, 1292 (Fed. Cir. 1994) (same); Conroy v. Reebok Int’l, Ltd., 14 F.3d 1570, 1575, 29
U.S.P.Q.2d (BNA) 1373, 1377 (Fed. Cir. 1994) (same); Keystone Retaining Wall Sys., Inc. v.
Westrock, Inc., 997 F.2d 1444, 1449, 27 U.S.P.Q.2d (BNA) 1297, 1301 (Fed. Cir. 1993) (same);
Glaxo Operations UK Ltd. v. Quigg, 894 F.2d 392, 395, 13 U.S.P.Q.2d (BNA) 1628, 1630 (Fed.
Cir. 1990) (same).
536. See Carroll Touch, Inc. v. Electro Mechanical Sys., 15 F.3d 1573, 1583, 27 U.S.P.Q.2d
(BNA) 1836, 1844 (Fed. Cir. 1993) (applying Seventh Circuit law to determine the standard of
review for a grant of summary judgment) (citing Aetna Cas. & Sur. Co. v. Chicago Ins. Co., 994
F.2d 1254, 1256 (7th Cir. 1993)).
537. See FED. R. CIV. P. 59(a).
538. See Celeritas Techs., Ltd. v. Rockwell Int’l Corp., 150 F.3d 1354, 1358, 47 U.S.P.Q.2d
(BNA) 1516, 1519 (Fed. Cir. 1998) (relying on Ninth Circuit precedent and reviewing a denial
of a motion for a new trial under an abuse of discretion standard) (citing Landes Constr. Co. v.
Royal Bank of Canada, 833 F.2d 1365, 1371 (9th Cir. 1987)); Standard Havens Prods. Inc. v.
Gencor Indus., Inc., 953 F.2d 1360, 1367, 21 U.S.P.Q.2d (BNA) 1321, 1327 (Fed. Cir. 1991)
(relying on Eighth Circuit precedent and reviewing denial of a motion for a new trial under an
abuse of discretion standard) (citing Leichihman v. Pickwick Int’l, 814 F.2d 1263, 1267 (8th Cir.
1987)).
539. See DMI, Inc. v. Deere & Co., 802 F.2d 421, 427, 231 U.S.P.Q. (BNA) 276, 280 (Fed. Cir.
1986) (stating that the denial of a motion for a new trial is reviewed under an abuse of
discretion standard); Railroad Dynamics, Inc. v. A. Stucki Co., 727 F.2d 1506, 1512, 220
U.S.P.Q. (BNA) 929, 935-36 (Fed. Cir. 1984) (same).
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12. Relief from judgment
The Federal Rules of Civil Procedure permit a district court to
grant relief from the judgment for various reasons.540  In reviewing
rulings based on Rule 60(b), the Federal Circuit generally defers to
the law of the regional circuit in which the district court sits because
such rulings commonly involve procedural matters that are not
unique to patent law.541  The Federal Circuit reviews the district
court’s ruling under Rule 60(b) to determine whether an abuse of
discretion occurred.542
13. Contempt
A patent holder may bring contempt proceedings against a party
enjoined by court order from further infringement.543  The patent
holder must prove contempt by clear and convincing evidence.544
The Federal Circuit reviews for an abuse of discretion the district
court’s finding of contempt.545  Given the summary nature of
contempt proceedings, the Federal Circuit generally admonishes
against them.546
The district court may award damages in a civil contempt
proceeding, which requires proof of both the fact of injury to the
aggrieved party and the amount of damages the aggrieved party has
suffered.547  The Federal Circuit applies the relevant law of the
                                                 
540. See FED. R. CIV. P. 60(b).
541. See Fraige v. American-National Watermattress Corp., 996 F.2d 295, 299-300, 27
U.S.P.Q.2d (BNA) 1149, 1152-53 (Fed. Cir. 1993) (deferring to Ninth Circuit law to set aside a
jury verdict and order a new trial on the issue of patent validity); W.L. Gore & Assocs., Inc. v.
C.R. Bard, Inc., 977 F.2d 558, 561 n.3, 24 U.S.P.Q.2d (BNA) 1451, 1453 n.3 (Fed. Cir. 1992)
(applying Third Circuit law in declining to modify a consent order following a change of law);
Amstar Corp. v. Envirotech Corp., 823 F.2d 1538, 1550, 3 U.S.P.Q.2d (BNA) 1412, 1421 (Fed.
Cir. 1987) (applying Tenth Circuit law in reviewing the denial of a 60(b) motion since it
involved a procedural issue not unique to patent law); Ashland Oil, Inc. v. Delta Oil Prods.
Corp., 806 F.2d 1031, 1033, 1 U.S.P.Q.2d (BNA) 1073, 1075 (Fed. Cir. 1986).  But see Broyhill
Furniture Indus. Inc. v. Craftmaster Furniture Corp., 12 F.3d 1080, 1083, 29 U.S.P.Q.2d (BNA)
1283, 1285 (Fed. Cir. 1993) (“The issues before us are whether a consent judgment enjoining
infringement of a patent should be set aside pursuant to certain subsections of Rule 60(b)
following a judicial determination that the patent was procured through inequitable conduct in
the PTO.  Because we perceive a clear need for uniformity and certainty in the way the district
courts treat this issue, we resolve it as a matter of Federal Circuit law.”).
542. See Fraige, 996 F.2d at 297, 27 U.S.P.Q.2d (BNA) at 1150 (stating that an order denying
a Rule 60(b) motion is reviewed under an abuse of discretion standard).
543. See KSM Fastening Sys., Inc. v. H.A. Jones Co., 776 F.2d 1522, 1530, 227 U.S.P.Q. (BNA)
676, 682 (Fed. Cir. 1985) (stating that contempt proceedings can go forward only when there is
not more than a “colorable difference” between the patented devices).
544. See id., 227 U.S.P.Q. (BNA) at 682.
545. See id. at 1532, 227 U.S.P.Q. (BNA) at 684 (stating that without an abuse of discretion,
the Federal Circuit will defer to the district court’s ruling).
546. See id. at 1530, 227 U.S.P.Q. (BNA) at 682-83 (holding that allowing patentees to go
ahead in contempt proceedings would deter other parties from legitimate endeavors).
547. Graves v. Kemsco Group, Inc., 864 F.2d 754, 756, 9 U.S.P.Q.2d (BNA) 1404, 1406 (Fed.
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appropriate regional circuit.548  The Federal Circuit reviews the
district court’s award for an abuse of discretion and considers
whether the award was based on clearly erroneous factual findings.549
14. Settlement
The judicial system favors dispute resolution through voluntary
settlements.550  Accordingly, a party seeking to invalidate a settlement
agreement bears a heavy burden of persuasion.551  The Federal Circuit
reviews de novo trial court orders such as consent orders, consent
judgments, and consent decrees.552
15. Remand
On remand from the Federal Circuit, a district court may issue
rulings based implicitly or explicitly on its interpretation of the
appellate mandate.553  On subsequent appeal from such a ruling, the
Federal Circuit’s interpretation of its own mandate is a question of
law, which the court reviews de novo.554
The Federal Circuit reviews the district court’s refusal to allow the
parties to supplement the record on remand for abuse of discretion,
applying the appropriate regional circuit law.555
16. Writ of mandamus
The Federal Circuit has authority to issue extraordinary writs.556
Only when there has been a clear abuse of discretion or usurpation
                                                 
Cir. 1988).
548. See id. at 755, 9 U.S.P.Q.2d (BNA) at 1406 (stating that the court should apply the law
of the regional circuit in reviewing damage awards).
549. See id. at 756-57, 9 U.S.P.Q.2d (BNA) at 1407 (finding that the lower court has
discretion to determine the amount of damages and whether abuse of discretion existed).
550. See S & T Mfg. Co. v. County of Hillsborough, 815 F.2d 676, 678, 2 U.S.P.Q.2d (BNA)
1280, 1281 (Fed. Cir. 1987) (reiterating the well established notion that courts favor voluntary
settlement).
551. See id., 2 U.S.P.Q.2d (BNA) at 1281 (holding that a party attacking a settlement bears “a
properly heavy burden”).
552. See Laitram Corp. v. NEC Corp., 115 F.3d 947, 950, 42 U.S.P.Q.2d (BNA) 1897, 1899
(Fed. Cir. 1997) (stating that both consent order judgments and decrees are reviewed de novo)
(citing Kenny v. Quigg, 820 F.2d 665, 670 (4th Cir. 1987)); Turner v. Orr, 759 F.2d 817, 821
(11th Cir. 1985) (same); United States v. National Steel Corp., 767 F.2d 1176, 1183 (6th Cir.
1985) (same).
553. See Laitram, 115 F.3d at 951, 42 U.S.P.Q.2d (BNA) at 1900 (stating that the district
court’s interpretation should be consistent with the appellate mandate under a de novo
standard).
554. See id. at 950, 42 U.S.P.Q.2d (BNA) at 1899 (ruling that the court should interpret its
own appellate mandate under a de novo standard).
555. See Westvaco Corp. v. International Paper Co., 991 F.2d 735, 745, 26 U.S.P.Q.2d (BNA)
1353, 1362 (Fed. Cir. 1993) (holding that denial of a motion to supplement the record is
reviewed under an abuse of discretion standard).
556. See 28 U.S.C. § 1651 (1994).
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of judicial authority will orders under review by extraordinary writ be
overturned.557  The petitioner has the burden of establishing that its
right to obtain the writ is clear and indisputable.558
CONCLUSION
The standard of review employed by the Federal Circuit in patent-
related cases facilitates predictable outcomes based upon a
framework for the disposition of technology-based cases without
resort to uninformed or misinformed assessments of the underlying
scientific merits.  The explicit and faithful application of such
standards by the Federal Circuit will help alleviate public
dissatisfaction with the administration of U.S. patent protection by
dispelling any misapprehension that technical merit alone drives the
resolution of patent cases.  In the present climate of growing public
discord, charging the hindrance to innovation by a runaway scope of
patent protection, the Federal Circuit’s conduct in this regard will fall
under increasing scrutiny.
                                                 
557. See In re Regents of the Univ. of Cal., 964 F.2d 1128, 1135, 22 U.S.P.Q.2d (BNA) 1748,
1754 (Fed. Cir. 1992) (stating that the writ of mandamus is an extraordinary remedy requiring a
showing of judicial usurpation of power); Gulfstream Aerospace Corp. v. Mayacamas Corp., 485
U.S. 271, 289 (1988) (same); In re Calmar, Inc., 854 F.2d 461, 464, 7 U.S.P.Q.2d (BNA) 1713,
1715 (Fed. Cir. 1988) (same).
558. See Allied Chem. Corp. v. Daiflon, Inc., 449 U.S. 33, 35 (1980) (stating that the
petitioner must show that his/her right to issuance of the writ is clear and indisputable); In re
Regents of the Univ. of Cal., 101 F.3d 1386, 1387, 40 U.S.P.Q.2d (BNA) 1784, 1785 (Fed. Cir.
1996) (finding that the petitioner has the burden of showing that he/she has a clear and
indisputable right to the issuance of the writ).
